Netmeds Marketplace Limited Financial Statements for FY 2022

NETMEDS MARKETPLACE LIMITED
Standalone Financial Statements for period 01/04/2021 to 31/03/2022
(generated by PrivateCircle)
[110000] Balance sheet
Unless otherwise specified, all monetary values are in Lakhs of INR

Period FY 2022 FY 2021 FY 2020
Balance sheet [Abstract]
Assets [Abstract]
Non-current assets [Abstract]
Property, plant and equipment (A) 219.5 (B) 179.06 (C) 9,683.97
Goodwill 0 0
Other intangible assets 11.6 42.43 84.32
Non-current financial assets [Abstract]
Non-current investments 0 0
Loans, non-current 0 0
Other non-current financial assets 244.14 242.57
Total non-current financial assets 244.14 242.57
Other non-current assets 2,361.64 2,923.19
Total non-current assets 2,836.88 3,387.25
Current assets [Abstract]
Inventories 0 0
Current financial assets [Abstract]
Current investments 2,471.77 50
Trade receivables, current 360.55 3,340.59
Cash and cash equivalents 566.67 314.93
Bank balance other than cash and cash equivalents (D) 4.24 (E) 4.03
Loans, current 0 0
Other current financial assets 1,008.81 343.65
Total current financial assets 4,412.04 4,053.2
Other current assets 1,024.11 1,407.41
Total current assets 5,436.15 5,460.61
Total assets 8,273.03 8,847.86
Equity and liabilities [Abstract]
Equity [Abstract]
Equity attributable to owners of parent [Abstract]
Equity share capital 929.24 929.24 904.26
Other equity (F) 2,032.1 (G) 1,332.48
Total equity attributable to owners of parent 2,961.34 2,261.72
Total equity 2,961.34 2,261.72
Liabilities [Abstract]
Non-current liabilities [Abstract]
Non-current financial liabilities [Abstract]
Borrowings, non-current 0 0
Other non-current financial liabilities (H) 1.97 (I) 13.1
Total non-current financial liabilities 1.97 13.1
Provisions, non-current 221.36 204.2
Total non-current liabilities 223.33 217.3
Current liabilities [Abstract]
Current financial liabilities [Abstract]
NETMEDS MARKETPLACE LIMITED Standalone Financial Statements for period 01/04/2021 to 31/03/2022 (generated by PrivateCircle)
Borrowings, current 745.74 3,928.33

Trade payables, current (J) 1,713.81 (K) 793.7
Other current financial liabilities (L) 488.12 (M) 550.97
Total current financial liabilities 2,947.67 5,273
Other current liabilities 2,091.45 1,050.64
Provisions, current 49.24 45.2
Total current liabilities 5,088.36 6,368.84
Total liabilities 5,311.69 6,586.14
Total equity and liabilities 8,273.03 8,847.86
Footnotes
(A)
Particulars 2021-22
Property, plant and equipment 206.44
Right-of-use assets 13.06
Total 219.50
(B)
Particulars 2020-21
Total 179.06
(C)
Particulars 2019-20
Right-of-use assets 9,469.35
Total 9,683.97
(D) Deposits with maturity of more than 3 months and less than 12 months
(E) Deposits with maturity of more than 3 months and less than 12 months
(F)
Particulars 2021-22
Instruments classified as Equity 1,200.00
Reserves and surplus 832.10
Total 2,032.10
(G)
Particulars 2020-21
Instruments classified as Equity 1,580.00
Reserves and surplus (247.52)
Total 1,332.48
(H) Lease Liabilities
(I) Lease Liabilities
(J)
Particulars 2021-22
total outstanding dues of micro enterprises and small enterprises 16.53
total outstanding dues of creditors other than micro enterprises and small enterprises 1,697.28
Total 1,713.81
2
(K)
Particulars 2020-21
total outstanding dues of micro enterprises and small enterprises 28.70
total outstanding dues of creditors other than micro enterprises and small enterprises 765.00
Total 793.70
(L)
Particulars 2021-22
Lease Liabilities 11.13
Other Financial Liabilities 476.99
Total 488.12
(M)
Particulars 2020-21
Total 550.97
3
[210000] Statement of profit and loss

Period FY 2022 FY 2021
Statement of profit and loss [Abstract]
Income [Abstract]
Revenue from operations (A) 10,776.96 (B) 13,423.42
Other income 371.76 1,700.34
Total income 11,148.72 15,123.76
Expenses [Abstract]
Cost of materials consumed 0 0
Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
Employee benefit expense 2,268.13 2,540.99
Finance costs 144.12 943.52
Depreciation, depletion and amortisation expense 134.19 2,139.63
Other expenses 7,544.59 9,396.35
Total expenses 10,091.03 15,020.49
Profit before exceptional items and tax 1,057.69 103.27
Exceptional items before tax 0 (C) 1.5
Total profit before tax 1,057.69 104.77
Tax expense [Abstract]
Current tax 0 0
Total tax expense 0 0
Total profit (loss) for period from continuing operations 1,057.69 104.77
Total profit (loss) for period 1,057.69 104.77
Comprehensive income OCI components presented net of tax [Abstract]
Whether company has other comprehensive income OCI components presented net of tax Yes Yes
Other comprehensive income net of tax [Abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax
[Abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans 21.93 63.34
Total other comprehensive income that will not be reclassified to profit or loss, net of tax 21.93 63.34
Other comprehensive income that will be reclassified to profit or loss, net of tax, others 0 0
Total other comprehensive income that will be reclassified to profit or loss, net of tax 0 0
Total other comprehensive income 21.93 63.34
Total comprehensive income 1,079.62 168.11
Comprehensive income OCI components presented before tax [Abstract]
Whether company has comprehensive income OCI components presented before tax No No
Other comprehensive income before tax [Abstract]
Total other comprehensive income 21.93 63.34
Footnotes
(A)
Particulars 2021-22
Income from Services 12,760.52
Less: GST Recovered 1,983.56
Revenue from Operations 10,776.96
(B)
Particulars 2020-21
(C)
The Company, during the previous year, sold its entire stake in Netmeds Health Private Limited for Rs. 1.5 Lakh. The Company had earlier
impaired its investment and hence, entire sale proceed has been recognized as gain or loss on sale of investment.
Earnings per share [Table]

4
Classes of equity share capital [Axis] Equity shares [Member] Equity shares 1 [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Earnings per share [Abstract]
Earnings per share [Line items]
Basic earnings per share [Abstract]
Basic earnings (loss) per share from continuing operations [INR/shares] 5.69 [INR/shares] 0.57 [INR/shares] 5.69 [INR/shares] 0.57
Total basic earnings (loss) per share [INR/shares] 5.69 [INR/shares] 0.57 [INR/shares] 5.69 [INR/shares] 0.57
Diluted earnings per share [Abstract]
Diluted earnings (loss) per share from continuing operations [INR/shares] 1.92 [INR/shares] 0.33 [INR/shares] 1.92 [INR/shares] 0.33
Total diluted earnings (loss) per share [INR/shares] 1.92 [INR/shares] 0.33 [INR/shares] 1.92 [INR/shares] 0.33
5
[210000a] Statement of profit and loss

Other comprehensive income that will be reclassified to profit or loss, net of tax, others [Abstract]
Other comprehensive income that will be reclassified to profit or loss, net of tax, others [Line items]
Other comprehensive income that will be reclassified to profit or loss, net of tax, others 0 0
6
[310000] Cash flow statement,direct

Statement of cash flows [Abstract]
Whether cash flow statement is applicable on company Yes Yes
Cash flows from used in operating activities [Abstract]
Net cash flows from (used in) operations 6,278.37 -2,960.99
Income taxes paid (refund) -93.14 -59.67
Net cash flows from (used in) operating activities 6,371.51 -2,901.32
Cash flows from used in investing activities [Abstract]
Purchase of property, plant and equipment 143.81 55.74
Proceeds from sales of other long-term assets (A) 7,936.73 (B) 2,053.25
Purchase of other long-term assets (C) 10,340.03 (D) 2,100
Interest received 0.21 25.76
Other inflows (outflows) of cash (E) -0.21 (F) -0.26
Net cash flows from (used in) investing activities -2,547.11 -76.99
Cash flows from used in financing activities [Abstract]
Proceeds from issuing shares 0 1,309
Proceeds from issuing other equity instruments 0 (G) 790.03
Proceeds from issuing debentures notes bonds etc 0 1,580
Proceeds from borrowings 0 2,028.37
Repayments of borrowings 3,182.6 0
Payments of lease liabilities 11.95 2,360.29
Interest paid (H) -1.89 229.52
Other inflows (outflows) of cash -380 0
Net cash flows from (used in) financing activities -3,572.66 3,117.59
Net increase (decrease) in cash and cash equivalents before effect of exchange rate
changes 251.74 139.28
Net increase (decrease) in cash and cash equivalents 251.74 139.28
Cash and cash equivalents cash flow statement at end of period 566.67 314.93 175.65
Footnotes
(A) Proceeds from Sale of Financial instruments
(B) Proceeds from Sale of Financial instruments
(C) Purchase of Financial instruments
(D) Purchase of Financial instruments
(E) Deposits with bank (net)
(F) Deposits with bank (net)
(G) Equity Contribution
(H) Redemption of Debentures
7
[320000] Cash flow statement, indirect

Statement of cash flows [Abstract]
Whether cash flow statement is applicable on company Yes Yes
Profit before tax 1,057.69 104.77
Adjustments for reconcile profit (loss) [Abstract]
Adjustments for finance costs 0 943.52
Adjustments for decrease (increase) in trade receivables, current 2,980.04 -2,361.56
Adjustments for decrease (increase) in other current assets (A) 851.72 (B) 515.61
Adjustments for other financial assets, current -666.72 249.45
Adjustments for increase (decrease) in trade payables, current 919.65 -2,114.14
Adjustments for increase (decrease) in other current liabilities 1,142.87 -1,376.76
Adjustments for depreciation and amortisation expense 134.19 2,139.64
Adjustments for provisions, current 43.13 34.01
Adjustments for other financial liabilities, current -63.92 34.42
Adjustments for interest income 0.21 (C) 25.76
Adjustments for share-based payments 0 82.59
Other adjustments for which cash effects are investing or financing cash flow (D) -18.02 (E) -820.79
Other adjustments for non-cash items (F) -102.05 (G) -365.99
Total adjustments for reconcile profit (loss) 5,220.68 -3,065.76
Net cash flows from (used in) operations 6,278.37 -2,960.99
Income taxes paid (refund) -93.14 -59.67
Purchase of property, plant and equipment 143.81 55.74
Proceeds from sales of other long-term assets (H) 7,936.73 (I) 2,053.25
Purchase of other long-term assets (J) 10,340.03 (K) 2,100
Interest received 0.21 25.76
Other inflows (outflows) of cash (L) -0.21 (M) -0.26
Proceeds from issuing shares 0 1,309
Proceeds from issuing other equity instruments 0 (N) 790.03
Proceeds from issuing debentures notes bonds etc 0 1,580
Proceeds from borrowings 0 2,028.37
Repayments of borrowings 3,182.6 0
Payments of lease liabilities 11.95 2,360.29
Interest paid (O) -1.89 229.52
Other inflows (outflows) of cash -380 0
Net increase (decrease) in cash and cash equivalents before effect of exchange rate
changes 251.74 139.28
Net increase (decrease) in cash and cash equivalents 251.74 139.28
Cash and cash equivalents cash flow statement at end of period 566.67 314.93 175.65
Footnotes
(A) (Increase)/Decrease in other current and non-current assets
(B) (Increase)/Decrease in other current and non-current assets
(C) Interest income on refund of Income Tax
(D)
Particulars 2021-22
Unwinding of interest on security deposit (0.84)
Gain/ loss on Investment (17.18)
Total (18.02)
(E)
Particulars 2020-21
Unwinding of interest on security deposit (3.92)
8
Gain or loss on termination of lease (813.63)
Gain/ loss on Investment (1.50)
Net Gain on Financial Assets (1.74)
Total (820.79)
(F) Liabilities written back
(G)
Particulars 2020-21
Provision for financial guarantee contracts (210.40)
Provision for doubtful advances 24.71
Reversal of provision for doubtful balances (186.81)
Goodwill written off 9.40
Sundry Creditors written back (2.89)
Total (365.99)
(H) Proceeds from Sale of Financial instruments
(I) Proceeds from Sale of Financial instruments
(J) Purchase of Financial instruments
(K) Purchase of Financial instruments
(L) Deposits with bank (net)
(M) Deposits with bank (net)
(N) Equity Contribution
(O) Redemption of Debentures
9
[400100] Notes - Equity share capital

Textual
Disclosure of notes on equity share capital explanatory [Text Block] Information (1)
Disclosure of reduction in capital [Abstract]
Whether reduction in capital done during year No No
Disclosure of public offering [Abstract]
Whether money raised from public offering during year No No
Disclosure of classes of equity share capital [Table] ..(1)

Classes of equity share capital [Axis] Equity shares [Member]
Disclosure of classes of equity share capital [Abstract]
Disclosure of classes of equity share capital [Line items]
[shares] [shares]
Number of shares authorised 20,000,000 20,000,000
Value of shares authorised 1,000 1,000
[shares] [shares]
Number of shares issued 18,584,788 18,584,788
Value of shares issued 929.24 929.24
[shares] [shares]
Number of shares subscribed and fully paid 18,584,788 18,584,788
Value of shares subscribed and fully paid 929.24 929.24
Number of shares subscribed but not fully paid [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0
[shares] [shares]
Total number of shares subscribed 18,584,788 18,584,788
Total value of shares subscribed 929.24 929.24
Value of shares paid-up [Abstract]
[shares] [shares]
Number of shares paid-up 18,584,788 18,584,788
Value of shares called 929.24 929.24
Value of shares paid-up 929.24 929.24
Reconciliation of number of shares outstanding [Abstract]
Changes in number of shares outstanding [Abstract]
Increase in number of shares outstanding [Abstract]
Number of other issues of shares [shares] 0 [shares] 499,616
Total aggregate number of shares issued during period [shares] 0 [shares] 499,616
Total increase (decrease) in number of shares outstanding [shares] 0 [shares] 499,616
[shares] [shares] [shares]
Number of shares outstanding at end of period 18,584,788 18,584,788 18,085,172
Reconciliation of value of shares outstanding [Abstract]
Changes in equity share capital [Abstract]
Increase in equity share capital during period [Abstract]
Amount of other issues during period 0 24.98
Total aggregate amount of increase in equity share capital during period 0 24.98
Total increase (decrease) in share capital 0 24.98
Equity share capital at end of period 929.24 929.24 904.26
Shares in company held by holding company or ultimate holding company or by its
subsidiaries or associates [Abstract]
[shares] [shares]
Shares in company held by holding company 18,584,788 18,584,788
Total shares in company held by holding company or ultimate holding company or [shares] [shares]
by its subsidiaries or associates 18,584,788 18,584,788
Details of application money received for allotment of securities and due for refund
and interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund and
interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund,
interest accrued 0 0
Total application money received for allotment of securities and due for refund
and interest accrued thereon 0 0
Disclosure of classes of equity share capital [Table] ..(2)
10

Classes of equity share capital [Axis] Equity shares 1 [Member]
Disclosure of classes of equity share capital [Abstract]
Disclosure of classes of equity share capital [Line items]
Type of share Equity share Equity share
[shares] [shares]
Number of shares authorised 20,000,000 20,000,000
Value of shares authorised 1,000 1,000
[shares] [shares]
Number of shares issued 18,584,788 18,584,788
Value of shares issued 929.24 929.24
[shares] [shares]
Number of shares subscribed and fully paid 18,584,788 18,584,788
Value of shares subscribed and fully paid 929.24 929.24
Number of shares subscribed but not fully paid [shares] 0 [shares] 0
Value of shares subscribed but not fully paid 0 0
[shares] [shares]
Total number of shares subscribed 18,584,788 18,584,788
Total value of shares subscribed 929.24 929.24
Value of shares paid-up [Abstract]
[shares] [shares]
Number of shares paid-up 18,584,788 18,584,788
Value of shares called 929.24 929.24
Value of shares paid-up 929.24 929.24
Par value per share [INR/shares] 5 [INR/shares] 5
Amount per share called in case shares not fully called [INR/shares] 0 [INR/shares] 0
Reconciliation of number of shares outstanding [Abstract]
Changes in number of shares outstanding [Abstract]
Increase in number of shares outstanding [Abstract]
Number of other issues of shares [shares] 0 [shares] 499,616
Total aggregate number of shares issued during period [shares] 0 [shares] 499,616
Total increase (decrease) in number of shares outstanding [shares] 0 [shares] 499,616
[shares] [shares] [shares]
Number of shares outstanding at end of period 18,584,788 18,584,788 18,085,172
Reconciliation of value of shares outstanding [Abstract]
Changes in equity share capital [Abstract]
Increase in equity share capital during period [Abstract]
Amount of other issues during period 0 24.98
Total aggregate amount of increase in equity share capital during period 0 24.98
Total increase (decrease) in share capital 0 24.98
Textual Textual
Rights preferences and restrictions attaching to class of share capital Information (2) Information (3)
Shares in company held by holding company or ultimate holding company or by its
subsidiaries or associates [Abstract]
[shares] [shares]
Shares in company held by holding company 18,584,788 18,584,788
Total shares in company held by holding company or ultimate holding company or [shares] [shares]
by its subsidiaries or associates 18,584,788 18,584,788
Details of application money received for allotment of securities and due for refund
and interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund and
interest accrued thereon [Abstract]
Application money received for allotment of securities and due for refund,
interest accrued 0 0
Total application money received for allotment of securities and due for refund
and interest accrued thereon 0 0
Disclosure of shareholding more than five per cent in company [Table] ..(1)

Classes of equity share capital [Axis] Equity shares [Member]
Name of shareholder [Axis] Name of shareholder [Member]
Disclosure of shareholding more than five per cent in company [Abstract]
Whether there are any shareholders holding more than five per cent shares in company Yes Yes
Disclosure of shareholding more than five per cent in company [Table] ..(2)
11

Classes of equity share capital [Axis] Equity shares 1 [Member]
Name of shareholder [Axis] Name of shareholder [Member] Shareholder 1 [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of shareholding more than five per cent in company
[Abstract]
Disclosure of shareholding more than five per cent in company
[Line Items]
Type of share Equity share Equity share Equity share Equity share
TRESARA TRESARA
HEALTH HEALTH
Name of shareholder LIMITED LIMITED
U74900TN2015P U74900TN2015P
CIN of shareholder LC101916 LC101916
Country of incorporation or residence of shareholder INDIA INDIA
[shares] [shares]
Number of shares held in company 18,584,788 18,584,788
Percentage of shareholding in company 100% 100%
Textual information (1): Disclosure of notes on equity share capital explanatory [Text Block]
Share Capital
As at As at
March 31, 2022 March 31, 2021
Share Capital
Authorised:
20,000,000 Equity shares of Rs. 5 each (20,000,000) 1,000.00 1,000.00
Total 1,000.00 1,000.00
Issued, Subscribed and Paid-Up:
18,584,788 Equity shares of Rs. 5 each (18,584,788) 929.24 929.24
Total 929.24 929.24
Figures in bracket represents Previous year's figures.

1. The details of Shares held by the holding company
As at As at
March 31, 2022 March 31, 2021
No. of Shares % held No. of Shares % held
Equity shares of Rs. 5 each
Tresara Health Limited*# 18,584,788 100.00% 18,584,788 100.00%
* Includes shares held by nominees

# formerly Tresara Health Private Limited
2. Shareholding of Promoter
As at March 31, 2022
No of Shares at the Change during No of Shares at the % of Total % change during

S. No. Promoter Name
beginning of the year the year end of the year Shares the year
Fully Paid up Equity Shares of

Rs. 5 each
1 Tresara Health Limited* 18,584,788 - 18,584,788 100.00% 0.00%
As at March 31, 2021
No of Shares at the Change during No of Shares at the % of Total % change during

S. No. Promoter Name
beginning of the year the year end of the year Shares the year
Fully Paid up Equity Shares of

Rs. 5 each
1 Tresara Health Limited* 18,584,788 - 18,584,788 100.00% 0.00%
* formerly Tresara Health Private Limited

3. The details of Shareholders holding more than 5% shares :
12
As at As at
March 31, 2022 March 31, 2021
Name of the Shareholders No. of Shares % held No. of Shares % held
Tresara Health Limited* 18,584,788 100% 18,584,788 100%
4. The Reconciliation of the number of shares outstanding is set out below :
As at As at
Particulars March 31, 2022 March 31, 2021
No. of shares No. of shares
Equity shares of Rs. 5 each
Equity Shares outstanding at the beginning of the year 18,584,788 18,085,172
Add: Equity Shares issued during the year - 499,616
Equity Shares outstanding at the end of the year 18,584,788 18,584,788
5. Rights, Preference and Restrictions

The Company has only one class of equity shares having a par value of Rs. 5 per share. Each shareholder is eligible for one vote per share held.
The dividend proposed, if any by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting,
except in case of interim dividend. In the event of liquidation, the equity shareholders are eligible to receive the remaining assets of the Company
after distribution of all preferential amounts, in proportion to their shareholding.
Textual information (2): Rights preferences and restrictions attaching to class of share capital
Textual information (3): Rights preferences and restrictions attaching to class of share capital
13
[400200] Statement of changes in equity

Textual
Disclosure of notes on changes in equity [Text Block] Information (4)
Statement of changes in equity [Abstract]
Equity share capital [Abstract]
Increase (decrease) in share capital 0 24.98
Statement of changes in equity [Table] ..(1)

Components of equity [Axis] Equity [Member]
Other equity [Abstract]
Statement of changes in equity [Line items]
Equity [Abstract]
Changes in equity [Abstract]
Comprehensive income [Abstract]
Profit (loss) for period 1,057.69 104.77
Changes in comprehensive income components 21.93 63.34
Other changes in equity [Abstract]
Other changes in equity, others -380 3,485.31
Total other changes in equity -380 3,485.31
Total increase (decrease) in equity 699.62 3,653.42
Other equity at end of period 2,032.1 1,332.48 -2,320.94

Components of equity [Axis] Equity attributable to the equity holders of the parent [Member]
Equity [Abstract]
Other changes in equity, others -380 3,485.31
Total other changes in equity -380 3,485.31
Total increase (decrease) in equity 699.62 3,653.42
Other equity at end of period 2,032.1 1,332.48 -2,320.94

Components of equity [Axis] Equity component of financial instrument [Member]
Equity [Abstract]
Profit (loss) for period 0 0
Total comprehensive income 0 0
Other changes in equity, others (A) -380 (B) 1,580
Total other changes in equity -380 1,580
Total increase (decrease) in equity -380 1,580
Other equity at end of period 1,200 1,580 0
14
Footnotes
(A) Redemption of Instrument Classified as Equity
(B) Issue of Optionally fully convertible debentures

Components of equity [Axis] Reserves [Member]
Equity [Abstract]
Other changes in equity, others 0 1,905.31
Total other changes in equity 0 1,905.31
Total increase (decrease) in equity 1,079.62 2,073.42
Other equity at end of period 832.1 -247.52 -2,320.94

Components of equity [Axis] Securities premium reserve [Member]
Equity [Abstract]
Other changes in equity, others 0 1,284.02
Total other changes in equity 0 1,284.02
Total increase (decrease) in equity 0 1,284.02
Other equity at end of period 45,246.6 45,246.6 43,962.58

Components of equity [Axis] Employee stock options outstanding [Member]
Equity [Abstract]
Other changes in equity, others 0 (A) -168.74
Total other changes in equity 0 -168.74
Total increase (decrease) in equity 0 -168.74
Other equity at end of period 0 0 168.74
Footnotes
(A)
Particulars 2020-21
Lapse of employee stock options (21.61)
15
Transfer to Employee stock option liability (147.13)
Total (168.74)

Components of equity [Axis] Retained earnings [Member]
Equity [Abstract]
Other changes in equity, others 0 0
Total other changes in equity 0 0
Total increase (decrease) in equity 1,079.62 168.11
Other equity at end of period -45,204.53 -46,284.15 -46,452.26

Components of equity [Axis] Other retained earning [Member]
Equity [Abstract]
Other changes in equity, others 0 0
Total other changes in equity 0 0
Total increase (decrease) in equity 1,079.62 168.11
Other equity at end of period -45,204.53 -46,284.15 -46,452.26

Components of equity [Axis] Other reserves [Member]
Equity [Abstract]
Other changes in equity, others 0 (A) 790.03
Total other changes in equity 0 790.03
Total increase (decrease) in equity 0 790.03
Other equity at end of period 790.03 790.03 0
DEEMED DEEMED
EQUITY EQUITY
CONTRIBUTION CONTRIBUTION
- GROUP SHARE - GROUP SHARE
BASED BASED
PAYMENT PAYMENT
Description of nature of other reserves SCHEME SCHEME
Footnotes
16
(A) Received from Holding Company
Textual information (4): Disclosure of notes on changes in equity [Text Block]
Other Equity
1. Instruments Classified as Equity
As at As at
March 31, 2022 March 31, 2021
12,000 0.001% Optionally Fully Convertible Debentures Face

1,200.00 1,580.00
Value Rs.10,000 (15,800)
Total 1,200.00 1,580.00
Figures in bracket represents Previous year's figures.

ii) Terms of 0.001% Optionally Fully Convertible Debentures
Instruments classified as Equity includes 12,000 fully paid (previous year: 15,800) 0.001% Unsecured Optionally Fully Convertible Debentures
(OFCDs) of Face Value Rs.10,000 each held by Tresara Health Limited (formerly Tresara Health Private Limited) (Holding Company). The
Company (issuer) has an option for early conversion at any time after allotment of the OFCDs by giving one month notice to the Holder.
The instrument is convertible into 2,000 equity shares for every 1 OFCD held, at the option of the Company at any time. Equity Shares arising out
of conversion of the OFCDs will rank pari-passu in all respects with the then outstanding Equity Shares of the Company on the date of such
conversion, except for dividend, which if declared, shall be paid on pro-rata basis from the date of allotment of such Equity Shares. The Company
will settle the outstanding OFCDs on expiry of 10 years. OFCDs may be redeemed at any time earlier than 10 years (at any date after expiry of
30 days from the date of allotment of the OFCDs) at the option of the Company. Since the OFCDs are unsecured, no security is required to be
created.
iii) The reconciliation of the number of 0.001% Optionally Fully Convertible Debentures Face Value Rs.10,000 outstanding is set out below :
As at As at
Particulars March 31, 2022 March 31, 2021
No of Debentures No of Debentures
Outstanding at the beginning of the year 15,800 -
Add: Issued during the year - 15,800
Less: Redeemed during the year (3,800) -
Outstanding at the end of the year 12,000 15,800
2 Reserves and Surplus
As at As at
March 31, 2022 March 31, 2021
Reserves and Surplus
i) Securities Premium
Balance at the Beginning of the Year 45,246.60 43,962.58
Add: On issue of equity shares - 1,284.02
Balance at the End of the Year 45,246.60 45,246.60
ii) Retained Earnings
Balance at the Beginning of the Year (46,284.15) (46,452.26)
Add: Profit / (loss) for the year 1,057.69 104.77
Add: Items of other comprehensive income directly recognised in retained

earnings
Remeasurements of post-employment benefit obligations (net of tax) 21.93 63.34
Balance at the End of the Year (45,204.53) (46,284.15)
iii) Deemed Equity Contribution - Group Share-based payment scheme
Balance at the Beginning of the Year 790.03 -
Add: Received From Holding Company / Fellow Subsidiary - 790.03
Balance at the End of the Year 790.03 790.03
17
iv) Employees stock option reserve
Balance at the Beginning of the Year - 168.74
Less: Employee stock option expense/(lapse) of employee stock option (refer

- (21.61)
note 24.1)
Less: Transfer to employee stock option liability - (147.13)
Balance at the End of the Year - -
Total 832.10 (247.52)
v) Nature and purpose of reserves

Securities premium
Securities premium is used to record the premium on issue of shares. It is utilised in accordance with the provisions of the Companies Act, 2013.
Retained earnings / General reserves
Company's cumulative loss since its formation minus dividends. These are available for distribution.
Deemed Equity Contribution - Group Share-based payment scheme
Represents amounts paid by Reliance Retail Ventures Limited through Vitalic Health Private Limited (erstwhile Holding company) to compensate
the ESOP Holders of Vitalic ESOP 2019 of subsidiary company Netmeds Marketplace Limited.
Employees stock option reserve
Share-based compensation benefits provided to employees via the "Vitalic ESOP 2019" plan, an employee share scheme by the Company's
erstwhile ultimate holding company Vitalic Health Private Limited was discontinued in the previous year vide resolution passed in the
Extraordinary General Meeting of Vitalic Health Private Limited (erstwhile ultimate Holding company) held on 15th June 2020 and cancellation of
all options under the plan((Refer Note 22.2). Accordingly, the reserve is reversed during the previous year.
The option was treated as an equity-settled share-based payment as the Company did not have an obligation to settle the award. The fair value
of options granted under the plan was recognised as an employee benefits expense with a corresponding increase in equity. The total amount to
be expensed was determined by reference to the fair value of the options granted:
a. excluding the impact of any service and non-market performance vesting conditions (e.g. remaining an employee of the entity over a specified
time period), and
b. including the impact of any non-vesting conditions (e.g. the requirement for employees to save or hold shares for a specific period of time).
The total expense was supposed to be recognised over the vesting period, which was the period over which all of the specified vesting conditions
were to be satisfied. At the end of each period, any revision to the estimates of the number of options that were expected to vest based on the
non-market vesting and service conditions, if any, were supposed to be recognised, in profit or loss, with a corresponding adjustments to equity.
Share options outstanding account
The employees stock option reserve is used to recognise the grant date fair value of options issued to employees under Vitalic ESOP 2019 plan.
18
[400300] Notes - Borrowings

Period FY 2022
Textual
Disclosure of notes on borrowings explanatory [Text Block] Information (5)
Classification of borrowings [Table]

Classification based on current non-current [Axis] Current [Member]
Loans and advances from related parties
Classification of borrowings [Axis] [Member] Loans and advances from others [Member]
Subclassification of borrowings [Axis] Unsecured borrowings [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Details of borrowings [Abstract]
Details of borrowings [Line items]
Borrowings 745.74 3,928.33 745.74 3,928.33
Textual information (5): Disclosure of notes on borrowings explanatory [Text Block]
Borrowings - Current
As at As at
March 31, 2022 March 31, 2021
Unsecured - At amortised Cost
Loans from related parties 745.74 3928.33
Total 745.74 3928.33
(i) Unsecured loan from Vitalic Health Private Limited (Current Year: Rs. 745.74 lakhs and Previous Year: Rs. 2,338.33 lakhs) and Reliance
Retail Ventures Limited (Current Year: Rs. Nil and Previous Year: Rs. 1,590 lakhs) are repayable on demand and carries a interest rate of 7.5%
p.a (Previous Year 8.5% p.a. on loan from Vitalic Health Private Limited and 12.5% p.a. on loan from Reliance Retail Ventures Limited up to
August 18, 2020 and 7% p.a. on both loans after August 18, 2020 until March 31,2021)
1. Refer note 31.2 on Liquidity Risk for maturity profile.
2. Net Debt Reconciliation
This section sets out an analysis of net debt and the movements in net debt for each of the periods presented
As at As at
March 31, 2022 March 31, 2021
Cash and Cash Equivalents 566.67 314.93
Current Investments 2,471.77 50.00
Lease liabilities (13.10) (23.16)
Current borrowings (745.74) (3,928.33)
2,279.60 (3,586.56)
Liabilities from
Other Assets
Financing Activities
Cash and Cash Current Non Current

Current Borrowings Lease Liabilities
Equivalents Investments Borrowings
Net debt as at March 31, 2020 175.65 - (1,899.96) - (9,945.98)
Cash flows 139.28 50.00 1,754.75 (3,698.81) 2,360.30
Additions - - - - -
Interest expense - - - (229.52) (714.00)
Termination of Lease/Loan - - 145.21 0.00 8,276.52
Net debt as at March 31, 2021 314.93 50.00 - (3,928.33) (23.16)
Cash flows 251.74 2,421.77 - 3,182.59 10.06
Additions - - - - -
19
Interest expense - - - 142.23 (1.89)
Interest paid - - - (142.23) 1.89
Net debt as at March 31, 2022 566.67 2,471.77 - (745.74) (13.10)
20
[400500] Notes - Current investments

Current investments [Abstract]
Aggregate amount of quoted current investments 0 0
Market value of quoted current investments 0 0
Aggregate amount of unquoted current investments 2,471.77 50
Aggregate provision for diminution in value of current investments 0 0
Details of current investments [Table]

Classification of current investments [Axis] Current investment 1
Disclosure of details of current investments [Abstract]
Details of current investments [Line items]
Investments in Investments in
Type of current investments mutual funds mutual funds
Current Current
Class of current investments investments investments
Nature of current investments Unquoted Unquoted
Current investments 2,471.77 50
Investments Investments
Measured at Fair Measured at Fair
Value Through Value Through
Profit and Loss Profit and Loss
Basis of valuation of current investments (FVTPL) (FVTPL)
21
[400600] Notes - Property, plant and equipment
Disclosure of detailed information about property, plant and equipment [Table] ..(1)

Classes of property, plant and equipment [Axis] Property, plant and equipment [Member]
Sub classes of property, plant and equipment [Axis] Owned and leased assets [Member]
Carrying amount accumulated depreciation and gross carrying amount [Axis] Carrying amount [Member]
Disclosure of detailed information about property, plant and equipment [Abstract]
Disclosure of detailed information about property, plant and equipment [Line items]
Reconciliation of changes in property, plant and equipment [Abstract]
Changes in property, plant and equipment [Abstract]
Additions other than through business combinations, property, plant and
equipment 143.81 55.72
Depreciation, property, plant and equipment [Abstract]
Depreciation recognised in profit or loss -103.36 -2,097.74
Total Depreciation property plant and equipment -103.36 -2,097.74
Disposals and retirements, property, plant and equipment [Abstract]
Disposals, property, plant and equipment 0.01 7,462.89
Total disposals and retirements, property, plant and equipment 0.01 7,462.89
Total increase (decrease) in property, plant and equipment 40.44 -9,504.91
Property, plant and equipment at end of period (A) 219.5 (B) 179.06 (C) 9,683.97
Footnotes
(A)
Particulars 2021-22
Total 219.50
(B)
Particulars 2020-21
Total 179.06
(C)
Particulars 2019-20
Right-of-use assets 9,469.35
Total 9,683.97

Carrying amount accumulated depreciation and gross carrying amount [Axis] Gross carrying amount [Member]
Disposals, property, plant and equipment 0.01 12,085.49
Total disposals and retirements, property, plant and equipment 0.01 12,085.49
22
Property, plant and equipment at end of period 818.57 674.77 12,704.54

Carrying amount accumulated depreciation and gross carrying amount [Axis] Accumulated depreciation and impairment [Member]
Depreciation recognised in profit or loss 103.36 2,097.74
Total Depreciation property plant and equipment 103.36 2,097.74
Disposals, property, plant and equipment 0 4,622.6
Total disposals and retirements, property, plant and equipment 0 4,622.6

Sub classes of property, plant and equipment [Axis] Assets held under lease [Member]
equipment 10.94 0
Total increase (decrease) in property, plant and equipment -4.66 -9,459.14

equipment 10.94 0
23

Sub classes of property, plant and equipment [Axis] Owned assets [Member]
Depreciation recognised in profit or loss -87.76 -101.49
Total Depreciation property plant and equipment -87.76 -101.49
Disposals, property, plant and equipment 0.01 0
Total disposals and retirements, property, plant and equipment 0.01 0
Total increase (decrease) in property, plant and equipment 45.1 -45.77
Property, plant and equipment at end of period 185.33 140.23 186

Total increase (decrease) in property, plant and equipment 132.86 55.72
Property, plant and equipment at end of period 634.81 501.95 446.23

24
Depreciation recognised in profit or loss 87.76 101.49

Total Depreciation property plant and equipment 87.76 101.49
Disposals, property, plant and equipment 0 0
Total disposals and retirements, property, plant and equipment 0 0

Classes of property, plant and equipment [Axis] Buildings [Member]
equipment 0 0
Total increase (decrease) in property, plant and equipment -10.46 -9,445.83

equipment 0 0
Total increase (decrease) in property, plant and equipment 0 -12,085.49

25

Classes of property, plant and equipment [Axis] Furniture and fixtures [Member]
equipment 0 0
Total increase (decrease) in property, plant and equipment -6.92 -9.32
Property, plant and equipment at end of period 19.76 26.68 36

equipment 0 0
Total increase (decrease) in property, plant and equipment -0.01 0


Classes of property, plant and equipment [Axis] Office equipment [Member]
26

equipment 1.64 0
Total increase (decrease) in property, plant and equipment -3.52 -9.54

equipment 1.64 0
Total increase (decrease) in property, plant and equipment 1.64 0


Classes of property, plant and equipment [Axis] Computer equipments [Member]
27




Classes of property, plant and equipment [Axis] Leasehold improvements [Member]
equipment 10.94 0
28

equipment 10.94 0
Total increase (decrease) in property, plant and equipment 10.94 0

Disclosure of additional information about property plant and equipment [Table] ..(1)

Classes of property, plant and equipment [Axis] Buildings [Member] Furniture and fixtures [Member]
Sub classes of property, plant and equipment [Axis] Assets held under lease [Member] Owned assets [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of additional information about property plant and
equipment [Abstract]
equipment [Line items]
Straight-line Straight-line Written down Written down
Depreciation method, property, plant and equipment method method value method value method
Short-term leases Short-term leases
are leases with a are leases with a
Useful lives or depreciation rates, property, plant and lease term of 12 lease term of 12
equipment months or less. months or less. 10 years 10 years
Whether property, plant and equipment are stated at revalued
amount No No No No
29
Classes of property, plant and equipment [Axis] Office equipment [Member] Computer equipments [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
equipment [Abstract]
equipment [Line items]
Written down Written down Written down Written down
Depreciation method, property, plant and equipment value method value method value method value method
Servers and Servers and
networks - 6 networks - 6
years, End user years, End user
devices, such as devices, such as
Useful lives or depreciation rates, property, plant and laptops, desktops, laptops, desktops,
equipment 5 years 5 years etc. - 3 years etc. - 3 years
Whether property, plant and equipment are stated at revalued
amount No No No No

Disclosure of additional information about property plant and equipment [Abstract]
Disclosure of additional information about property plant and equipment [Line items]
Written down Written down
Depreciation method, property, plant and equipment value method value method
Useful lives or depreciation rates, property, plant and equipment 3 years 3 years
Whether property, plant and equipment are stated at revalued amount No No
30
[400700] Notes - Investment property

Depreciation method, investment property, cost model Not Applicable Not Applicable
Useful lives or depreciation rates, investment property, cost model Not Applicable Not Applicable
31
[400800] Notes - Goodwill
Disclosure of reconciliation of changes in goodwill [Table]

Carrying amount accumulated amortization and impairment and gross carrying amount [Axis] Carrying amount [Member]
Disclosure of reconciliation of changes in goodwill [Abstract]
Disclosure of reconciliation of changes in goodwill [Line items]
Goodwill at end of period 0 0
32
[400900] Notes - Other intangible assets

Whether there are intangible assets with indefinite useful life No No
Disclosure of detailed information about other intangible assets [Table] ..(1)

Classes of other intangible assets [Axis] Company other intangible assets [Member]
Internally generated and other than internally generated intangible
Sub classes of other intangible assets [Axis] assets [Member]
Carrying amount accumulated amortization and impairment and gross carrying amount
[Axis] Carrying amount [Member]
Disclosure of detailed information about other intangible assets [Abstract]
Disclosure of detailed information about other intangible assets [Line items]
Reconciliation of changes in other intangible assets [Abstract]
Changes in Other intangible assets [Abstract]
Additions other than through business combinations 0 0
Amortisation other intangible assets -30.83 -41.89
Total increase (decrease) in Other intangible assets -30.83 -41.89
Other intangible assets at end of period 11.6 42.43 84.32

[Axis] Gross carrying amount [Member]
Total increase (decrease) in Other intangible assets 0 0

[Axis] Accumulated amortization and impairment [Member]
Amortisation other intangible assets 30.83 41.89
Total increase (decrease) in Other intangible assets 30.83 41.89

Sub classes of other intangible assets [Axis] Intangible assets other than internally generated [Member]
33




Classes of other intangible assets [Axis] Computer software [Member]

34


Classes of other intangible assets [Axis] Licenses and franchise [Member]
Amortisation other intangible assets 0 0
Other intangible assets at end of period 0 0 0


Amortisation other intangible assets 0 0
35
Classes of other intangible assets [Axis] Other intangible assets [Member]

Other intangible assets at end of period 0 3.18 8.41



Classes of other intangible assets [Axis] Other intangible assets, others [Member]
Nature of other intangible assets others Non Compete Fee Non compete fee
Other intangible assets at end of period 0 3.18 8.41
36

Disclosure of additional information about other intangible assets [Table] ..(1)

Classes of other intangible assets [Axis] Computer software [Member] Licenses and franchise [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of additional information about other intangible assets
[Abstract]
Disclosure of additional information about other intangible
assets [Line items]
Straight-line Straight-line Straight-line Straight-line
Amortisation method, other intangible assets method method method method
Useful lives or amortisation rates, other intangible assets 4 years 4 years 4 years 4 years
Whether other intangible assets are stated at revalued amount No No No No
Disclosure of additional information about other intangible assets [Table] ..(2)

Classes of other intangible assets [Axis] Other intangible assets [Member] Other intangible assets, others [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of additional information about other intangible assets
[Abstract]
Disclosure of additional information about other intangible
assets [Line items]
Straight-line Straight-line Straight-line Straight-line
Amortisation method, other intangible assets method method method method
Non compete fee : Non compete fee : Non compete fee : Non compete fee :
Useful lives or amortisation rates, other intangible assets 3 years 3 years 3 years 3 years
Whether other intangible assets are stated at revalued amount No No No No
37
[401000] Notes - Biological assets other than bearer plants

Depreciation method, biological assets other than bearer plants, at cost Not Applicable Not Applicable
Useful lives or depreciation rates, biological assets other than bearer plants, at cost Not Applicable Not Applicable
38
[401100] Notes - Subclassification and notes on liabilities and assets

Subclassification and notes on liabilities and assets [Abstract]
Disclosure of notes on trade receivables [Abstract]
Textual
Disclosure of notes on trade receivables explanatory [Text Block] Information (6)
Other non-current financial assets notes [Abstract]
Other non-current financial assets [Abstract]
Other non-current financial assets, others 244.14 242.57
Total other non-current financial assets 244.14 242.57
Other non-current assets notes [Abstract]
Other non-current assets [Abstract]
Advances, non-current 2,361.64 2,923.19
Total other non-current assets 2,361.64 2,923.19
Cash and bank balances notes [Abstract]
Cash and bank balances [Abstract]
Classification of cash and bank balances [Abstract]
Cash and cash equivalents [Abstract]
Balance with banks [Abstract]
Fixed deposits with banks 0 0
Other balances with banks (A) 547.62 (B) 314.9
Total balance with banks 547.62 314.9
Cheques, drafts on hand 19.02 0
Cash on hand 0.03 0.03
Total cash and cash equivalents 566.67 314.93
Bank balance other than cash and cash equivalents (C) 4.24 (D) 4.03
Total cash and bank balances 570.91 318.96
Details of balances held with banks to extent held as margin money or security against borrowings,
guarantees or other commitments [Abstract]
Balances held with banks to extent held against other commitments 0 0
Total balances held with banks to extent held as margin money or security against borrowings,
guarantees or other commitments 0 0
Bank deposits with more than 12 months maturity 0 0
Other current financial assets [Abstract]
Textual
Disclosure of notes on other current financial assets explanatory [Text Block] Information (7)
Other current financial assets others 1,008.81 343.65
Total other current financial assets 1,008.81 343.65
Other current assets notes [Abstract]
Other current assets [Abstract]
Advances, current 1,024.11 1,407.41
Total other current assets 1,024.11 1,407.41
Disclosure of other non-current financial liabilities notes [Abstract]
Other non-current financial liabilities [Abstract]
Other non-current financial liabilities, others 1.97 13.1
Total other non-current financial liabilities (E) 1.97 (F) 13.1
Disclosure of other current financial liabilities notes [Abstract]
Other current financial liabilities [Abstract]
Interest accrued on borrowings 0 0
Interest accrued on public deposits 0 0
Interest accrued others 0 0
Unpaid dividends 0 0
Application money received for allotment of securities and due for refund and interest accrued thereon
[Abstract]
Application money received for allotment of securities and due for refund, interest accrued 0 0
Total application money received for allotment of securities and due for refund and interest accrued
thereon 0 0
Unpaid matured deposits and interest accrued thereon 0 0
Unpaid matured debentures and interest accrued thereon 0 0
Debentures claimed but not paid 0 0
Public deposit payable, current 0 0
Other current financial liabilities, others 488.12 550.97
Total other current financial liabilities (G) 488.12 (H) 550.97
Disclosure of other current liabilities notes [Abstract]
Other current liabilities [Abstract]
Revenue received in advance 45.42 38.21
39
Other advance [Abstract]

Advance received from customers 4.72 4.45
Total other advance 4.72 4.45
Other payables, current [Abstract]
Taxes payable other tax (I) 88.05 (J) 199.52
Current liabilities portion of share application money pending allotment 0 0
Total other payables, current 88.05 199.52
Other current liabilities, others 1,953.26 808.46
Total other current liabilities 2,091.45 1,050.64
Footnotes
(A) Balances with banks - In Current Accounts
(B) Balances with banks - In Current Accounts
(C) Deposits with maturity of more than 3 months and less than 12 months
(D) Deposits with maturity of more than 3 months and less than 12 months
(E) Lease Liabilities
(F) Lease Liabilities
(G)
Particulars 2021-22
Total 488.12
(H)
Particulars 2020-21
Total 550.97
(I) Statutory Dues
(J) Statutory Dues
Subclassification of trade receivables [Table]

Classification of assets based on security [Axis] Unsecured considered good [Member]
Subclassification of trade receivables [Abstract]
Subclassification of trade receivables [Line items]
Breakup of trade receivables [Abstract]
Trade receivables, gross 360.55 3,340.59
Allowance for bad and doubtful debts 0 0
Total trade receivables 360.55 3,340.59
Details of trade receivables due by directors, other officers or others [Abstract]
Trade receivables due by directors 0 0
Trade receivables due by other officers 0 0
Total trade receivables due by directors, other officers or others 0 0
Details of trade receivables due by firms or companies in which any director is partner or director
[Abstract]
Trade receivables due by firms in which any director is partner 0 0
Total trade receivables due by firms or companies in which any director is partner or director 0 0
Other non-current financial assets, others [Table]

40
Classification of other non-current financial assets others [Axis] Other non-current financial assets, others 1
Other non-current financial assets, others [Abstract]
Other non-current financial assets, others [Line items]
Description other non-current financial assets, others Security Deposits Security Deposits
Other non-current financial assets, others (A) 244.14 (B) 242.57
Footnotes
(A)
Particulars 2021-22
Unsecured and Considered Good 244.14
Unsecured and Credit Impaired 2.00
Less: Loss allowance for Credit Impairment (2.00)
Total 244.14
(B)
Particulars 2020-21
Total 242.57
Details of advances [Table] ..(1)

Classification based on current non-current [Axis] Non-current [Member]
Classification of advances [Axis] Capital advances [Member] Other Advances [Member]
Classification of assets based on security [Axis] Doubtful [Member] Unsecured considered good [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of advances [Abstract]
Disclosure of advances [Line items]
Advances (A) 0 (B) 0 2,361.64 2,923.19
Details of advance due by directors other officers or others
[Abstract]
Advance due by directors 0 0 0 0
Advance due by other officers 0 0 0 0
Total advance due by directors other officers or others 0 0 0 0
Details of advance due by firms or companies in which any
director is partner or director [Abstract]
Advance due by firms in which any director is partner 0 0 0 0
Total advance due by firms or companies in which any
director is partner or director 0 0 0 0
Footnotes
(A)
Particulars 2021-22
Total 0.00
(B)
2020-21
Total 0.00
41

Classification of advances [Axis] Advance tax [Member] Advance income tax paid [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Advances 361.64 268.5 (A) 361.64 (B) 268.5
[Abstract]
Footnotes
(A)
Particulars 2021-22
Advance Income Tax (Net of Provision)
At start of year 268.50
Charge for the year -
Tax paid during the year (net of refunds) 93.14
At end of year 361.64
(B)
Particulars 2020-21
Advance Income Tax (Net of Provision)
At start of year (0.38)
Charge for the year -
Tax paid during the year (net of refunds) 268.88
At end of year 268.50

Deposits with statutory authorities
Classification of advances [Axis] [Member]
Advances 2,000 2,654.69
Details of advance due by directors other officers or others [Abstract]
Advance due by directors 0 0
Advance due by other officers 0 0
Total advance due by directors other officers or others 0 0
Details of advance due by firms or companies in which any director is partner or director [Abstract]
Advance due by firms in which any director is partner 0 0
Total advance due by firms or companies in which any director is partner or director 0 0
42

Classification of advances [Axis] Advances given suppliers [Member]
Classification of assets based on security [Axis] Unsecured considered good [Member] Doubtful [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Advances 49.59 41.96 (A) 0 (B) 0
[Abstract]
Footnotes
(A)
Particulars 2021-22
Total 0.00
(B)
Particulars 2020-21
Total 0.00

Classification of advances [Axis] Other Advances [Member] Prepaid expenses [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Advances 974.52 1,365.45 82.82 236.91
[Abstract]

Deposits with statutory authorities
Classification of advances [Axis] [Member] Other advances, others [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Advances 855.46 1,080 36.24 48.54
Nature of other advance Other advances Other advances
43

[Abstract]
Other non-current assets, others [Table]

Other non-current assets, others [Axis] Other non-current assets, others 1
Other non-current assets, others [Abstract]
Other non-current assets, others [Line items]
Description of other non-current assets, others Credit unutilised Credit unutilised
Other non-current assets, others 0 180.19
Classification of inventories [Table]

Classification of inventories [Axis] Company inventories [Member]
Classification of inventories [Abstract]
Classification of inventories [Line items]
Inventories 0 0
Other current financial assets others [Table] ..(1)

Other current financial assets others [Axis] Other current financial assets others 1 Other current financial assets others 2
Period FY 2022 FY 2021 FY 2022 FY 2021
Other current financial assets others [Abstract]
Other current financial assets others [Line items]
Receivable from Receivable from
payment gateways payment gateways
and delivery and delivery
agents - agents - Contractually Contractually
Unsecured and Unsecured and reimbursable reimbursable
Description other current financial assets others Considered Good Considered Good expenses expenses
Other current financial assets others (A) 965.33 (B) 224.93 38.16 118.72
Footnotes
(A)
Particulars 2021-22
Less: Loss allowance for credit impairment (64.26)
Total 965.33
(B)
Particulars 2020-21
Less: Loss allowance for credit impairment (64.26)
Total 224.93
Other current financial assets others [Table] ..(2)
44

Other current financial assets others [Axis] Other current financial assets others 3
Other current financial assets others [Abstract]
Other current financial assets others [Line items]
Recoverable from Recoverable from
Description other current financial assets others Employees Employees
Other current financial assets others 5.32 0
Other non-current financial liabilities others [Table]

Other non-current financial liabilities
Other non-current financial liabilities others [Axis] others 1
Other non-current financial liabilities others [Abstract]
Other non-current financial liabilities others [Line items]
Description other non-current financial liabilities others Lease liabilities Lease liabilities
Other non-current financial liabilities, others 1.97 13.1
Disclosure of breakup of provisions [Table] ..(1)

Classification based on current non-current
Classification based on current non-current [Axis] [Member] Non-current [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of breakup of provisions [Abstract]
Disclosure of breakup of provisions [Line items]
Provisions [Abstract]
Provisions for employee benefits [Abstract]
Provision gratuity 145.9 145.89 123.99 124.4
Provision leave encashment 124.7 103.51 97.37 79.8
Total provisions for employee benefits 270.6 249.4 221.36 204.2
CSR expenditure provision 0 0 0 0
Total provisions 270.6 249.4 221.36 204.2
Disclosure of breakup of provisions [Table] ..(2)

Disclosure of breakup of provisions [Abstract]
Disclosure of breakup of provisions [Line items]
Provisions [Abstract]
Provisions for employee benefits [Abstract]
Provision gratuity 21.91 21.49
Provision leave encashment 27.33 23.71
Total provisions for employee benefits 49.24 45.2
CSR expenditure provision 0 0
Total provisions 49.24 45.2
Other current financial liabilities, others [Table] ..(1)

Other current financial liabilities, others [Axis] Other current financial liabilities, others 1 Other current financial liabilities, others 2
Period FY 2022 FY 2021 FY 2022 FY 2021
Other current financial liabilities, others [Abstract]
Other current financial liabilities, others [Line items]
Advances Advances
received from received from
Refundable Refundable customers of customers of
Description of other current financial liabilities, others Security deposits Security deposits fulfilment centres fulfilment centres
Other current financial liabilities, others 273.38 301.18 193.98 151.12
Other current financial liabilities, others [Table] ..(2)
45
Other current financial liabilities, others [Axis] Other current financial liabilities, others 3 Other current financial liabilities, others 4
Period FY 2022 FY 2021 FY 2022 FY 2021
Other current financial liabilities, others [Abstract]
Other current financial liabilities, others [Line items]
Employee benefits Employee benefits
Description of other current financial liabilities, others payable payable Lease Liabilities Lease Liabilities
Other current financial liabilities, others 9.63 (A) 88.61 11.13 10.06
Footnotes
(A)
Employee benefits include amount payable to employees who were ESOP holders arising out of acquisition of shares in Tresera Health Limited
(formerly Tresara Health Limited) (erstwhile Holding company) by Reliance Retail Ventures Limited during the year. [Rs. 76.45 lakhs]
Other current liabilities, others [Table]

Other current liabilities, others [Axis] Other current liabilities, others 1 Other current liabilities, others 2
Period FY 2022 FY 2021 FY 2022 FY 2021
Other current liabilities, others [Abstract]
Other current liabilities, others [Line items]
Amounts payable Amounts payable Other liabilities - Other liabilities -
to fulfillment to fulfillment Cash back to Cash back to
Description of other current liabilities, others centres centres customers customers
Other current liabilities, others (A) 1,941.36 (B) 557.41 11.9 251.05
Footnotes
(A) Advance payable to fulfillment centres represents amounts collected from customers of fulfillment centres.
(B) Advance payable to fulfillment centres represents amounts collected from customers of fulfillment centres.
Textual information (6): Disclosure of notes on trade receivables explanatory [Text Block]
As at As at
March 31, 2022 March 31, 2021
Trade Receivables
(Unsecured, Considered Good)
Trade receivables 360.55 3,340.59
Total 360.55 3,340.59
The trade receivables of the Company do not contain a significant financing component and accordingly, the Company has adopted the
simplified approach under Ind AS 109 for recognition of impairment of losses on trade receivables. Consequently, the disclosure of trade
receivables into "Trade receivables which have significant increase in credit risk" has not been given since it is not relevant in the context of the
Company.
1. Trade Receivables ageing schedule as on March 31, 2022
Outstanding for following

Particulars periods from due date of Total
payment
6 months- More than 3

Less than 6 Months 1-2 years 2-3 years
1year years
(i) Undisputed Trade receivables considered good 20.42 5.71 1.33 0.03 - 27.49
(ii) Undisputed Trade Receivables which have

- - - - - -
significant increase in credit risk
(iii) Undisputed Trade Receivables credit impaired - - - - - -
(iv) Disputed Trade Receivables considered good - - - - - -
(v) Disputed Trade Receivables which have

- - - - - -
(vi) Disputed Trade Receivables credit impaired - - - - - -
46
Total 20.42 5.71 1.33 0.03 - 27.49
2. Trade Receivables ageing schedule as on March 31, 2021
Outstanding for following

Particulars periods from due date of Total
payment
6 months - More than 3

Less than 6 Months 1-2 years 2-3 years
1 year years
(i) Undisputed Trade receivables considered good 3,334.07 - 6.52 - - 3,340.59
(ii) Undisputed Trade Receivables which have

- - - - - -
(iii) Undisputed Trade Receivables credit impaired - - - - - -
(iv) Disputed Trade Receivables considered good - - - - - -
(v) Disputed Trade Receivables which have

- - - - - -
(vi) Disputed Trade Receivables credit impaired - - - - - -
Total 3,334.07 - 6.52 - - 3,340.59
Textual information (7): Disclosure of notes on other current financial assets explanatory [Text Block]
Other financial assets
As at March 31, 2021 As at March 31, 2020
Current
Receivable from payment gateways and delivery agents
- Considered good, Unsecured 224.93 353.31
Receivable from payment gateways and delivery agents - credit impaired 64.26 50.19
Less: Loss allowance for credit impaired (64.26) (50.19)
Contractually reimburesable expenses 118.72 241.84
343.65 595.15
Movement in loss allowance for Receivable from payment gateways and delivery agents
Opening balance 50.19 50.19
Add: Addition during the year 14.07 -
Less: Reversed during the year - -
Closing balance 64.26 50.19
47
[401200] Notes - Additional disclosures on balance sheet

Textual
Disclosure of additional balance sheet notes explanatory [Text Block] Information (8)
Additional balance sheet notes [Abstract]
Contingent liabilities and commitments [Abstract]
Classification of contingent liabilities [Abstract]
Guarantees 3 3
Total contingent liabilities 3 3
Classification of commitments [Abstract]
Other commitments 0 0
Total commitments 0 0
Total contingent liabilities and commitments 3 3
Details regarding dividends [Abstract]
Amount of dividends proposed to be distributed to equity shareholders 0 0
Amount of per share dividend proposed to be distributed to equity shareholders [INR/shares] 0 [INR/shares] 0
Details of deposits [Abstract]
Deposits accepted or renewed during period 0 0
Deposits matured and claimed but not paid during period 0 0
Deposits matured and claimed but not paid 0 0
Deposits matured but not claimed 0 0
Interest on deposits accrued and due but not paid 0 0
Details of share application money received and paid [Abstract]
Share application money received during year 0 0
Share application money paid during year 0 0
Amount of share application money received back during year 0 0
Amount of share application money repaid returned back during year 0 0
Number of person share application money paid during year [pure] 0 [pure] 0
Number of person share application money received during year [pure] 0 [pure] 0
Number of person share application money paid as at end of year [pure] 0 [pure] 0
Number of person share application money received as at end of year [pure] 0 [pure] 0
Share application money received and due for refund 0 0
Details regarding cost records and cost audit[Abstract]
Details regarding cost records [Abstract]
Whether maintenance of cost records by company has been mandated under Companies (Cost Records
and Audit) Rules, 2014 No No
Details regarding cost audit [Abstract]
Whether audit of cost records of company has been mandated under Rules specified in SN 1 No No
Net worth of company 949.38 -171.65
Details of unclaimed liabilities [Abstract]
Unclaimed share application refund money 0 0
Unclaimed matured debentures 0 0
Unclaimed matured deposits 0 0
Interest unclaimed amount 0 0
Financial parameters balance sheet items [Abstract]
Investment in subsidiary companies 0 0
Investment in government companies 0 0
Amount due for transfer to investor education and protection fund (IEPF) 0 0
Gross value of transactions with related parties (A) 3,614.12 (B) 10,457.12
Number of warrants converted into equity shares during period [pure] 0 [pure] 0
Number of warrants converted into preference shares during period [pure] 0 [pure] 0
Number of warrants converted into debentures during period [pure] 0 [pure] 0
Number of warrants issued during period (in foreign currency) [pure] 0 [pure] 0
Number of warrants issued during period (INR) [pure] 0 [pure] 0
Footnotes
(A)
Particulars 2021-22
Borrowings Repaid 3,182.60
Redemption of Optionally Fully Convertible Debentures 380.00
Purchase of Plant Property & Equipment 51.52
48
Total 3,614.12
(B)
Particulars 2020-21
Borrowings 5,428.33
Share capital issued (including securities premium) 1,308.99
Issue of Optionally Fully convertible Debentures 1,580.00
Security Deposit received 300.00
Security Deposit repaid 300.00
Purchase of Plant Property & Equipment 39.80
Total 10,457.12
Details of disclosures required under MSMED Act 2006 [Table]

Micro small medium enterprises [Axis] Supplier 1
Details of disclosures required under MSMED Act 2006 [Abstract]
Details of disclosures required under MSMED Act 2006 [Line items]
Principal and interest due remaining unpaid [Abstract]
Principal due remaining unpaid 16.53 28.7
Interest due remaining unpaid 0 0
Total principal and interest due remaining unpaid 16.53 28.7
Amount of interest paid under MSMED Act 2006 0 0
Amount of payments made to supplier beyond due date during year 0 0
Amount of interest due and payable for period 0 0
Amount of interest accrued and remaining unpaid at end of accounting year 0 0
Amount of further interest due and payable even in succeeding year 0 0
Maximum amount outstanding for period from micro small medium enterprises 0 0
Name supplier being micro small medium enterprises - -
Textual information (8): Disclosure of additional balance sheet notes explanatory [Text Block]
1. Trade payables
As at As at
March 31, 2022 March 31, 2021
Trade payables
Total outstanding dues of micro enterprises and small enterprises 16.53 28.70
Total outstanding dues of creditors other than micro enterprises and

1,697.28 765.00
small enterprises
Total 1,713.81 793.70
1.1. There are no overdue amounts to Micro, Small and Medium Enterprises as at March 31, 2022
1.2. Trade Payables ageing schedule as on March 31, 2022
Outstanding for following periods

Particulars Total
from due date of payment
Less than 1 year 1-2 years 2-3 years More than 3 years
(i) MSME - - - - -
(ii) Others 154.25 34.77 5.30 0.17 194.49
(iii) Disputed Dues - MSME - - - - -
(iv) Disputed Dues - Others - - - - -
Total 154.25 34.77 5.30 0.17 194.49
1.3. Trade Payables ageing schedule as on March 31, 2022
49
Outstanding for following periods

Particulars Total
from due date of payment
Less than 1 year 1-2 years 2-3 years More than 3 years
(i) MSME - - - - -
(ii) Others 61.47 - - - 61.47
(iii) Disputed Dues - MSME - - - - -
(iv) Disputed Dues - Others - - - - -
Total 61.47 - - - 61.47
1.4. Disclosure required under Micro, Small and Medium Enterprises Development Act, 2006 (MSMED Act)
Particulars below as per Schedule III As at As at
March 31, 2022 March 31, 2021
Principal amount due to suppliers registered under the MSMED Act and remaining unpaid as at year
16.53 28.70
end
Interest due to suppliers registered under the MSMED Act and remaining unpaid as at year end - -
Principal amounts paid to suppliers registered under the MSMED Act, beyond the appointed day
- -
during the year
Interest paid, other than under Section 16 of MSMED Act, to suppliers registered under the MSMED
- -
Act, beyond the appointed day during the year
Interest paid, under Section 16 of MSMED Act, to suppliers registered under the MSMED Act, beyond
- -
the appointed day during the year
Interest due and payable towards suppliers registered under MSMED Act, for payments already made - -
Further interest remaining due and payable for earlier years - -
2. Ratio Analysis
Year Ended March 31, Year Ended March 31,

S. No. Particulars Variance
2022 2021
i Current Ratio 1.07 0.86 24.60%
ii Debt - Equity Ratio (1) 0.25 1.74 (85.50%)
iii Debt Service Coverage Ratio (2) 0.36 1.11 (67.44%)
iv Return on Equity Ratio (3) 40.50% 24.80% 63.34%
v Inventory Turnover Ratio - -
vi Trade Receivables Turnover Ratio 6.90 7.33 (5.88%)
vii Trade Payable Turnover Ratio 6.02 5.07 18.62%
viii Net Capital Turnover Ratio (4) 36.69 (17.43) (310.47%)
ix Net Profit Ratio (5) 8.29% 0.66% 1152.65%
Return on Capital Employed (Excluding Working

x 25.26% 17.33% 45.76%
Capital Financing) (6)
xi Return on Investment (7) 1.05% 0.74% 42.16%
Reason for variance:

(1) Debt Equity Ratio has reduced due to repayment of borrowing during the year.
(2) Debt Service Coverage ratio has decreased due to repayment of principal portions of demand loans during the year.
(3) Return of Equity ratio has improved due to increase in profit during the year.
(4) Net Capital Turnover Ratio has increased due to increase in working capital while turnover has decreased.
(5) Net Profit Ratio has increased due to increase in operating margin during the year.
(6) Return on Capital Employed has increased due to increase in profit during the year.
(7) Return on Investment has increased due to increase in net gains on sale of investment during the year.
2.1 Formulae for computation of ratios are as follows:
Sr. No. Particulars Formula
1 Current Ratio Current Assets
Current Liabilites
50
2 Debt Equity Ratio Total Debt
Total Equity
3 Debt Service Coverage ratio Earnings before Interest, Tax and Exceptional Items
Interest Expense + Principal Repayments made during period for long term
loans
4 Return on Equity Ratio Profit After Tax (Attributable to Owners)
Average Net Worth
5 Inventory Turnover Ratio Cost of Goods Sold (Purchases + Changes in Inventory)
Average Inventories of Stock-in-Trade
6 Trade Recievables Turnover Ratio Value of Sales
Average Trade Receivables
7 Trade Payable Turnover Ratio Purchases of Stock-in-Trade + Other Expenses
Average Trade Payables
8 Net Capital Turnover Ratio Value of Sales
Average Working Capital (Current Assets -Current Liabilities)
9 Net Profit Ratio Profit After Tax (after exceptional items)
Value of Sales
Return on Capital Employed (Excluding Working Net Profit After Tax + Deferred Tax Expense/(Income) + Finance Cost (-) Other
10
Capital Financing) Income
Average Capital Employed**
11 Return on Investment Other Income (Excluding Dividend)
Average Cash, Cash Equivalents Other Marketable Securities
Note: Capital employed includes Equity, Borrowings, Deferred Tax Liabilities, Creditor for Capital Expenditure and reduced by Investments, Cash
and Cash Equivalents, Capital Work-in-Progress and Intangible Assets under Development.
3. Other Statutory Information
i) As per section 248 of the Companies Act, 2013, there are no balances outstanding with struck off companies.
ii) The Company do not have any Capital-work-in progress or intangible assets under development, whose completion is overdue or has
exceeded its cost compared to its original plan.
iii) The Company has not advanced or loaned or invested funds to any other person(s) or entity(ies), including foreign entities (Intermediaries)
with the understanding that the Intermediary shall:
(a) Directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the company (Ultimate
Beneficiaries) or
(b) Provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.
iv) The Company has not received any fund from any person(s) or entity(ies), including foreign entities (Funding Party) with the understanding
(whether recorded in writing or otherwise) that the Company shall:
(a) Directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party
(Ultimate Beneficiaries) or
(b) Provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.
v) The Company does not have any such transaction which is not recorded in the books of accounts that has been surrendered or disclosed as
income during the year in the tax assessments under the Income-tax Act, 1961
4. Impact of Covid-19 Pandemic
The spread of COVID-19 has severely affected business around the globe. Many countries, including India, have undertaken various measures
to contain the spread of the virus including lock-downs, travel bans, quarantines, social distancing and other emergency measures. These
measures have had a direct impact on businesses and have affected the supply chains and production of goods. Lower economic activity has
also resulted in the suppressed demand for goods and services.
The Company operates as an e-commerce marketplace for pharmaceutical products. The business model collaborates pharmacy and
technology, which has gained more relevance in the Covid-19 scenario.
The Company being in the essential services segment has not experienced any significant disruptions affecting its business. In view of the
lockdown and curfew announced across many states in India, the Company has undertaken and strengthened various measures to ensure the
safety and wellbeing of its employees and has focused on continued delivery of pharmaceutical products across the country by ensuring that its
51
online platforms continue to operate smoothly.

In assessing the recoverability of various assets including investments, property, plant and equipment, intangible assets, receivables and its
obligations, the Company has considered internal and external information up to the date of approval of financial statements including liquidity
and solvency position for the Company for the ensuing twelve months and economic forecasts relevant to the Company. The Company based on
current indicators of future economic conditions and factors mentioned above, expects to recover the carrying amount of its assets and meet its
obligations and concluded that no material adjustments are required in their financial statements.
The impact of the global health pandemic may be different from that estimated, as at the date of approval of the financial statements, consequent
to the highly uncertain economic environment and the Company will continue to closely monitor any material changes to the future economic
conditions and to carry out a definitive reassessment of the impact as circumstances evolve.
5. The figures of the corresponding year has been regrouped / reclassified wherever necessary in accordance with requirements of Schedule III
of Companies Act, 2013 to make them comparable.
6. Approval of Financial Statements
The financial statements were approved for issue by the Board of Directors on 19th April 2022.
52
[500100] Notes - Subclassification and notes on income and expenses

Disclosure of revenue from operations [Abstract]
Disclosure of revenue from operations for other than finance company [Abstract]
Revenue from sale of products 0 0
Revenue from sale of services (A) 10,528.52 (B) 13,186.14
Other operating revenues 248.44 237.28
Total revenue from operations other than finance company 10,776.96 13,423.42
Total revenue from operations (C) 10,776.96 (D) 13,423.42
Disclosure of other operating revenues [Abstract]
Other operating revenues [Abstract]
Miscellaneous other operating revenues 248.44 237.28
Total other operating revenues 248.44 237.28
Disclosure of other income [Abstract]
Interest income [Abstract]
Interest income on current investments [Abstract]
Interest on fixed deposits, current investments 0.21 0.26
Total interest income on current investments 0.21 0.26
Total interest income 0.21 0.26
Dividend income [Abstract]
Dividend income current investments [Abstract]
Dividend income current investments from others 0 0
Total dividend income current investments 0 0
Total dividend income 0 0
Net gain/loss on sale of investments [Abstract]
Net gain/loss on sale of current investments (E) 17.71 (F) 1.74
Total net gain/loss on sale of investments 17.71 1.74
Other non-operating income [Abstract]
Miscellaneous other non-operating income (G) 353.84 (H) 1,698.34
Total other non-operating income 353.84 1,698.34
Total other income 371.76 1,700.34
Disclosure of finance cost [Abstract]
Interest expense [Abstract]
Interest expense non-current loans [Abstract]
Interest expense non-current loans, others (I) 142.23 (J) 229.52
Total interest expense non-current loans 142.23 229.52
Interest lease financing 1.89 714
Total interest expense 144.12 943.52
Total finance costs 144.12 943.52
Employee benefit expense [Abstract]
Salaries and wages 1,959.87 2,202.25
Managerial remuneration [Abstract]
Remuneration to directors [Abstract]
Other benefits to directors 0 0
Total remuneration to directors 0 0
Total managerial remuneration 0 0
Contribution to provident and other funds [Abstract]
Contribution to provident and other funds for others 103.15 111.77
Total contribution to provident and other funds 103.15 111.77
Employee share based payment [Abstract]
Employee share based payment- Equity settled 49.79 82.59
Total employee share based payment 49.79 82.59
Gratuity 34.75 41.95
Staff welfare expense 120.57 102.43
Total employee benefit expense 2,268.13 2,540.99
Depreciation, depletion and amortisation expense [Abstract]
Depreciation expense (K) 103.36 (L) 2,097.74
Amortisation expense 30.83 41.89
Total depreciation, depletion and amortisation expense 134.19 2,139.63
Breakup of other expenses [Abstract]
Consumption of stores and spare parts 0 0
Power and fuel 0 0
Rent 334.41 310.19
Repairs to building 0 0
Repairs to machinery 0 0
Insurance 0 0
53
Rates and taxes excluding taxes on income [Abstract]

Other cess taxes 8.21 7.53
Total rates and taxes excluding taxes on income 8.21 7.53
Electricity expenses 33.64 45.44
Telephone postage 270.88 240.63
Printing stationery 0.54 53.65
Travelling conveyance 5.52 49.69
Legal professional charges 311.08 280.47
Safety security expenses 14.45 10.17
Directors sitting fees 0 0
Donations subscriptions 0 0
Advertising promotional expenses 187.84 3,072.84
Secondary packing expenses 0 (M) 422.16
Cost repairs maintenance other assets 33.37 54.64
Cost transportation [Abstract]
Cost freight (N) 7.14 (O) 1,970.64
Total cost transportation 7.14 1,970.64
Cost warehousing (P) 45.79 (Q) 5.16
Cost technical services 1,422.19 662.38
Net provisions charged [Abstract]
Other provisions created 0 (R) 24.71
Total net provisions charged 0 24.71
Loss on disposal of intangible Assets 0 0
Loss on disposal, discard, demolishment and destruction of depreciable property plant and equipment 0 0
Payments to auditor [Abstract]
Payment for audit services 15.42 14
Payment for taxation matters 0 3.1
Payment for other services 0 0.25
Total payments to auditor 15.42 17.35
CSR expenditure 0 0
Miscellaneous expenses (S) 4,854.11 (T) 2,168.7
Total other expenses 7,544.59 9,396.35
Current tax [Abstract]
Current tax pertaining to current year 0 0
Total current tax 0 0
Footnotes
(A)
Particulars 2021-22
Technical Support Services 10,454.63
Commission income 12.76
Franchisee fees 4.76
Customer subscription charges 56.37
Total 10,528.52
(B)
Particulars 2020-21
Commission income 2,807.88
Shipping charges received from customers 322.72
Total 13,186.14
(C)
Particulars 2021-22
54
(D)
Particulars 2020-21
(E)
Particulars 2021-22
Gain on sale of investments in mutual funds
Realised gain on sale 17.18
Unrealised gain on valuation at year end 0.53
Total 17.71
(F) Gain on sale of investments in mutual funds - Realised gain on sale
(G)
Particulars 2021-22
Support services to group companies 236.51
Provision for Cashback no longer required 102.05
Others 15.28
Total 353.84
(H)
Particulars 2020-21
Support services to group companies 297.00
Gain on de-recognition of line of credit 145.22
Provision for financial guarantee contracts no longer required 210.41
Gain/(loss) on termination of lease 813.63
Others 232.08
Total 1,698.34
(I)
Interest Expenses - on loans from related parties
(J)
Interest Expenses - on loans from related parties
(K)
Particulars 2021-22
Depreciation of property, plant and equipment 92.91
Depreciation of right-of-use assets 10.45
Total 103.36
(L)
Particulars 2020-21
Depreciation of property, plant and equipment 114.80
Depreciation of right-of-use assets 1,982.94
Total 2,097.74
(M)
Stores and Packing Materials
55
(N) Freight and delivery charges
(O) Freight and delivery charges
(P)
Warehousing and Distribution Expenses
(Q)
Warehousing and Distribution Expenses
(R)
Provision for doubtful balances
(S)
Particulars 2021-22
Business support and advisory charges 42.72
Web hosting expenses 4,326.63
Payment Gateway Charges 481.39
General Expenses 3.37
Total 4,854.11
(T)
Particulars 2020-21
Business support and advisory charges 363.31
Web hosting expenses 1,301.14
Payment Gateway Charges 432.17
Goodwill writen off 9.40
Net Expenses from doctor consultation 10.45
Loss on Diagnostics consultation 48.89
General Expenses 3.34
Total 2,168.70
Miscellaneous other operating revenues [Table] ..(1)

Miscellaneous other operating revenues [Axis] Other operating revenue 1 Other operating revenue 2
Period FY 2022 FY 2021 FY 2022 FY 2021
Miscellaneous other operating revenues [Abstract]
Miscellaneous other operating revenues [Line Items]
Revenue from Revenue from
Marketing Marketing Diagnostic Diagnostic
Description of miscellaneous other operating revenues services services Consultation Consultation
Miscellaneous other operating revenues 10.75 86.37 22.25 0

Miscellaneous other operating revenues [Axis] Other operating revenue 3 Other operating revenue 4
Period FY 2022 FY 2021 FY 2022 FY 2021
Revenue From Revenue From
Doctor Doctor
Description of miscellaneous other operating revenues Consultation Consultation Marketplace fees Marketplace fees
Miscellaneous other operating revenues 5.93 0 208.21 142.85
56
Miscellaneous other operating revenues [Axis] Other operating revenue 5

Description of miscellaneous other operating revenues Software Income Software Income
Miscellaneous other operating revenues 1.3 8.06
57
[500200] Notes - Additional information statement of profit and loss

Textual
Additional information on profit and loss account explanatory [Text Block] Information (9)
Additional information on profit and loss account [Abstract]
Changes in inventories of finished goods, work-in-progress and stock-in-trade [Abstract]
Changes in other inventories 0 0
Total changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
Details of exceptional items [Abstract]
Exceptional items after tax [Abstract]
Exceptional items before tax 0 (A) 1.5
Total exceptional items 0 1.5
Gain or Loss on Gain or Loss on
Details of nature of exceptional items Sale of Investment Sale of Investment
Breakup of revenue as export and domestic [Abstract]
Revenue from sale of products [Abstract]
Domestic turnover goods, gross [Abstract]
Domestic sale manufactured goods 0 0
Total domestic turnover goods, gross 0 0
Total revenue from sale of products 0 0
Revenue from sale of services [Abstract]
Domestic revenue services 10,528.52 13,186.14
Total revenue from sale of services (B) 10,528.52 (C) 13,186.14
Gross value of transaction with related parties (D) 11,029.47 (E) 10,986.46
Bad debts of related parties 0 0
Footnotes
(A)
The Company, during the previous year, sold its entire stake in Netmeds Health Private Limited for Rs. 1.5 Lakh. The Company had earlier
impaired its investment and hence, entire sale proceed has been recognized as gain or loss on sale of investment.
(B)
Particulars 2021-22
Commission income 12.76
Total 10,528.52
(C)
Particulars 2020-21
Commission income 2,807.88
Shipping charges received from customers 322.72
Total 13,186.14
(D)
Particulars 2021-22
Revenue from Operations - Technical Support Services 10,454.66
Other Income - Support Service to Group Companies 236.51
Other Income - Other Non-Operating Income 0.70
Business support and advisory Charges etc. 42.72
58
Technical Support Charges 24.20
Communication Expenses 124.56
Staff Welfare 3.38
Remuneration paid 0.50
Interest Expenses on Loans 142.24
Total 11,029.47
(E)
Particulars 2020-21
Revenue from Operations - Technical Support Services 10,000.00
Other Income - Support Service to Group Companies 297.00
Business support and advisory Charges etc. 363.31
Technical Support Charges 3.60
Communication Expenses 33.87
Staff Welfare 7.76
Remuneration paid 13.75
Rent including Lease Rentals 21.21
Sales Promotion and Advertisement Expenses 26.90
Total 10,986.46
Textual information (9): Additional information on profit and loss account explanatory [Text Block]
1. The figures of the corresponding year has been regrouped / reclassified wherever necessary in accordance with requirements of Schedule III
of Companies Act, 2013 to make them comparable.
2. Approval of Financial Statements
The financial statements were approved for issue by the Board of Directors on 19th April 2022.
59
[610100] Notes - List of accounting policies

Period FY 2022
Textual
Disclosure of significant accounting policies [Text Block] Information (10)
Textual information (10): Disclosure of significant accounting policies [Text Block]
SIGNIFICANT ACCOUNTING POLICIES

This note provides a list of the significant accounting policies adopted in the preparation of these financial statements. These policies have been
consistently applied to all the years presented, unless otherwise stated.
1. BASIS OF PREPARATION AND PRESENTATION
(i) Compliance with Ind AS
The financial statements comply in all material aspects with Indian Accounting Standards (Ind AS) notified under Section 133 of the Companies
Act, 2013 (the "Act") [Companies (Indian Accounting Standards) Rules, 2015] and other relevant provisions of the Act.
(ii) Historical cost convention
The financial statements have been prepared on a historical cost basis, except for the following:
- certain financial assets and liabilities are measured at fair value
(iii) Going Concern
These financial statements of the Company are prepared on a going concern basis.
(vi) Current and Non-Current Classification
The Company presents assets and liabilities in the Balance Sheet based on Current / Non-Current classification.
An asset is treated as Current when it is -
- Expected to be realised or intended to be sold or consumed in normal operating cycle;
- Held primarily for the purpose of trading;
- Expected to be realised within twelve months after the reporting period, or
- Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.
All other assets are classified as non-current.
A liability is current when -
- It is expected to be settled in normal operating cycle;
- It is held primarily for the purpose of trading;
- It is due to be settled within twelve months after the reporting period, or
- There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period.
The Company classifies all other liabilities as non-current.
Deferred tax assets and liabilities are classified as non-current assets and liabilities.
2. CRITICAL ESTIMATES AND JUDGEMENTS
The preparation of financial statements in conformity with Ind AS requires the management to make judgments, estimates and assumptions
about the carrying amounts of assets and liabilities recognised in the financial statements that are not readily apparent from other sources. The
judgements, estimates and associated assumptions are based on historical experience and other factors including estimation of effects of
uncertain future events that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates (accounted on a prospective
basis) are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and
future periods if the revision affects both current and future periods.
The following are the critical judgements and estimations that have been made by the management:
Estimation of current tax expense and payable - Note B.6 and Note 26
Estimated useful life of property, plant and equipment - Note B.13
Estimation of defined benefit obligation - Note B.19 and Note 22.1
Fair value measurements and valuation processes - Note B.12 and Note 30
Impairment of financial assets - Note B.12 and Note 31.1
3. SEGMENT REPORTING
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker (CODM).
The board of directors assesses the financial performance and position of the Company, and makes strategic decisions. The board of directors
have been identified as being the CODM.
Refer Note 33 for segment information presented.
4. FOREIGN CURRENCY TRANSLATION
(i) Functional and presentation currency:
Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates
('the functional currency'), i.e., Indian Rupee (INR), which is the Company's functional and presentation currency.
(ii) Transactions and balances:
Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities
denominated in foreign currencies at year end exchange rates are generally recognised in profit or loss.
All other foreign exchange gains and losses are presented in the statement of profit and loss on a net basis within other gains / (losses).
60
5. REVENUE RECOGNITION
Sale of services
Marketplace fees
Revenue from providing services is recognised at a point in time when the performance obligations are fulfilled.
Diagnostic services
Revenue from diagnostic consultation is recognised at a point in time, when the services are performed and the customer has availed the
services.
Doctor consultation
Revenue from doctor consultation is recognised over time, when the performance obligation of providing the consultation is performed.
Marketing services
Revenue from marketing services are in the nature of time and space provided in the online marketplace for advertisement. Revenue is
recognised over time when the performance obligations are satisfied in the accounting periods it is performed.
Business consultancy, technical services and related advisory / support services
Revenue in the nature of Business Consultancy, technical services and related advisory / support services is recognised over time when the
performance obligations are fulfilled and there is no uncertainty over the realisation of revenue from the customer.
Collections from marketing services are due as per the agreed credit terms of the contract.
Payment for the doctor consultation is received upfront when the customer blocks appointment through the portal.
Payment for the diagnostic consultation is received either when the end customer blocks the appointment for the services, or when the
consultation services is performed.
Payment for Business Consultancy, technical services and related advisory/support services are as per the terms of the contract.
The Company does not expect to have any contracts where the period between the transfer of the promised goods or services to the customer
and payment by the customer exceeds one year. As a consequence, the Company does not adjust any of the transaction prices for the time
value of money.
6. TAX EXPENSES
The tax expenses for the period comprises of current tax and deferred income tax. Tax is recognised in Statement of Profit and Loss, except to
the extent that it relates to items recognised in the Other Comprehensive Income or in Equity. In which case, the tax is also recognised in Other
Comprehensive Income or Equity.
i) Current Tax
Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to the Income Tax authorities, based on tax
rates and laws that are enacted at the Balance sheet date.
ii) Deferred Tax
Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities in the Financial Statements and the
corresponding tax bases used in the computation of taxable profit.
Deferred tax assets are recognised to the extent it is probable that taxable profit will be available against which the deductible temporary
differences, and the carry forward of unused tax losses can be utilized.
Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset
realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.
7. LEASES.
As a lessee
Leases are recognised as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the
Company. Contracts may contain both lease and non-lease components. The Company allocates the consideration in the contract to the lease
and non-lease components based on their relative stand-alone prices.
Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the
following lease payments:
(i) fixed payments (including in-substance fixed payments), less any lease incentives receivable
(ii) variable lease payment that are based on an index or a rate, initially measured using the index or rate as at the commencement date
(iii) amounts expected to be payable by the Company under residual value guarantees
(iv) the exercise price of a purchase option if the Company is reasonably certain to exercise that option, and
(v) payments of penalties for terminating the lease, if the lease term reflects the Company exercising that option.
Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease
payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for
leases in the Company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the
funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and
conditions.
To determine the incremental borrowing rate, the Company:
(i) where possible uses a third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing
conditions since third party financing was received
(ii) uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by the Company, which does not have
recent third party financing, and
(iii) makes adjustments specific to the lease, e.g. term, country, currency and security.
Potential future increases in variable lease payments based on an index or rate are not included in the lease liability until they take effect. When
adjustments to lease payments based on an index or rate take effect, the lease liability is reassessed and adjusted against the right-of-use asset.
Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to
produce a constant periodic rate of interest on the remaining balance of the liability for each period.
61
Variable lease payments that depend on sales are recognised in profit or loss in the period in which the condition that triggers those payments
occurs.
Right-of-use assets are measured at cost comprising the following:
(i) the amount of the initial measurement of lease liability
(ii) any lease payments made at or before the commencement date less any lease incentives received
(iii) any initial direct costs, and
(iv) restoration costs.
Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the
Company is reasonably certain to exercise a purchase option, the right-of-use asset is depreciated over the underlying asset's useful life.
Payments associated with short-term leases and all leases of low-value assets are recognised on a straight-line basis as an expense in profit or
loss. Short-term leases are leases with a lease term of 12 months or less.
8. BUSINESS COMBINATIONS
The acquisition method of accounting is used to account for all business combinations, regardless of whether equity instruments or other assets
are acquired. The consideration transferred for the acquisition of a subsidiary comprises the:
(i) fair values of the assets transferred;
(ii) liabilities incurred to the former owners of the acquired business;
(iii) equity interests issued by the Company; and
(iv) fair value of any asset or liability resulting from a contingent consideration arrangement.
Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured
initially at their fair values at the acquisition date. The Company recognises any non - controlling interest in the acquired entity on an
acquisition-by-acquisition basis either at fair value or at the non-controlling interest's proportionate share of the acquired entity's net identifiable
assets.
Acquisition-related costs are expensed as incurred.
The excess of the:
(i) consideration transferred;
(ii) amount of any non-controlling interest in the acquired entity, and
(iii) acquisition-date fair value of any previous equity interest in the acquired entity
over the fair value of the net identifiable assets acquired is recorded as goodwill. If those amounts are less than the fair value of the net
identifiable assets of the business acquired, the difference is recognised in other comprehensive income and accumulated in equity as capital
reserve provided there is clear evidence of the underlying reasons for classifying the business combination as a bargain purchase. In other
cases, the bargain purchase gain is recognised directly in equity as capital reserve.
Where settlement of any part of cash consideration is deferred, the amounts payable in the future are discounted to their present value as at the
date of exchange. The discount rate used is the entity's incremental borrowing rate, being the rate at which a similar borrowing could be obtained
from an independent financier under comparable terms and conditions.
9. IMPAIRMENT OF NON-FINANCIAL ASSETS - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS
The Company assesses at each reporting date as to whether there is any indication that any Property, Plant and Equipment and Intangible
assets or group of assets, called Cash Generating Units (CGU) may be impaired. If any such indication exists, the recoverable amount of an
asset or CGU is estimated to determine the extent of impairment, if any. When it is not possible to estimate the recoverable amount of an
individual asset, the Company estimates the recoverable amount of the CGU to which the asset belongs.
An impairment loss is recognised in the Statement of Profit and Loss to the extent, asset’s carrying amount exceeds its recoverable amount. The
recoverable amount is higher of an asset’s fair value less cost of disposal and value in use. Value in use is based on the estimated future cash
flows, discounted to their present value using pre-tax discount rate that reflects current market assessments of the time value of money and risk
specific to the assets. The impairment loss recognised in prior accounting period is reversed if there has been a change in the estimate of
recoverable amount.
10. CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise of cash on hand, cash at banks, short term deposits and short-term highly liquid investments that are
readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.
11. TRADE RECEIVABLES
Trade receivables are amounts due from customers for services performed in the ordinary course of business. Trade receivables are recognised
initially at the amount of consideration that is unconditional unless they contain significant financing components, when they are recognised at
the fair value. The Company holds the trade receivables with the objective to collect the contractual cash flows and therefore measures them
subsequently at amortised cost using the effective interest rate method, less loss allowance.
12. INVESTMENTS AND OTHER FINANCIAL ASSETS
Financial Instruments
i) Financial Assets
A. Initial Recognition and Measurement
All Financial Assets are initially recognized at fair value. Transaction costs that are directly attributable to the acquisition or issue of Financial
Assets, which are not at Fair Value Through Profit or Loss, are adjusted to the fair value on initial recognition. Purchase and sale of Financial
Assets are recognized using trade date accounting.
B. Subsequent Measurement
(a) Financial Assets Measured at Amortised Cost (AC)
A Financial Asset is measured at Amortised Cost if it is held within a business model whose objective is to hold the asset in order to collect
contractual cash flows and the contractual terms of the Financial Asset give rise on specified dates to cash flows that represents solely payments
of principal and interest on the principal amount outstanding.
62
(b) Financial Assets Measured at Fair Value Through Other Comprehensive Income (FVTOCI)
A Financial Asset is measured at FVTOCI if it is held within a business model whose objective is achieved by both collecting contractual cash
flows and selling Financial Assets and the contractual terms of the Financial Asset give rise on specified dates to cash flows that represents
solely payments of principal and interest on the principal amount outstanding.
(c) Financial Assets Measured at Fair Value Through Profit or Loss (FVTPL)
A Financial Asset which is not classified in any of the above categories are measured at FVTPL
Financial assets are reclassified subsequent to their recognition, if the Company changes its business model for managing those financial
assets. Changes in business model are made and applied prospectively from the reclassification date which is the first day of immediately next
reporting period following the changes in business model in accordance with principles laid down under Ind AS 109 – Financial Instruments.
C. Investment in Subsidiaries, Associates and Joint ventures
The Company has accounted for its investments in Subsidiaries, associates and joint venture at cost less impairment loss (if any).
D. Other Equity Investments
All other equity investments are measured at fair value, with value changes recognised in Statement of Profit and Loss, except for those equity
investments for which the Company has elected to present the value changes in ‘Other Comprehensive Income’. However, dividend on such
equity investments are recognized in Statement of Profit and loss when the company’s right to receive payment is established.
E. Impairment of Financial Assets
In accordance with Ind AS 109, the Company uses “Expected Credit Loss” (ECL) model, for evaluating impairment of Financial Assets other than
those measured at Fair Value Through Profit and Loss (FVTPL).
Expected credit losses are measured through a loss allowance at an amount equal to:
• The 12 months expected credit losses (expected credit losses that result from those default events on the financial instrument that are possible
within 12 months after the reporting date);
or
• Full lifetime expected credit losses (expected credit losses that result from all possible default events over the life of the financial instrument)
For Trade Receivables the Company applies ‘simplified approach’ which requires expected lifetime losses to be recognised from initial
recognition of the receivables. The Company uses historical default rates to determine impairment loss on the portfolio of trade receivables. At
every reporting date these historical default rates are reviewed and changes in the forward looking estimates are analysed.
For other assets, the Company uses 12 month ECL to provide for impairment loss where there is no significant increase in credit risk. If there is
significant increase in credit risk full lifetime ECL is used.
ii) Financial Liabilities
All Financial Liabilities are recognized at fair value and in case of borrowings, net of directly attributable cost. Fees of recurring nature are directly
recognised in the Statement of Profit and Loss as finance cost.
Financial Liabilities are carried at amortized cost using the effective interest method. For trade and other payables maturing within one year from
the balance sheet date, the carrying amounts approximate fair value due to the short maturity of these instruments.
(iii) Derecognition of financial assets
The Company derecognizes a Financial Asset when the contractual rights to the cash flows from the Financial Asset expire or it transfers the
Financial Asset and the transfer qualifies for derecognition under Ind AS 109.
A Financial Liability (or a part of a Financial Liability) is derecognized from the Company’s Balance Sheet when the obligation specified in the
contract is discharged or cancelled or expires.
(iv) Income recognition
A. Interest income
Interest Income from a Financial Asset is recognised using effective interest rate method.
B. Dividends
Dividend Income is recognised when the Company’s right to receive the amount has been established.
13. PROPERTY, PLANT AND EQUIPMENT
All property, plant and equipment are stated at historical cost less depreciation. Historical cost includes expenditure that is directly attributable to
the acquisition of the items.
Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that
future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying
amount of any component accounted for as a separate asset is derecognised when replaced. All other repairs and maintenance are charged to
profit or loss during the reporting period in which they are incurred.
Depreciation methods, estimated useful lives and residual value
Depreciation is calculated using the written down value method to allocate their cost, net of their residual values, over their estimated useful lives
or, in the case of certain leased furniture, fittings and equipment, the shorter lease term as follows:
Asset Useful life
Office equipments 5 years
Furniture and fixtures 10 years
Computers and accessories
-Servers and networks 6 years
-End user devices, such as laptops, desktops, etc. 3 years
63
Leasehold improvements 3 years
The useful lives have been determined based on technical evaluation done by the Management's expert, in order to reflect the actual usage of
the assets and are in line with those specified by Schedule II to the Companies Act, 2013.
The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are reviewed, and
adjusted if appropriate, at the end of each reporting period.
An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated
recoverable amount. Gains and losses on disposals are determined by comparing proceeds with carrying amount. These are included in profit or
loss within other income / (expenses).
14. INTANGIBLE ASSETS
Intangible Assets are stated at cost of acquisition net of recoverable taxes, trade discount and rebates less accumulated amortisation / depletion
and impairment loss, if any. Such cost includes purchase price and any cost directly attributable to bringing the asset to its working condition for
the intended use.
future economic benefits associated with the item will flow to the entity and the cost can be measured reliably.
Other Indirect Expenses incurred relating to project, net of income earned during the project development stage prior to its intended use, are
considered as pre-operative expenses and disclosed under Intangible Assets Under Development.
Gains or losses arising from derecognition of an Intangible Asset are measured as the difference between the net disposal proceeds and the
carrying amount of the asset and are recognized in the Statement of Profit and Loss when the asset is derecognized.
i) Goodwill
Goodwill on past business combination is included in intangible assets. Goodwill is not amortised but it is tested for impairment annually, or more
frequently if events or changes in circumstances indicate that it might be impaired, and is carried at cost less accumulated impairment losses.
Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.
A cash-generating unit to which goodwill has been allocated is tested for impairment annually, or when there is an indication that the unit may be
impaired. The recoverable amount of cash generating unit is determined for each cash generating unit based on a value in use calculation which
uses cash flow projections and appropriate discount rate is applied. The discount rate takes into account the expected rate of return to
shareholders, the risk of achieving the business projections, risks specific to the investments and other factors. If the recoverable amount of the
cash-generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated
to the unit and then to the other assets of the unit pro rata based on the carrying amount of each asset in the unit. Any impairment loss for
goodwill is recognised directly in profit or loss. An impairment loss recognised for goodwill is not reversed in subsequent periods.
On disposal of the relevant cash-generating unit, the attributable amount of goodwill is included in the determination of the profit or loss on
disposal.
ii) Computer software including internally developed software
Costs associated with maintaining software programmes are recognised as an expense as incurred. Development costs that are directly
attributable to the design and testing of identifiable and unique software products controlled by the Company are recognised as intangible assets
where the following criteria are met:
- it is technically feasible to complete the software so that it will be available for use
- Management intends to complete the software and use or sell it
- there is an ability to use or sell the software
- it can be demonstrated how the software will generate probable future economic benefits
- adequate technical, financial and other resources to complete the development and to use or sell the software are available, and
- the expenditure attributable to the software during its development can be reliably measured.
Directly attributable costs that are capitalised as part of the software include employee costs and an appropriate portion of relevant overheads.
Capitalised development costs are recorded as intangible assets and amortised from the point at which the asset is available for use. They are
stated at cost net of accumulated amortisation.
iii) Amortisation methods and periods
The Company amortises intangible assets with a finite useful life using the straight-line method over the following periods:
Asset Useful life
Computer software 4 years
Licenses 4 years
Non compete fee 3 years
The amortisation period and the amortisation method for Intangible Assets with a finite useful life are reviewed at each reporting date.
15. TRADE AND OTHER PAYABLES
These amounts represent liabilities for services provided to the Company prior to the end of financial year which are unpaid. The amounts are
unsecured and are usually paid within the period agreed with the vendors.
Trade and other payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are
recognised initially at their fair value and subsequently measured at amortised cost using the effective interest rate method.
16. BORROWINGS
Borrowings are initially recognised at fair value net of transaction costs incurred. Borrowings are subsequently measured at amortised cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognised in profit or loss over the period of the
borrowings using the effective interest rate method.
Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
64
including any non-cash assets transferred or liabilities assumed, is recognised in profit or loss as other income / (expenses).
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period. Where there is a breach of a material provision of a long-term loan arrangement on or before the end of the
reporting period with the effect that the liability becomes payable on demand on the reporting date, the entity does not classify the liability as
current, if the lender agreed, after the reporting period and before the approval of the financial statements for issue, not to demand payment as a
consequence of the breach.
17. BORROWING COSTS
General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalised during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets
that necessarily take a substantial period of time to get ready for their intended use or sale.
Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from
the borrowing costs eligible for capitalisation.
Other borrowing costs are expensed in the period in which they are incurred.
18. PROVISIONS AND CONTINGENT LIABILITIES
i) Provisions:
Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an
outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of
the obligation and a reliable estimate can be made of the amount of the obligation.
If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, when appropriate, the risks
specific to the liability. When discounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.
ii) Contingent liabilities:
Disclosure of contingent liability is made when there is a possible obligation arising from past events, the existence of which will be confirmed
only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the Company or a present
obligation that arises from past events where it is either not probable that an outflow of resources embodying economic benefits will be required
to settle or a reliable estimate of amount cannot be made.
19. EMPLOYEE BENEFITS
i) Short-term obligations
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognised in respect of employees' services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.
ii) Other long-term employee benefit obligations
The liabilities for earned leave are not expected to be settled wholly within 12 months after the end of the period in which the employees render
the related service. They are therefore measured as the present value of expected future payments to be made in respect of services provided
by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the appropriate
market yields at the end of the reporting period that have terms approximating to the terms of the related obligation. Remeasurements as a result
of experience adjustments and changes in actuarial assumptions are recognised in profit or loss.
The obligations are presented as current liabilities in the balance sheet if the entity does not have an unconditional right to defer settlement for at
least 12 months after the reporting period, regardless of when the actual settlement is expected to occur.
iii) Post-employment obligations
A. Defined contribution plans
Provident Fund
The Company pays provident fund contributions to publicly administered provident funds as per local regulations. The Company has no further
payment obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the
contributions are recognised as employee benefits expense when they are due. Prepaid contributions are recognised as an asset to the extent
that a cash refund or a reduction in the future payments is available.
B. Defined benefit plans
Gratuity
The liability or asset recognised in the balance sheet in respect of defined benefit gratuity plan is the present value of the defined benefit
obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuary
using the projected unit credit method.
The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows by reference to market yields
at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation. The net interest cost
is calculated by applying the discount rate to the net balance of defined benefit obligation and the fair value of plan assets. This cost is included
in employee benefits expense in the statement of profit and loss.
Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognised in the period in
which they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
Balance Sheet.
Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognised immediately in
profit or loss as past service cost.
iv) Bonus plans
The Company recognises a liability and an expense for bonuses. The Company recognises a provision where contractually obliged or where
there is a past practice that has created a constructive obligation.
v) Share-based payments
Share-based compensation benefits provided to employees under the "Vitalic ESOP 2019" plan, an employee share scheme was discontinued in
65
the previous year vide resolution passed in the Extraordinary General Meeting held on 15th June 2020 and cancellation of all options under the
plan.
Employee options
The option is treated as an equity-settled share-based payment as the Company does not have an obligation to settle the award. The fair value
of options granted under the plan is recognised as an employee benefits expense with a corresponding increase in equity. Options granted under
the plan to employees of the Company's subsidiaries including step-down subsidiaries are recognsied as investment with a corresponding
increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:
time period), and
The total expense is recognised over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.
At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and
service conditions. It recognises the impact of the original to revised estimates, if any, in profit or loss, with a corresponding adjustments to
equity.
20. CONTRIBUTED EQUITY
Equity shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a
deduction, net of tax, from the proceeds.
21. EARNINGS PER SHARE
i) Basic earnings per share
Basic earnings per share is calculated by dividing:
- the profit attributable to owners of the Company
- by the weighted average number of equity shares outstanding during the financial year, equity shares issued during the year
ii) Diluted earnings per share
Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account:
- the after income tax effect of interest and other financing costs associated with dilutive potential equity shares, and
- the weighted average number of additional equity shares that would have been outstanding assuming the conversion of all dilutive potential
equity shares.
22. ROUNDING OF AMOUNTS
All amounts disclosed in the financial statements and notes have been rounded off to the nearest lakhs as per the requirement of Schedule III,
unless otherwise stated.
23. STANDARDS ISSUED BUT NOT EFFECTIVE
On March 23, 2022, the Ministry of Corporate Affairs (MCA) has notified Companies (Indian Accounting Standards) Amendment Rules, 2022.
This notification has resulted into amendments in the following existing accounting standards which are applicable to company from April 1,
2022.
Ind AS 101 – First time adoption of Ind AS
Ind AS 103 – Business Combination
Ind AS 109 – Financial Instrument
Ind AS 16 – Property, Plant and Equipment
Ind AS 37 –Provisions, Contingent Liabilities and Contingent Assets
Ind AS 41 – Agriculture
Application of above standards are not expected to have any significant impact on the company’s financial statements.
66
[610200] Notes - Corporate information and statement of IndAs compliance

Textual
Disclosure of corporate information notes and other explanatory information [Text Block] Information (11)
Textual Textual
Statement of Ind AS compliance [Text Block] Information (12) Information (13)
Whether there is any departure from Ind AS No No
Whether there are reclassifications to comparative amounts No No
Textual
Disclosure of significant accounting policies [Text Block] Information (14)
Textual information (11): Disclosure of corporate information notes and other explanatory information [Text Block]
CORPORATE INFORMATION
Netmeds Marketplace Limited ('the Company') is a company incorporated in India having its registered office at No.1, Lalithapuram, Royapettah,
Chennai, Tamil Nadu-600014, India. The Company’s immediate holding company is Tresara Health Limited (formerly known as Tresara Health
Private Limited), intermediate holding company is Reliance Retail Ventures Limited and the Ultimate Holding Company is Reliance Industries
Limited.
The Company is carrying on the business of providing business consultancy, technical services and related advisory/support services. The
Company is also rendering agency services relating to doctor consultations, diagnostics and customer subscriptions.
Textual information (12): Statement of Ind AS compliance [Text Block]
Compliance with Ind AS

Textual information (13): Statement of Ind AS compliance [Text Block]
Compliance with Ind AS

Textual information (14): Disclosure of significant accounting policies [Text Block]
SIGNIFICANT ACCOUNTING POLICIES

This note provides a list of the significant accounting policies adopted in the preparation of these financial statements. These policies have been
consistently applied to all the years presented, unless otherwise stated.
1. BASIS OF PREPARATION AND PRESENTATION
(i) Compliance with Ind AS
(ii) Historical cost convention
The financial statements have been prepared on a historical cost basis, except for the following:
- certain financial assets and liabilities are measured at fair value
(iii) Going Concern
These financial statements of the Company are prepared on a going concern basis.
(vi) Current and Non-Current Classification
The Company presents assets and liabilities in the Balance Sheet based on Current / Non-Current classification.
An asset is treated as Current when it is -
- Expected to be realised or intended to be sold or consumed in normal operating cycle;
- Held primarily for the purpose of trading;
- Expected to be realised within twelve months after the reporting period, or
- Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.
All other assets are classified as non-current.
A liability is current when -
- It is expected to be settled in normal operating cycle;
- It is held primarily for the purpose of trading;
- It is due to be settled within twelve months after the reporting period, or
- There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period.
The Company classifies all other liabilities as non-current.
67
Deferred tax assets and liabilities are classified as non-current assets and liabilities.
2. CRITICAL ESTIMATES AND JUDGEMENTS
The preparation of financial statements in conformity with Ind AS requires the management to make judgments, estimates and assumptions
about the carrying amounts of assets and liabilities recognised in the financial statements that are not readily apparent from other sources. The
judgements, estimates and associated assumptions are based on historical experience and other factors including estimation of effects of
uncertain future events that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates (accounted on a prospective
basis) are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and
future periods if the revision affects both current and future periods.
The following are the critical judgements and estimations that have been made by the management:
Estimation of current tax expense and payable - Note B.6 and Note 26
Estimated useful life of property, plant and equipment - Note B.13
Estimation of defined benefit obligation - Note B.19 and Note 22.1
Fair value measurements and valuation processes - Note B.12 and Note 30
Impairment of financial assets - Note B.12 and Note 31.1
3. SEGMENT REPORTING
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker (CODM).
The board of directors assesses the financial performance and position of the Company, and makes strategic decisions. The board of directors
have been identified as being the CODM.
Refer Note 33 for segment information presented.
4. FOREIGN CURRENCY TRANSLATION
(i) Functional and presentation currency:
Items included in the financial statements are measured using the currency of the primary economic environment in which the entity operates
('the functional currency'), i.e., Indian Rupee (INR), which is the Company's functional and presentation currency.
(ii) Transactions and balances:
Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities
denominated in foreign currencies at year end exchange rates are generally recognised in profit or loss.
All other foreign exchange gains and losses are presented in the statement of profit and loss on a net basis within other gains / (losses).
5. REVENUE RECOGNITION
Sale of services
Marketplace fees
Revenue from providing services is recognised at a point in time when the performance obligations are fulfilled.
Diagnostic services
Revenue from diagnostic consultation is recognised at a point in time, when the services are performed and the customer has availed the
services.
Doctor consultation
Revenue from doctor consultation is recognised over time, when the performance obligation of providing the consultation is performed.
Marketing services
Revenue from marketing services are in the nature of time and space provided in the online marketplace for advertisement. Revenue is
recognised over time when the performance obligations are satisfied in the accounting periods it is performed.
Business consultancy, technical services and related advisory / support services
Revenue in the nature of Business Consultancy, technical services and related advisory / support services is recognised over time when the
performance obligations are fulfilled and there is no uncertainty over the realisation of revenue from the customer.
Collections from marketing services are due as per the agreed credit terms of the contract.
Payment for the doctor consultation is received upfront when the customer blocks appointment through the portal.
Payment for the diagnostic consultation is received either when the end customer blocks the appointment for the services, or when the
consultation services is performed.
Payment for Business Consultancy, technical services and related advisory/support services are as per the terms of the contract.
The Company does not expect to have any contracts where the period between the transfer of the promised goods or services to the customer
and payment by the customer exceeds one year. As a consequence, the Company does not adjust any of the transaction prices for the time
value of money.
6. TAX EXPENSES
The tax expenses for the period comprises of current tax and deferred income tax. Tax is recognised in Statement of Profit and Loss, except to
the extent that it relates to items recognised in the Other Comprehensive Income or in Equity. In which case, the tax is also recognised in Other
Comprehensive Income or Equity.
i) Current Tax
Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to the Income Tax authorities, based on tax
rates and laws that are enacted at the Balance sheet date.
ii) Deferred Tax
Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities in the Financial Statements and the
corresponding tax bases used in the computation of taxable profit.
Deferred tax assets are recognised to the extent it is probable that taxable profit will be available against which the deductible temporary
differences, and the carry forward of unused tax losses can be utilized.
68
Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset
realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.
7. LEASES.
As a lessee
Leases are recognised as a right-of-use asset and a corresponding liability at the date at which the leased asset is available for use by the
Company. Contracts may contain both lease and non-lease components. The Company allocates the consideration in the contract to the lease
and non-lease components based on their relative stand-alone prices.
Assets and liabilities arising from a lease are initially measured on a present value basis. Lease liabilities include the net present value of the
following lease payments:
(i) fixed payments (including in-substance fixed payments), less any lease incentives receivable
(ii) variable lease payment that are based on an index or a rate, initially measured using the index or rate as at the commencement date
(iii) amounts expected to be payable by the Company under residual value guarantees
(iv) the exercise price of a purchase option if the Company is reasonably certain to exercise that option, and
(v) payments of penalties for terminating the lease, if the lease term reflects the Company exercising that option.
Lease payments to be made under reasonably certain extension options are also included in the measurement of the liability. The lease
payments are discounted using the interest rate implicit in the lease. If that rate cannot be readily determined, which is generally the case for
leases in the Company, the lessee's incremental borrowing rate is used, being the rate that the individual lessee would have to pay to borrow the
funds necessary to obtain an asset of similar value to the right-of-use asset in a similar economic environment with similar terms, security and
conditions.
To determine the incremental borrowing rate, the Company:
(i) where possible uses a third-party financing received by the individual lessee as a starting point, adjusted to reflect changes in financing
conditions since third party financing was received
(ii) uses a build-up approach that starts with a risk-free interest rate adjusted for credit risk for leases held by the Company, which does not have
recent third party financing, and
(iii) makes adjustments specific to the lease, e.g. term, country, currency and security.
Potential future increases in variable lease payments based on an index or rate are not included in the lease liability until they take effect. When
adjustments to lease payments based on an index or rate take effect, the lease liability is reassessed and adjusted against the right-of-use asset.
Lease payments are allocated between principal and finance cost. The finance cost is charged to profit or loss over the lease period so as to
produce a constant periodic rate of interest on the remaining balance of the liability for each period.
Variable lease payments that depend on sales are recognised in profit or loss in the period in which the condition that triggers those payments
occurs.
Right-of-use assets are measured at cost comprising the following:
(i) the amount of the initial measurement of lease liability
(ii) any lease payments made at or before the commencement date less any lease incentives received
(iii) any initial direct costs, and
(iv) restoration costs.
Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease term on a straight-line basis. If the
Company is reasonably certain to exercise a purchase option, the right-of-use asset is depreciated over the underlying asset's useful life.
Payments associated with short-term leases and all leases of low-value assets are recognised on a straight-line basis as an expense in profit or
loss. Short-term leases are leases with a lease term of 12 months or less.
8. BUSINESS COMBINATIONS
The acquisition method of accounting is used to account for all business combinations, regardless of whether equity instruments or other assets
are acquired. The consideration transferred for the acquisition of a subsidiary comprises the:
(i) fair values of the assets transferred;
(ii) liabilities incurred to the former owners of the acquired business;
(iii) equity interests issued by the Company; and
(iv) fair value of any asset or liability resulting from a contingent consideration arrangement.
Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are, with limited exceptions, measured
initially at their fair values at the acquisition date. The Company recognises any non - controlling interest in the acquired entity on an
acquisition-by-acquisition basis either at fair value or at the non-controlling interest's proportionate share of the acquired entity's net identifiable
assets.
Acquisition-related costs are expensed as incurred.
The excess of the:
(i) consideration transferred;
(ii) amount of any non-controlling interest in the acquired entity, and
(iii) acquisition-date fair value of any previous equity interest in the acquired entity
over the fair value of the net identifiable assets acquired is recorded as goodwill. If those amounts are less than the fair value of the net
identifiable assets of the business acquired, the difference is recognised in other comprehensive income and accumulated in equity as capital
reserve provided there is clear evidence of the underlying reasons for classifying the business combination as a bargain purchase. In other
cases, the bargain purchase gain is recognised directly in equity as capital reserve.
Where settlement of any part of cash consideration is deferred, the amounts payable in the future are discounted to their present value as at the
date of exchange. The discount rate used is the entity's incremental borrowing rate, being the rate at which a similar borrowing could be obtained
from an independent financier under comparable terms and conditions.
9. IMPAIRMENT OF NON-FINANCIAL ASSETS - PROPERTY, PLANT AND EQUIPMENT AND INTANGIBLE ASSETS
The Company assesses at each reporting date as to whether there is any indication that any Property, Plant and Equipment and Intangible
69
assets or group of assets, called Cash Generating Units (CGU) may be impaired. If any such indication exists, the recoverable amount of an
asset or CGU is estimated to determine the extent of impairment, if any. When it is not possible to estimate the recoverable amount of an
individual asset, the Company estimates the recoverable amount of the CGU to which the asset belongs.
An impairment loss is recognised in the Statement of Profit and Loss to the extent, asset’s carrying amount exceeds its recoverable amount. The
recoverable amount is higher of an asset’s fair value less cost of disposal and value in use. Value in use is based on the estimated future cash
flows, discounted to their present value using pre-tax discount rate that reflects current market assessments of the time value of money and risk
specific to the assets. The impairment loss recognised in prior accounting period is reversed if there has been a change in the estimate of
recoverable amount.
10. CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise of cash on hand, cash at banks, short term deposits and short-term highly liquid investments that are
readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.
11. TRADE RECEIVABLES
Trade receivables are amounts due from customers for services performed in the ordinary course of business. Trade receivables are recognised
initially at the amount of consideration that is unconditional unless they contain significant financing components, when they are recognised at
the fair value. The Company holds the trade receivables with the objective to collect the contractual cash flows and therefore measures them
subsequently at amortised cost using the effective interest rate method, less loss allowance.
12. INVESTMENTS AND OTHER FINANCIAL ASSETS
Financial Instruments
i) Financial Assets
All Financial Assets are initially recognized at fair value. Transaction costs that are directly attributable to the acquisition or issue of Financial
Assets, which are not at Fair Value Through Profit or Loss, are adjusted to the fair value on initial recognition. Purchase and sale of Financial
Assets are recognized using trade date accounting.
(a) Financial Assets Measured at Amortised Cost (AC)
A Financial Asset is measured at Amortised Cost if it is held within a business model whose objective is to hold the asset in order to collect
contractual cash flows and the contractual terms of the Financial Asset give rise on specified dates to cash flows that represents solely payments
of principal and interest on the principal amount outstanding.
(b) Financial Assets Measured at Fair Value Through Other Comprehensive Income (FVTOCI)
A Financial Asset is measured at FVTOCI if it is held within a business model whose objective is achieved by both collecting contractual cash
flows and selling Financial Assets and the contractual terms of the Financial Asset give rise on specified dates to cash flows that represents
solely payments of principal and interest on the principal amount outstanding.
(c) Financial Assets Measured at Fair Value Through Profit or Loss (FVTPL)
A Financial Asset which is not classified in any of the above categories are measured at FVTPL
Financial assets are reclassified subsequent to their recognition, if the Company changes its business model for managing those financial
assets. Changes in business model are made and applied prospectively from the reclassification date which is the first day of immediately next
reporting period following the changes in business model in accordance with principles laid down under Ind AS 109 – Financial Instruments.
C. Investment in Subsidiaries, Associates and Joint ventures
The Company has accounted for its investments in Subsidiaries, associates and joint venture at cost less impairment loss (if any).
D. Other Equity Investments
All other equity investments are measured at fair value, with value changes recognised in Statement of Profit and Loss, except for those equity
investments for which the Company has elected to present the value changes in ‘Other Comprehensive Income’. However, dividend on such
equity investments are recognized in Statement of Profit and loss when the company’s right to receive payment is established.
E. Impairment of Financial Assets
In accordance with Ind AS 109, the Company uses “Expected Credit Loss” (ECL) model, for evaluating impairment of Financial Assets other than
those measured at Fair Value Through Profit and Loss (FVTPL).
Expected credit losses are measured through a loss allowance at an amount equal to:
• The 12 months expected credit losses (expected credit losses that result from those default events on the financial instrument that are possible
within 12 months after the reporting date);
or
• Full lifetime expected credit losses (expected credit losses that result from all possible default events over the life of the financial instrument)
For Trade Receivables the Company applies ‘simplified approach’ which requires expected lifetime losses to be recognised from initial
recognition of the receivables. The Company uses historical default rates to determine impairment loss on the portfolio of trade receivables. At
every reporting date these historical default rates are reviewed and changes in the forward looking estimates are analysed.
For other assets, the Company uses 12 month ECL to provide for impairment loss where there is no significant increase in credit risk. If there is
significant increase in credit risk full lifetime ECL is used.
ii) Financial Liabilities
All Financial Liabilities are recognized at fair value and in case of borrowings, net of directly attributable cost. Fees of recurring nature are directly
recognised in the Statement of Profit and Loss as finance cost.
Financial Liabilities are carried at amortized cost using the effective interest method. For trade and other payables maturing within one year from
the balance sheet date, the carrying amounts approximate fair value due to the short maturity of these instruments.
(iii) Derecognition of financial assets
The Company derecognizes a Financial Asset when the contractual rights to the cash flows from the Financial Asset expire or it transfers the
70
Financial Asset and the transfer qualifies for derecognition under Ind AS 109.
A Financial Liability (or a part of a Financial Liability) is derecognized from the Company’s Balance Sheet when the obligation specified in the
contract is discharged or cancelled or expires.
(iv) Income recognition
A. Interest income
Interest Income from a Financial Asset is recognised using effective interest rate method.
B. Dividends
Dividend Income is recognised when the Company’s right to receive the amount has been established.
13. PROPERTY, PLANT AND EQUIPMENT
All property, plant and equipment are stated at historical cost less depreciation. Historical cost includes expenditure that is directly attributable to
the acquisition of the items.
future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying
amount of any component accounted for as a separate asset is derecognised when replaced. All other repairs and maintenance are charged to
profit or loss during the reporting period in which they are incurred.
Depreciation methods, estimated useful lives and residual value
Depreciation is calculated using the written down value method to allocate their cost, net of their residual values, over their estimated useful lives
or, in the case of certain leased furniture, fittings and equipment, the shorter lease term as follows:
Asset Useful life
Office equipments 5 years
Furniture and fixtures 10 years
Computers and accessories
-Servers and networks 6 years
-End user devices, such as laptops, desktops, etc. 3 years
Leasehold improvements 3 years
The useful lives have been determined based on technical evaluation done by the Management's expert, in order to reflect the actual usage of
the assets and are in line with those specified by Schedule II to the Companies Act, 2013.
The residual values are not more than 5% of the original cost of the asset. The assets’ residual values and useful lives are reviewed, and
adjusted if appropriate, at the end of each reporting period.
An asset’s carrying amount is written down immediately to its recoverable amount if the asset’s carrying amount is greater than its estimated
recoverable amount. Gains and losses on disposals are determined by comparing proceeds with carrying amount. These are included in profit or
loss within other income / (expenses).
14. INTANGIBLE ASSETS
Intangible Assets are stated at cost of acquisition net of recoverable taxes, trade discount and rebates less accumulated amortisation / depletion
and impairment loss, if any. Such cost includes purchase price and any cost directly attributable to bringing the asset to its working condition for
the intended use.
future economic benefits associated with the item will flow to the entity and the cost can be measured reliably.
Other Indirect Expenses incurred relating to project, net of income earned during the project development stage prior to its intended use, are
considered as pre-operative expenses and disclosed under Intangible Assets Under Development.
Gains or losses arising from derecognition of an Intangible Asset are measured as the difference between the net disposal proceeds and the
carrying amount of the asset and are recognized in the Statement of Profit and Loss when the asset is derecognized.
i) Goodwill
Goodwill on past business combination is included in intangible assets. Goodwill is not amortised but it is tested for impairment annually, or more
frequently if events or changes in circumstances indicate that it might be impaired, and is carried at cost less accumulated impairment losses.
Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.
A cash-generating unit to which goodwill has been allocated is tested for impairment annually, or when there is an indication that the unit may be
impaired. The recoverable amount of cash generating unit is determined for each cash generating unit based on a value in use calculation which
uses cash flow projections and appropriate discount rate is applied. The discount rate takes into account the expected rate of return to
shareholders, the risk of achieving the business projections, risks specific to the investments and other factors. If the recoverable amount of the
cash-generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated
to the unit and then to the other assets of the unit pro rata based on the carrying amount of each asset in the unit. Any impairment loss for
goodwill is recognised directly in profit or loss. An impairment loss recognised for goodwill is not reversed in subsequent periods.
On disposal of the relevant cash-generating unit, the attributable amount of goodwill is included in the determination of the profit or loss on
disposal.
ii) Computer software including internally developed software
Costs associated with maintaining software programmes are recognised as an expense as incurred. Development costs that are directly
attributable to the design and testing of identifiable and unique software products controlled by the Company are recognised as intangible assets
where the following criteria are met:
- it is technically feasible to complete the software so that it will be available for use
- Management intends to complete the software and use or sell it
71
- there is an ability to use or sell the software

- it can be demonstrated how the software will generate probable future economic benefits
- adequate technical, financial and other resources to complete the development and to use or sell the software are available, and
- the expenditure attributable to the software during its development can be reliably measured.
Directly attributable costs that are capitalised as part of the software include employee costs and an appropriate portion of relevant overheads.
Capitalised development costs are recorded as intangible assets and amortised from the point at which the asset is available for use. They are
stated at cost net of accumulated amortisation.
iii) Amortisation methods and periods
The Company amortises intangible assets with a finite useful life using the straight-line method over the following periods:
Asset Useful life
Computer software 4 years
Licenses 4 years
Non compete fee 3 years
The amortisation period and the amortisation method for Intangible Assets with a finite useful life are reviewed at each reporting date.
15. TRADE AND OTHER PAYABLES
These amounts represent liabilities for services provided to the Company prior to the end of financial year which are unpaid. The amounts are
unsecured and are usually paid within the period agreed with the vendors.
Trade and other payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are
recognised initially at their fair value and subsequently measured at amortised cost using the effective interest rate method.
16. BORROWINGS
Borrowings are initially recognised at fair value net of transaction costs incurred. Borrowings are subsequently measured at amortised cost. Any
difference between the proceeds (net of transaction costs) and the redemption amount is recognised in profit or loss over the period of the
borrowings using the effective interest rate method.
Borrowings are removed from the balance sheet when the obligation specified in the contract is discharged, cancelled or expired. The difference
between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid,
including any non-cash assets transferred or liabilities assumed, is recognised in profit or loss as other income / (expenses).
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12
months after the reporting period. Where there is a breach of a material provision of a long-term loan arrangement on or before the end of the
reporting period with the effect that the liability becomes payable on demand on the reporting date, the entity does not classify the liability as
current, if the lender agreed, after the reporting period and before the approval of the financial statements for issue, not to demand payment as a
consequence of the breach.
17. BORROWING COSTS
General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying asset are
capitalised during the period of time that is required to complete and prepare the asset for its intended use or sale. Qualifying assets are assets
that necessarily take a substantial period of time to get ready for their intended use or sale.
Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from
the borrowing costs eligible for capitalisation.
Other borrowing costs are expensed in the period in which they are incurred.
18. PROVISIONS AND CONTINGENT LIABILITIES
i) Provisions:
Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an
outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of
the obligation and a reliable estimate can be made of the amount of the obligation.
If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, when appropriate, the risks
specific to the liability. When discounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.
ii) Contingent liabilities:
Disclosure of contingent liability is made when there is a possible obligation arising from past events, the existence of which will be confirmed
only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the Company or a present
obligation that arises from past events where it is either not probable that an outflow of resources embodying economic benefits will be required
to settle or a reliable estimate of amount cannot be made.
19. EMPLOYEE BENEFITS
i) Short-term obligations
Liabilities for wages and salaries, including non-monetary benefits that are expected to be settled wholly within 12 months after the end of the
period in which the employees render the related service are recognised in respect of employees' services up to the end of the reporting period
and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit
obligations in the balance sheet.
ii) Other long-term employee benefit obligations
The liabilities for earned leave are not expected to be settled wholly within 12 months after the end of the period in which the employees render
the related service. They are therefore measured as the present value of expected future payments to be made in respect of services provided
by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the appropriate
market yields at the end of the reporting period that have terms approximating to the terms of the related obligation. Remeasurements as a result
of experience adjustments and changes in actuarial assumptions are recognised in profit or loss.
72
The obligations are presented as current liabilities in the balance sheet if the entity does not have an unconditional right to defer settlement for at
least 12 months after the reporting period, regardless of when the actual settlement is expected to occur.
iii) Post-employment obligations
A. Defined contribution plans
Provident Fund
The Company pays provident fund contributions to publicly administered provident funds as per local regulations. The Company has no further
payment obligations once the contributions have been paid. The contributions are accounted for as defined contribution plans and the
contributions are recognised as employee benefits expense when they are due. Prepaid contributions are recognised as an asset to the extent
that a cash refund or a reduction in the future payments is available.
B. Defined benefit plans
Gratuity
The liability or asset recognised in the balance sheet in respect of defined benefit gratuity plan is the present value of the defined benefit
obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by actuary
using the projected unit credit method.
The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows by reference to market yields
at the end of the reporting period on government bonds that have terms approximating to the terms of the related obligation. The net interest cost
is calculated by applying the discount rate to the net balance of defined benefit obligation and the fair value of plan assets. This cost is included
in employee benefits expense in the statement of profit and loss.
Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognised in the period in
which they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and in the
Balance Sheet.
Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognised immediately in
profit or loss as past service cost.
iv) Bonus plans
The Company recognises a liability and an expense for bonuses. The Company recognises a provision where contractually obliged or where
there is a past practice that has created a constructive obligation.
v) Share-based payments
Share-based compensation benefits provided to employees under the "Vitalic ESOP 2019" plan, an employee share scheme was discontinued in
the previous year vide resolution passed in the Extraordinary General Meeting held on 15th June 2020 and cancellation of all options under the
plan.
Employee options
The option is treated as an equity-settled share-based payment as the Company does not have an obligation to settle the award. The fair value
of options granted under the plan is recognised as an employee benefits expense with a corresponding increase in equity. Options granted under
the plan to employees of the Company's subsidiaries including step-down subsidiaries are recognsied as investment with a corresponding
increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:
time period), and
The total expense is recognised over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.
At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and
service conditions. It recognises the impact of the original to revised estimates, if any, in profit or loss, with a corresponding adjustments to
equity.
20. CONTRIBUTED EQUITY
Equity shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a
deduction, net of tax, from the proceeds.
21. EARNINGS PER SHARE
i) Basic earnings per share
Basic earnings per share is calculated by dividing:
- the profit attributable to owners of the Company
- by the weighted average number of equity shares outstanding during the financial year, equity shares issued during the year
ii) Diluted earnings per share
Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account:
- the after income tax effect of interest and other financing costs associated with dilutive potential equity shares, and
- the weighted average number of additional equity shares that would have been outstanding assuming the conversion of all dilutive potential
equity shares.
22. ROUNDING OF AMOUNTS
All amounts disclosed in the financial statements and notes have been rounded off to the nearest lakhs as per the requirement of Schedule III,
unless otherwise stated.
23. STANDARDS ISSUED BUT NOT EFFECTIVE
On March 23, 2022, the Ministry of Corporate Affairs (MCA) has notified Companies (Indian Accounting Standards) Amendment Rules, 2022.
This notification has resulted into amendments in the following existing accounting standards which are applicable to company from April 1,
2022.
Ind AS 101 – First time adoption of Ind AS
Ind AS 103 – Business Combination
Ind AS 109 – Financial Instrument
73
Ind AS 16 – Property, Plant and Equipment

Ind AS 37 –Provisions, Contingent Liabilities and Contingent Assets
Ind AS 41 – Agriculture
Application of above standards are not expected to have any significant impact on the company’s financial statements.
74
[610300] Notes - Accounting policies, changes in accounting estimates and errors

Whether initial application of an Ind AS has an effect on the current period or any prior period No No
Whether there is any voluntary change in accounting policy No No
Whether there are changes in acounting estimates during the year No No
75
[610500] Notes - Events after reporting period

Whether there are non adjusting events after reporting period No No
76
[610700] Notes - Business combinations

Whether there is any business combination No No
Whether there is any goodwill arising out of business combination No No
Whether there are any acquired receivables from business combination No No
Whether there are any contingent liabilities in business combination No No
Disclosure of reconciliation of changes in goodwill [Table]

Business combinations [Axis] Business combination 1
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis] Carrying amount [Member]
Disclosure of reconciliation of changes in goodwill [Abstract]
Disclosure of reconciliation of changes in goodwill [Line items]
Name of acquiree -
Reconciliation of changes in goodwill [Abstract]
Changes in goodwill [Abstract]
Increase (decrease) through transfers and other changes -9.4
Total increase (decrease) in goodwill -9.4
Goodwill at end of period 0 9.4
77
[610800] Notes - Related party

Textual
Disclosure of related party [Text Block] Information (15)
(A) TRESARA
HEALTH
Name of parent entity LIMITED
RELIANCE
INDUSTRIES
Name of ultimate parent of group LIMITED
Whether there are any related party transactions during year Yes Yes
Whether entity applies exemption in Ind AS 24.25 No No
Other information subsidiary details [Abstract]
Whether company is subsidiary company Yes Yes
Section under which company is subsidiary Section 2(87)(ii) Section 2(87)(ii)
Footnotes
(A)
Formerly known as Tresara Health Private Limited
Disclosure of transactions between related parties [Table] ..(1)

Categories of related parties [Axis] Parent [Member]
Related party [Axis] Related Party 1 Related Party 2
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of transactions between related parties [Abstract]
Disclosure of transactions between related parties [Line items]
RELIANCE RELIANCE
RETAIL RETAIL (A) TRESARA (B) TRESARA
VENTURES VENTURES HEALTH HEALTH
Name of related party LIMITED LIMITED LIMITED LIMITED
Country of incorporation or residence of related party INDIA INDIA INDIA INDIA
U51909MH2006P U51909MH2006P U74900TN2015P U74900TN2015P
CIN of related party LC166166 LC166166 LC101916 LC101916
Borrowings
Repaid, Interest Borrowings,
Expenses on Interest Expenses
Description of nature of transactions with related party Loans on Loans
(C) Holding
Description of nature of related party relationship Holding company company Holding company Holding company
Related party transactions [Abstract]
Revenue from rendering of services related party
transactions (D) 170.51 (E) 231
Transfers under finance agreements from entity, related
party transactions 0 (F) 1,590 0 (G) 1,800
Transfers under finance agreements to entity, related party
transactions (H) 1,590 0 0 (I) 1,800
Other related party transactions expense (J) 7.19 (K) 68.91 (L) 0.79 (M) 48.61
Other related party transactions contribution made (N) 380 0
Other related party transactions contribution received 0 (O) 2,889.99
Outstanding balances for related party transactions [Abstract]
Amounts payable related party transactions 0 (P) 1,590 (Q) 1,200 (R) 1,588.4
Amounts receivable related party transactions 0 (S) 106.23
Footnotes
(A) Formerly Tresara Health Private Limited
(B) Formerly Tresara Health Private Limited
(C) Intermediate Holding Company from August 18, 2020
(D) Other Income - Support Service to Group Companies
(E) Other Income - Support Service to Group Companies
78
(F) Borrowings
(G)
Particulars 2020-21
Borrowings 1,500.00
Security Deposit received 300.00
Total 1,800.00
(H) Borrowings Repaid
(I)
Particulars 2020-21
Security Deposit repaid 300.00
Total 1,800.00
(J) Interest Expenses on Loans
(K) Interest Expenses on Loans
(L)
Particulars 2021-22
Staff Welfare 0.78
Total 0.79
(M)
Particulars 2020-21
Staff Welfare 7.76
Total 48.61
(N) Redemption of Optionally Fully Convertible Debentures
(O)
Particulars 2020-21
Share capital issued (including securities premium) 1,308.99
Issue of Optionally Fully convertible Debentures 1,580.00
Total 2,888.99
(P) Borrowings
(Q) Optionally Fully Convertible Debentures
(R)
Particulars 2020-21
Trade Payables 8.40
Optionally Fully convertible Debentures 1,580.00
Total 1,588.40
(S) Other Financial Assets- Current
79
Entities with joint control or significant

Categories of related parties [Axis] influence over entity [Member]
Related party [Axis] Related Party 1
DADHA DADHA
PHARMA PHARMA
PRIVATE PRIVATE
Name of related party LIMITED LIMITED
Country of incorporation or residence of related party INDIA INDIA
U24231TN1935P U24231TN1935P
CIN of related party TC003302 TC003302
Rent including
Lease Rentals,
Sales Promotion
and
Advertisement
Description of nature of transactions with related party - Expenses
Entities with joint Entities with joint
control or control or
significant significant
influence over influence over
Description of nature of related party relationship entity entity
Other related party transactions expense 0 (A) 48.11
Amounts payable related party transactions 0 (B) 1.98
Footnotes
(A)
Particulars 2020-21
Rent including Lease Rentals 21.21
Sales Promotion and Advertisement Expenses 26.90
Total 48.11
(B) Trade Payables

Categories of related parties [Axis] Key management personnel of entity or parent [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
RAMYA RAMYA
ADVAIT SUHAS ADVAIT SUHAS KRISHNA KRISHNA
Name of related party PANDIT PANDIT SINGARAPU SINGARAPU
Permanent account number of related party BILPR4172C BILPR4172C
Remuneration Remuneration Remuneration
Description of nature of transactions with related party - paid paid paid
Key management Key management Key management Key management
personnel of entity personnel of entity personnel of entity personnel of entity
Description of nature of related party relationship or parent or parent or parent or parent
Other related party transactions expense 0 (A) 7.19 (B) 0.5 (C) 6.56
Footnotes
(A) Remuneration paid
(B) Remuneration paid
(C) Remuneration paid
80

Categories of related parties [Axis] Other related parties [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
(A) VITALIC (B) VITALIC JIO HAPTIK TEC (C) JIO HAPTIK
HEALTH HEALTH HNOLOGIES TECHNOLOGIES
U74999TN2015P U74999TN2015P U72900GJ2013PL U72900GJ2013PL
CIN of related party LC102106 LC102106 C107560 C107560
Borrowings
Repaid, Other Borrowings, Other
Income - Support Income - Support
Service to Group Service to Group
Companies, Companies,
Business support Business support
and advisory and advisory
Charges etc., Charges etc.,
Interest Expenses Interest Expenses Technical Support Technical Support
Description of nature of transactions with related party on Loans on Loans Charges Charges
Fellow (D) Fellow Fellow (E) Fellow
Description of nature of related party relationship subsidiaries subsidiaries subsidiaries subsidiaries
transactions (F) 66 (G) 66
Transfers under finance agreements from entity, related
party transactions 0 (H) 2,338.33
Transfers under finance agreements to entity, related party
transactions (I) 1,592.6 0
Other related party transactions expense (J) 177.76 (K) 472.49 24.2 3.6
Amounts payable related party transactions (L) 745.74 (M) 2,413.55 0 (N) 0.58
Amounts receivable related party transactions 0 (O) 6.08
Footnotes
(A)
Formerly known as Vitalic Health Private Limited
(B)
Formerly known as Vitalic Health Private Limited
(C) Formerly known as Reliance Jio Digital Services Limited
(D) Ultimate Holding Company up to August 17, 2020. Fellow Subsidiary from August 18, 2020.
(E) Fellow Subsidiary from August 18th, 2020.
(F) Other Income - Support Service to Group Companies - Fellow Subsidiary
(G)
Particulars 2020-21
Support services to group companies
Ultimate Holding Company 22.00
Fellow Subsidiary 44.00
Total 66.00
(H) Borrowings - Ultimate Holding Company
(I) Borrowings Repaid - Fellow Subsidiary
(J)
Particulars 2021-22
Business support and advisory Charges etc
81
Interest Expenses on Loans
Total 177.76
(K)
Particulars 2020-21
Business support and advisory Charges etc
Ultimate Holding Company 155.00
Interest Expenses on Loans
Total 472.49
(L)
Borrowings
(M)
Particulars 2021-22
Trade Payables 75.22
Borrowings 2,338.33
Total 2,413.55
(N) Trade Payables
(O) Other Financial Assets- Current

Period FY 2022 FY 2021 FY 2022 FY 2021
RELIANCE JIO RELIANCE JIO RELIANCE RELIANCE
INFOCOMM INFOCOMM RETAIL RETAIL
U72900GJ2007P U72900GJ2007PL U01100MH1999P U01100MH1999P
CIN of related party LC105869 C105869 LC120563 LC120563
Revenue from
Operations -
Revenue from Technical Support
Operations - Services, Business
Technical Support support and
Communication Communication Services, Staff advisory Charges
Description of nature of transactions with related party Expenses Expenses Welfare etc.
Fellow (A) Fellow Fellow (B) Fellow
Description of nature of related party relationship subsidiaries subsidiaries subsidiaries subsidiaries
Purchases of property and other assets, related party
transactions 51.52 39.8
transactions (C) 10,454.66 (D) 10,000
Other related party transactions expense 124.56 33.87 (E) 2.6 (F) 0.12
Amounts payable related party transactions 0 (G) 2.51 (H) 1,958.97 (I) 1,126.3
Amounts receivable related party transactions (J) 0.25 0 (K) 333.02 (L) 3,292.5
Footnotes
82
(A) Fellow Subsidiary from August 18, 2020
(B) Fellow Subsidiary from August 18, 2020
(C) Revenue from Operations - Technical Support Services
(D) Revenue from Operations - Technical Support Services
(E) Staff Welfare
(F) Business support and advisory Charges etc
(G) Trade Payables
(H) Trade Payables
(I) Trade Payables
(J) Advance to Supplier
(K) Trade Receivables
(L) Trade Receivables

Related party [Axis] Related Party 5
(A) URBAN (B) URBAN
LADDER HOME LADDER HOME
DECOR DECOR
SOLUTIONS SOLUTIONS
Name of related party LIMITED LIMITED
U74999KA2012P U74999KA2012P
CIN of related party LC062610 LC062610
Other Income -
Other
Non-Operating
Description of nature of transactions with related party Income -
Fellow (C) Fellow
Description of nature of related party relationship subsidiaries subsidiaries
Other related party transactions income (D) 0.7 0
Footnotes
(A) Formerly Urban Ladder Home Décor Solutions Private Limited
(B) Formerly Urban Ladder Home Décor Solutions Private Limited
(C) Fellow Subsidiary from August 18, 2020
(D) Other Income - Other Non-Operating Income
Textual information (15): Disclosure of related party [Text Block]
Related Party Disclosures :

As per Ind AS 24, disclosures of transactions with related parties are given below:
(i) List of related parties with whom transactions have taken place and relationship
Sr. No. Name of the Related Party Relationship
1 Reliance Industries Limited (from August 18, 2020) Ultimate Holding Company
2 Vitalic Health Private Limited (Up to August 17,2020)
3 Reliance Retail Ventures Limited (from August 18, 2020) Intermediate Holding Company
83
4 Tresara Health Limited (formerly Tresara Health Private Limited) Holding Company
5 Vitalic Health Private Limited (from August 18,2020) Fellow Subsidiary
Jio Haptik Technologies Limited (Formerly known as Reliance Jio Digital Services
6
Limited) (from August 18th, 2020)
7 Reliance Jio Infocomm Limited (from August 18,2020)
8 Dadha Pharma Distribution Private Limited
9 Reliance Retail Limited (from August 18,2020)
10 Urban Ladder Home Décor Solutions Private Limited
MedRx Technologies LLP (Previously known as "MedRx Distributors LLP") (Up to

11
August 14, 2020)
Netmeds Health Private Limited (formerly known as "Netmeds Health and Wellness
12 Subsidiary
Marketplace Private Limited") - (Up to July 30, 2020)*
Director / Key Managerial Personnel

13 Shri M Pradeep Dadha - Director*
(KMP)
14 Shri Advait Suhas Pandit - Director
15 Shri Jethu Singh Bhati - Director (from January 21, 2021)*
16 Ramya Krishna Singarapu - Company Secretary (up to April 25, 2021)
Entities in which Directors have an

17 Dadha Pharma Private Limited
interest
*No transactions with these related parties in current year and previous year
ii Transaction during the year with related parties (excluding reimbursements)
Ultimate /
Intermediate Holding Fellow Subsidiar Director /
Sr. No. Nature of Transactions Others Total
Holding Company Subsidiary y KMP
Company
1 Borrowings - - - - - - -
3,928.33 1,500.00 - - - - 5,428.33
2 Borrowings Repaid 1,590.00 - 1,592.60 - - - 3,182.60
- 1,500.00 - - - - 1,500.00
Share capital issued (including

3 - - - - - - -
securities premium)
- 1,308.99 - - - - 1,308.99
Issue of Optionally Fully

4 - - - - - - -
Convertible Debentures
- 1,580.00 - - - - 1,580.00
Redemption of Optionally Fully

5 - 380.00 - - - - 380.00
- - - - - - -
6 Security Deposit received - - - - - - -
- 300.00 - - - - 300.00
7 Security Deposit repaid - - - - - - -
- 300.00 - - - - 300.00
Revenue from Operations -

8 - - 10,454.66 - - - 10,454.66
Technical Support Services
- - 10,000.00 - - - 10,000.00
84
Other Income - Support Service to

9 - 170.51 66.00 - - - 236.51
Group Companies
22.00 231.00 44.00 - - - 297.00
Other Income - Other

10 - - 0.70 - - - 0.70
Non-Operating Income
- - - - - - -
Business support and advisory

11 - - 42.72 - - - 42.72
Charges etc.
155.00 - 208.31 - - - 363.31
12 Technical Support Charges - - 24.20 - - - 24.20
- - 3.60 - - - 3.60
13 Communication Expenses - - 124.56 - - - 124.56
- - 33.87 - - - 33.87
14 Staff Welfare - 0.78 2.60 - - - 3.38
- 7.76 - - - - 7.76
15 Remuneration paid - - - - 0.50 - 0.50
- - - - 13.75 - 13.75
16 Rent including Lease Rentals - - - - - - -
- - - - - 21.21 21.21
17 Interest Expenses on Loans - 0.01 142.23 - - - 142.24
- 40.85 178.21 - - - 219.06
Sales Promotion and

18 - - - - - - -
Advertisement Expenses
- - - - - 26.90 26.90
Purchase of Plant Property &

19 - - 51.52 - - - 51.52
Equipment
- - 39.80 - - - 39.80
Figures in italics represents previous year’s amount.

iii Balances outstanding at the year end
Ultimate /
Intermediate Holding Fellow Subsidiar Director /
Sr. No. Nature of Balances Others Total
Holding Company Subsidiary y KMP
Company
1 Trade Receivables
a) Reliance Retail Limited - - 333.02 - - - 333.02
- - 3,292.50 - - - 3,292.50
2 Trade Payables
a) Reliance Retail Limited - - 1,958.97 - - - 1,958.97
- - 1,126.30 - - - 1,126.30
b) Vitalic Health Private Limited - - - - - - -
- - 75.22 - - - 75.22
85
c) Dadha Pharma Private Limited - - - - - - -
- - - - - 1.98 1.98
d) Reliance Jio Infocomm Limited - - - - - - -
- - 2.51 - - - 2.51
Tresara Health Limited (formerly

e) - - - - - - -
Tresara Health Private Limited)
- 8.40 - - - - 8.40
f) Jio Haptik Technologies Limited -
- - 0.58 - - - 0.58
3 Advance to Supplier
a) Reliance Jio Infocomm Limited - - 0.25 - - - 0.25
- - - - - - -
4 Borrowings
a) Vitalic Health Private Limited - - 745.74 - - - 745.74
- - 2,338.33 - - - 2,338.33
b) Reliance Retail Ventures Limited - - - - - - -
1,590.00 - - - - - 1,590.00
5 Optionally Fully Convertible Debentures

a) - 1,200.00 - - - - 1,200.00
- 1,580.00 - - - - 1,580.00
6 Other Financial Assets - Current

a) - - - - - - -
- 106.23 - - - - 106.23
b) Vitalic Health Private Limited - - - - - - -
- - 6.08 - - - 6.08

Year Ended
Year Ended
Sr No Particulars Relationship March 31,
March 31, 2021
2022
1 Borrowings
Vitalic Health Private Limited Ultimate Holding Company - 2,338.33
Intermediate Holding
Reliance Retail Ventures Limited - 1,590.00
Company
Tresara Health Limited (formerly Tresara

Holding Company - 1,500.00
Health Private Limited)
2 Borrowings Repaid

Vitalic Health Private Limited Fellow Subsidiary 1,592.60 -
86
Intermediate Holding
Reliance Retail Ventures Limited 1,590.00 -
Company
Share capital issued

3
(including securities premium)

Issue of Optionally Fully

4

Redemption of Optionally
5
Fully Convertible Debentures

Holding Company 380.00 -
6 Security Deposit received

Holding Company - 300.00
7 Security Deposit repaid

Holding Company - 300.00
Revenue from Operations -

8
Technical Support Services
Reliance Retail Limited Fellow Subsidiary 10,454.66 10,000.00
Other Income - Support

9
Service to Group Companies
Vitalic Health Private Limited Ultimate Holding Company - 22.00
Vitalic Health Private Limited Fellow Subsidiary 66.00 44.00

Holding Company 170.51 231.00
Other Income - Other

10
Non-Operating Income
Urban Ladder Home Décor Solutions

Limited (formerly Urban Ladder Home Fellow Subsidiary 0.70 -
Décor Solutions Private Limited)
Business support and

11
advisory Charges etc.
Vitalic Health Private Limited Ultimate Holding Company - 155.00
Reliance Retail Limited Fellow Subsidiary - 0.12
12 Technical Support Charges
Jio Haptik Technologies Limited (Formerly

known as Reliance Jio Digital Services Fellow Subsidiary 24.20 3.60
Limited)
13 Communication Expenses
Reliance Jio Infocomm Limited Fellow Subsidiary 124.56 33.87
14 Staff Welfare
87

Reliance Retail Limited Fellow Subsidiary 2.60 -
15 Remuneration paid
Advait Suhas Pandit Director / KMP - 7.19
Ramya Krishna Singarapu Director / KMP 0.50 6.56
16 Rent including Lease Rentals
Entities in which Directors

Dadha Pharma Private Limited - 21.21
have an interest
17 Interest Expenses on Loans

Reliance Retail Ventures Limited Fellow Subsidiary 7.19 68.91
Sales Promotion and

18
Advertisement Expenses
Entities in which Directors

Dadha Pharma Private Limited - 26.90
have an interest
Purchase of Plant Property &

19
Equipment
Reliance Retail Limited Fellow Subsidiary 51.52 39.80
88
[610900] Notes - First time adoption

Whether company has adopted Ind AS first time No No
89
[611000] Notes - Exploration for and evaluation of mineral resources

Whether there are any exploration and evaluation activities No No
90
[611100] Notes - Financial instruments

Period FY 2022
Textual
Disclosure of financial instruments [Text Block] Information (16)
Disclosure of financial assets [Table] ..(1)

Financial assets at amortised cost, class
Classes of financial assets [Axis] [Member] Trade receivables [Member]
Categories of financial assets [Axis] Financial assets at amortised cost, category [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of financial assets [Abstract]
Disclosure of financial assets [Line items]
Financial assets 2,184.41 4,245.77 360.55 3,340.59
Financial assets, at fair value 0 0 0 0
Description of other financial assets at amortised cost class - - Trade receivables Trade receivables
Description of other financial assets at fair value class - - - -

Other financial assets at amortised cost Other financial assets at amortised cost
Classes of financial assets [Axis] class [Member] class 1 [Member]
Categories of financial assets [Axis] Financial assets at amortised cost, category [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Financial assets 1,823.86 905.18 570.91 318.96
Financial assets, at fair value 0 0 0 0
Cash and Bank Cash and Bank
Description of other financial assets at amortised cost class - - Balances Balances

Other financial assets at amortised cost
Classes of financial assets [Axis] class 2 [Member]
Financial assets at amortised cost, category
Categories of financial assets [Axis] [Member]
Financial assets 1,252.95 586.22
Financial assets, at fair value 0 0
Other Financial Other Financial
Description of other financial assets at amortised cost class Assets Assets
Description of other financial assets at fair value class - -

Classes of financial assets [Axis] Financial assets at fair value, class [Member]
Financial assets at fair value through profit
Financial assets at fair value through profit or loss, designated upon initial recognition
Categories of financial assets [Axis] or loss, category [Member] or subsequently, category [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Financial assets 0 0 0 0
Financial assets, at fair value 2,471.77 50 2,471.77 50
Description of other financial assets at amortised cost class - - - -
91
Classes of financial assets [Axis] Other financial assets at fair value class [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021

Classes of financial assets [Axis] Other financial assets at fair value class 1 [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Description of other financial assets at fair value class - - Investments Investments
Disclosure of financial liabilities [Table]

Financial liabilities at amortised cost, class
Classes of financial liabilities [Axis] [Member]
Financial liabilities at amortised cost,
Categories of financial liabilities [Axis] category [Member]
Disclosure of financial liabilities [Abstract]
Disclosure of financial liabilities [Line items]
Financial liabilities (A) 2,949.64 (B) 5,286.1
Financial liabilities, at fair value 0 0
Footnotes
(A)
Particulars 2021-22
Borrowings 745.74
Trade Payables 1,713.81
Total 2,949.64
(B)
Particulars 2020-21
Borrowings 3,928.33
Trade Payables 793.70
Total 5,286.10
Textual information (16): Disclosure of financial instruments [Text Block]
1. Capital Management
The Company’s objectives when managing capital are to: -
• safeguard their ability to continue as a going concern, so that they can continue to provide returns for shareholders and benefits for other
92
stakeholders, and
• manages its capital structure and makes adjustments in light of changes in economic condition and the requirements of the financial covenants.
For the purpose of capital management, capital includes issued equity capital, securities premium and all other reserves attributable to the equity
shareholders of the Company. Net debt includes all long and short-term borrowings (including current maturities of long-term borrowings and
interest accrued) as reduced by cash and cash equivalents.
Under the terms of borrowing facilities, the Company is required to comply with certain financial covenants which it has complied throughout the
reporting period.
The Net gearing ratio at the end of the reporting period was as follows:
As at As at
March 31, 2022 March 31, 2021
Gross Debt 758.84 3,951.49
Less: Cash and Marketable Securities* (3,038.44) (364.93)
Net Debt (A) (2,279.60) 3,586.56
Total Equity (As per Balance Sheet) (B) 2,961.34 2,261.72
Net Gearing (A/B) (76.98%) 158.58%
*Cash and Marketable Securities include Cash and Cash Equivalents of Rs. 566.67 lakhs (Previous Year Rs. 314.93 lakhs) and Current
Investments of Rs. 2471.77 lakhs (Previous Year Rs. 50 lakhs).
2. Financial Instruments
Valuation Methodology
All financial instruments are initially recognized and subsequently re-measured at fair value as described below:
a) The fair value of investment in unquoted Mutual Funds is measured at quoted price or NAV.
b) The fair value of the remaining financial instruments is determined using discounted cash flow analysis.
Fair value measurement hierarchy:
As at March 31, As at March 31,

Particulars Note
2022 2021
Level of Level of
Carrying Amount Carrying Amount
input used in input used in
Level 1 Level 2 Level 3 Level 1 Level 2 Level 3
Financial Assets
At Amortised Cost
Trade Receivables 5 360.55 - - - 3,340.59 - - -
Cash and Bank Balances 6&7 570.91 - - - 318.96 - - -
Other Financial Assets 2&8 1,252.95 - - - 586.22 - - -
At FVTPL
Investments 4 2,471.77 2,471.77 - - 50.00 50.00 - -
Financial Liabilities
At Amortised Cost
Borrowings 14 745.74 - - - 3,928.33 - - -
Trade Payables 16 1,713.81 - - - 793.70 - - -
Lease Liabilities 12 & 15 13.10 - - - 23.16 - - -
Other Financial Liabilities 17 476.99 - - - 540.91 - - -
Fair value hierarchy:

The financial instruments are categorized into three levels based on the inputs used to arrive at fair value measurements as described below:
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities; and
Level 2: Inputs other than the quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3: Inputs for the asset or liability that are not based on observable market data (unobservable inputs).
The Company’s policy is to recognise transfers into and transfers out of fair value hierarchy levels as at the end of the reporting period. There are
no transfers between levels 1 and 2 during the year.
The carrying amounts of trade receivables, trade payables, cash and cash equivalents and financial liabilities are considered to be the same as
their fair values, due to their short-term nature.
93
Assets and liabilities which are measured at amortised cost for which fair values are disclosed
There has been no significant change between the discounting rate used on the date of transaction and as at the end of the period for assets and
liabilities measured at amortised cost. Hence, the carrying value is taken as fair value.
3. Financial Risk Management
The Company’s principal financial liabilities comprises borrowings, lease liabilities, trade payables and other financial liabilities. The main
purpose of these financial liabilities to finance the Company's operation. The Company’s main financial assets includes trade receivable, cash
and cash equivalent, other bank balances and other financial assets derived from its operations.
Risk Exposure arising from Measurement
Cash and cash equivalents, trade receivables, financial assets

Credit risk (Refer Note 3.1) Ageing analysis Credit ratings
measured at amortised cost
Liquidity risk (Refer Note 3.2) Borrowings, lease liabilities and other liabilities Rolling cash flow forecasts
3.1 Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual
obligation. Credit risk arises from cash and cash equivalents, deposits with banks, as well as credit exposures to customers including outstanding
receivables and financial assets measured at amortised cost.
Credit risk management
i) Credit risk on deposits is mitigated by depositing the funds in reputed private sector banks.
ii) Credit risk on unsecured deposits is managed based on Company's established policy, procedures and controls. Outstanding deposits are
regularly monitored and assessed for their recoverability.
Impairment of Financial Assets
Expected credit loss trade receivables - simplified approach
Customer credit risk is managed by the Company based on established policy, procedures and control relating to customer credit risk
management. Credit quality of a customer is assessed based on prior experience. Outstanding customer receivables are regularly monitored and
assessed for its recoverability. Default is said to occur when the amount remains outstanding beyond the agreed credit period. An impairment
analysis is performed at each reporting date on an individual basis for major clients. This is done by taking into account the financial position,
past experience and other industry-wide factors.
Expected credit loss for financial assets other than trade receivables
The Company assesses whether there has been a significant increase in credit risk by comparing the risk of default at inception of the contract
with the risk of default as at the reporting date by considering forward-looking information. Based on such assessment, the management
considered that there has not been a significant risk in credit risk and has accordingly provided for 12-month expected credit losses.
Other Non-Current Financial Assets - Security Deposits
Loss allowance
Loss allowance measured at life-time
Particulars measured at 12 month
expected credit losses
expected credit loss
Financial assets for which

Financial assets for which credit risk
credit risk has increased
has increased significantly and not
significantly and
credit-impaired
credit-impaired
Loss allowance on March 31, 2020 - - -
Changes in loss allowance
- Provision made during the year 2.00 - -
- Written off - - -
- Recoveries - - -
Loss allowance on March 31, 2021 2.00 - -
- Provision made during the year - - -
- Written off - - -
- Recoveries - - -
Other Non-Current Assets - Capital Advances
Loss allowance measured

Particulars at 12 month expected
credit loss
94

significantly and
credit-impaired
credit-impaired
- Written off - - -
- Recoveries - - -
- Written off - - -
- Recoveries (7.49) - -
Other Non-Current Assets - Balances with Government Authorities

credit loss

significantly and
credit-impaired
credit-impaired
- Written off - - -
- Written off - - -
- Recoveries - - -
Other Financial Assets - Receivable from payment gateways and delivery agents

credit loss

significantly and
credit-impaired
credit-impaired
- Written off - - -
- Recoveries - - -
95
- Written off - - -
- Recoveries - - -
Other Current Assets - Advances to Suppliers

credit loss

significantly and
credit-impaired
credit-impaired
- Written off - - -
- Recoveries - - -
- Written off - - -
3.2 Liquidity Risk

The Company manages its liquidity risk in a manner so as to meet its normal financial obligations without any significant delay or stress.
Management monitors the Company’s liquidity requirements on the basis of monthly and yearly projections. The Company's principal source of
liquidity are cash flows that are generated from operations through equity infusion from Holding Company and surplus cash is deposited in the
banks which are liquidated based on working capital requirements.
Maturity Profile of Financial Liabilities as on March 31, 2022
Liquidity Risks Below 3 months 3-6 Months 6-12 Months 1-3 Years 3-5 Years Above 5 Years Grand Total
Borrowings - - - - - 745.74 745.74
Trade Payables 1,713.81 - - - - - 1,713.81
Other Financial Liabilities 476.99 - - - - - 476.99
Sub-Total 2,190.80 - - - - 745.74 2,936.54
Lease Liabilities* 2.99 2.99 5.98 1.00 - - 12.96
Total 2,193.79 2.99 5.98 1.00 - 745.74 2,949.50
Maturity Profile of Financial Liabilities as on March 31, 2021
Liquidity Risks Below 3 months 3-6 Months 6-12 Months 1-3 Years 3-5 Years Above 5 Years Grand Total
Borrowings - - - - - 3,928.33 3,928.33
Trade Payables 793.70 - - - - - 793.70
Other Financial Liabilities 540.91 - - - - - 540.91
Sub-Total 1,334.61 - - - - 3,928.33 5,262.94
Lease Liabilities* 2.99 2.99 5.98 13.95 - - 25.91
Total 1,337.60 2.99 5.98 13.95 - 3,928.33 5,288.85
* Lease maturities are on undiscounted basis.
96
[611200] Notes - Fair value measurement

Whether assets have been measured at fair value Yes Yes
Whether liabilities have been measured at fair value No No
Whether equity have been measured at fair value No No
Disclosure of fair value measurement of assets [Table] ..(1)

Measurement [Axis] At fair value [Member]
Classes of assets [Axis] Other assets [Member] Other assets 1 [Member]
Levels of fair value hierarchy [Axis] Level 1 of fair value hierarchy [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of fair value measurement of assets [Abstract]
Disclosure of fair value measurement of assets [Line items]
Assets 2,471.77 50 2,471.77 50
Nature of other assets - - - -
Description of valuation techniques used in fair value
measurement, assets - - - -
Reconciliation of changes in fair value measurement, assets
[Abstract]
Assets at end of period 2,471.77 50 2,471.77 50
Description of line items in profit or loss where gains (losses)
are recognised, fair value measurement, assets - - - -
Description of line items in other comprehensive income
where gains (losses) are recognised, fair value measurement,
assets - - - -
Disclosure of fair value measurement of assets [Table] ..(2)

Measurement [Axis] Recurring fair value measurement [Member]
Classes of assets [Axis] Other assets [Member] Other assets 1 [Member]
Levels of fair value hierarchy [Axis] Level 1 of fair value hierarchy [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of fair value measurement of assets [Abstract]
Disclosure of fair value measurement of assets [Line items]
Assets 2,471.77 50 2,471.77 50
Nature of other assets - - Investments Investments
Fair Value Fair Value
Description of valuation techniques used in fair value Through Profit or Through Profit or
measurement, assets - - Loss (FVTPL) Loss (FVTPL)
Reconciliation of changes in fair value measurement, assets
[Abstract]
Assets at end of period 2,471.77 50 2,471.77 50
Description of line items in profit or loss where gains (losses)
are recognised, fair value measurement, assets - - - -
Description of line items in other comprehensive income
where gains (losses) are recognised, fair value measurement,
assets - - - -
97
[611500] Notes - Interests in other entities

Whether company has subsidiary companies No No
Whether company has subsidiary companies which are yet to commence operations No No
Whether company has subsidiary companies liquidated or sold during year No Yes
Whether company has invested in associates No No
Whether company has associates which are yet to commence operations No No
Whether company has associates liquidated or sold during year No No
Whether company has invested in joint ventures No No
Whether company has joint ventures which are yet to commence operations No No
Whether company has joint ventures liquidated or sold during year No No
Whether there are unconsolidated structured entities No No
Whether there are unconsolidated subsidiaries No No
Whether there are unconsolidated structured entities controlled by investment entity No No
Details of subsidiaries liquidated or sold during year [Table]

Subsidiaries liquidated or sold during year [Axis] Subsidiary 1
Period FY 2021
Details of subsidiaries liquidated or sold during year [Abstract]
Details of subsidiaries liquidated or sold during year [Line Items]
NETMEDS
HEALTH
PRIVATE
Name of subsidiary liquidated or sold during year LIMITED
Country of incorporation or residence of subsidiary liquidated or sold during year India
U74900TN2015P
CIN of subsidiary company liquidated or sold during year TC102803
98
[611600] Notes - Non-current asset held for sale and discontinued operations

Cash flows from continuing and discontinued operations [Abstract]
Net cash flows from (used in) operating activities, continuing operations 6,371.51 -2,901.32
Net cash flows from (used in) investing activities, continuing operations -2,547.11 -76.99
Net cash flows from (used in) financing activities, continuing operations -3,572.66 3,117.59
99
[611700] Notes - Other provisions, contingent liabilities and contingent assets

Whether there are any contingent liabilities Yes Yes
Disclosure of contingent liabilities [Table] ..(1)

Classes of contingent liabilities [Axis] Contingent liabilities [Member] Other contingent liabilities [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of contingent liabilities [Abstract]
Disclosure of contingent liabilities [Line items]
Description of nature of obligation, contingent liabilities - - - -
Estimated financial effect of contingent liabilities 3 3 3 3
Disclosure of contingent liabilities [Table] ..(2)

Classes of contingent liabilities [Axis] Other guarantees given [Member]
Disclosure of contingent liabilities [Abstract]
Disclosure of contingent liabilities [Line items]
Outstanding Outstanding
guarantees guarantees
furnished to banks furnished to banks
including in including in
respect of letters respect of letters
Description of nature of obligation, contingent liabilities of credit of credit
Estimated financial effect of contingent liabilities 3 3
100
[611800] Notes - Revenue

Period FY 2022
Textual
Disclosure of revenue [Text Block] Information (17)
Textual information (17): Disclosure of revenue [Text Block]
Revenue from Operations
Year Ended March 31, 2022 Year Ended March 31, 2021
Revenue from Operations
Income from Services
Technical Support Services 10,454.63 10,000.00
Commission income 12.76 2,807.88
Franchisee fees 4.76 4.61
Customer subscription charges 56.37 50.93
Shipping charges received from customers - 322.72
Other operating revenue
Marketing services 10.75 86.37
Revenue from Diagnostic Consultation (1) 22.25 -
Revenue From Doctor Consultation (2) 5.93 -
Marketplace fees 208.21 142.85
Software Income 1.30 8.06
Total * 10,776.96 13,423.42
* Net of GST
(1) Net Revenue from Diagnostic Consultation: Rs. 22.25 lakhs (Gross revenue: Rs. 94.85 lakhs less expenses: Rs. 72.60 lakhs)
(2) Net Revenue from Doctor Consultation: Rs. 5.93 lakhs (Gross revenue: Rs. 38.53 lakhs less expenses: Rs. 32.60 lakhs)
1. Disaggregated revenue
The Company derives revenue from transfer of goods and services over time and at a point in time as given below:
Timing of recognition
Over time
Franchisee fees 4.76 4.61
Customer subscription charges 56.37 50.93
Marketing services 10.75 86.37
Revenue from doctor consultation 5.93 -
10,532.44 10,464.63
Point in time
Marketplace Fees 208.21 142.85
Revenue from diagnostic consultation 22.25 -
Software Income 1.30 8.06
244.52 2,958.79
Total 10,776.96 13,423.42
2. Reconciliation of revenue with contract price
101
Particulars Year Ended March 31, 2022 Year Ended March 31, 2021
Contract price:
Revenue from doctor consultation 5.93 46.52
Revenue from diagnostic consultation 22.25 172.27
Others 281.39 292.82
Adjustments:
Incentives - relating to commissions income, revenue from diagnostics and

7.21 (16.85)
consultation
Contract liabilities - commission income, franchisee fees and customer

(7.21) 22.46
subscription charges
Negative revenue disclosed under other expenses (Refer note 24) - 218.80
Revenue from operations as per Statement of Profit and Loss 10,776.96 13,423.42
3. The Company has only one reportable segment. The requirement to disclose relationship with operating segments under Ind AS 108 is not
required.
4. Payment for the revenue recognised is collected as per the terms of the contract. In case of Customer Subscription charges, revenue is
received in advance. Such Revenue is deferred in accordance with Ind AS 115.
5. Performance obligations
The Contracts with customers are structured in such a way that the Company has the right to consideration from a customer in an amount that
corresponds directly with the value to the customer of the performance obligation complete to date and the Company has the right to invoice.
Therefore, taking the practical expedient, the details on transaction price allocated to the remaining performance obligations are not disclosed.
102
[611900] Notes - Accounting for government grants and disclosure of government assistance

Whether company has received any government grant or government assistance No No
103
[612000] Notes - Construction contracts

Whether there are any construction contracts No No
104
[612100] Notes - Impairment of assets

Whether there is any impairment loss or reversal of impairment loss during the year No No
Whether impairment loss recognised or reversed for individual Assets or cash-generating unit No No
105
[612200] Notes - Leases

Textual
Disclosure of leases [Text Block] Information (18)
Whether company has entered into any lease agreement Yes Yes
Lease and sublease payments recognised as expense [Abstract]
Minimum operating lease payments recognised as expense (A) 336.3 (B) 1,024.19
Total lease and sublease payments recognised as expense 336.3 1,024.19
Whether any operating lease has been converted to financial lease or vice-versa No No
Footnotes
(A)
Particulars 2021-22
Interest expense (included in finance costs) 1.89
Expense relating to short-term leases (included in other expenses) 334.41
Total 336.30
(B)
Particulars 2020-21
Interest expense (included in finance costs) 714.00
Expense relating to short-term leases (included in other expenses) 310.19
Total 1,024.19
Disclosure of finance lease and operating lease by lessee [Table] ..(1)

Maturity [Axis] Aggregated time bands [Member] Not later than one year [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of finance lease and operating lease by lessee
[Abstract]
Disclosure of finance lease and operating lease by lessee [Line
items]
Minimum finance lease payments payable 13.94 25.91 11.95 11.95
Disclosure of finance lease and operating lease by lessee [Table] ..(2)

Later than one year and not later than five
Maturity [Axis] years [Member] Later than five years [Member]
Period FY 2022 FY 2021 FY 2022 FY 2021
Disclosure of finance lease and operating lease by lessee
[Abstract]
Disclosure of finance lease and operating lease by lessee [Line
items]
Minimum finance lease payments payable 1.99 13.96 0 0
Textual information (18): Disclosure of leases [Text Block]
1. Lease Liabilities - Non Current
As at As at
March 31, 2022 March 31, 2021
Lease Liabilities - Non Current
Lease Liabilities 1.97 13.10
Total 1.97 13.10
1 As per Indian Accounting Standard 116 “Leases”, the disclosures as defined are given below :
This note provides information for leases where the Company is a lessee. The Company leases various offices and warehouses. Rental
106
contracts are typically made for fixed period of 11 months to 6 years, but may have extension clauses as described in (ii) below.
(i) Amounts recognised in the balance sheet
a) Refer note 1 for gross block, accumulated depreciation and net block of Right of Use Assets recognized in balance sheet.
b) Refer note 12 & 15 for non-current & current lease liabilities recognized in balance sheet respectively.
As at As at
c) Description of Liabilities March 31, 2022 March 31, 2021
Opening balance 23.16 9945.98
Additions - -
Finance cost accrued 1.89 714.00
Deletions - (8,276.52)
Payment of lease liabilities (11.95) (2,360.30)
Closing Balance 13.10 23.16
(ii) Amounts recognised in the statement of profit and loss

The statement of profit and loss shows the following amounts relating to leases:
As at As at
March 31, 2022 March 31, 2021
Depreciation Charge for right-of-use assets
Buildings 10.45 1,982.94
10.45 1,982.94
Interest expense (included in finance costs) 1.89 714.00
Expense relating to short-term leases (included in other expenses) 334.41 310.19
The total cash outflow for leases for the year ended March 31, 2022 was Rs. 11.95 lakhs (March 31, 2021 - Rs. 2,433.11 lakhs).
Extension and termination options:
Extension and termination options are included in a number of property leases. These are used to maximise operational flexibility in terms of
managing the assets used in the Company's operations. The majority of extension and termination options held are exercisable only by the
Company and not with the respective lessor.
(iii) Critical judgements in determining the lease term
In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension
option, or not to exercise a termination option. Extension options (or periods after termination options) are only included in the lease term if the
lease is reasonably certain to be extended (or not terminated).
For leases of buildings, the following factors are normally the most relevant:
(a) If there are significant penalties to terminate (or not extend), the Company is typically reasonably certain to extend and not terminate).
(b) If any leasehold improvements are expected to have a significant remaining value the Company is typically reasonably certain to extend (or
not terminate).
(c ) Otherwise, the Company considers other factors including historical lease durations and the costs and business disruption required to
replace the leased asset.
The lease term is reassessed if an option is actually exercised (or not exercised) or the Company becomes obliged to exercise (or not exercise)
it. The assessment of reasonable certainty is only revised if a significant event or a significant change in circumstances occurs, which affects the
assessment, and that is within the control of the lessee. During the current financial year, there was no revision in the lease terms.
4.2 The table below provides details regarding the contractual maturities of lease liabilities as at March 31, 2022 on an undiscounted basis:
Particulars As at As at
March 31, 2022 March 31, 2021
Less than one year 11.95 11.95
One to five years 1.99 13.96
More than five years - -
Total 13.94 25.91
2. Lease Liabilities - Current
As at As at
March 31, 2022 March 31, 2021
Lease Liabilities 11.13 10.06
Total 11.13 10.06
107
[612300] Notes - Transactions involving legal form of lease

Whether there are any arrangements involving legal form of lease No No
108
[612400] Notes - Service concession arrangements

Whether there are any service concession arrangments No No
109
[612500] Notes - Share-based payment arrangements

Whether there are any share based payment arrangement No No
110
[612600] Notes - Employee benefits

Textual
Disclosure of employee benefits [Text Block] Information (19)
Whether there are any defined benefit plans Yes Yes
Disclosure of defined benefit plans [Table]

Defined benefit plans [Axis] Domestic defined benefit plans [Member]
Defined benefit plans categories [Axis] Defined benefit plan 1
Disclosure of defined benefit plans [Abstract]
Disclosure of defined benefit plans [Line items]
Description of type of plan Gratuity Gratuity
Surplus (deficit) in plan [Abstract]
Defined benefit obligation, at present value 145.9 145.89
Net surplus (deficit) in plan -145.9 -145.89
Actuarial assumption of discount rates 5.91% 5.45%
Actuarial assumption of expected rates of salary increases 9% 9%
Rate of employee Rate of employee
turnover (per turnover (per
Other material actuarial assumptions annum) - 20.00% annum) - 25.00%
Disclosure of net defined benefit liability (assets) [Table]

Defined benefit plans [Axis] Domestic defined benefit plans [Member]
Net defined benefit liability (assets) [Axis] Present value of defined benefit obligation [Member]
Defined benefit plans categories [Axis] Defined benefit plan 1
Disclosure of net defined benefit liability (assets) [Abstract]
Disclosure of net defined benefit liability (assets) [Line items]
Description of type of plan Gratuity Gratuity
Changes in net defined benefit liability (assets) [Abstract]
Current service cost, net defined benefit liability (assets) 27.15 31.9
Interest expense (income), net defined benefit liability (assets) 7.6 10.05
Gain (loss) on remeasurement, net defined benefit liability (assets) [Abstract]
Actuarial losses (gains) arising from changes in financial assumptions, net
defined benefit liability (assets) 21.93 63.27
Total loss (gain) on remeasurement, net defined benefit liability (assets) 21.93 63.27
Payments from plan, net defined benefit liability (assets) 12.81 12.51
Payments in respect of settlements, net defined benefit liability (assets) 12.81 12.51
Total increase (decrease) in net defined benefit liability (assets) 0.01 -33.83
Net defined benefit liability (assets) at end of period 145.9 145.89 179.72
Textual information (19): Disclosure of employee benefits [Text Block]
Employee Benefits Expense
Employee Benefits Expense
Salaries and Wages 1,959.87 2,202.25
Contribution to Provident and Other Funds 103.15 111.77
Gratuity 34.75 41.95
Employee share-based payment expense 49.79 82.59
Staff Welfare Expenses 120.57 102.43
Total 2,268.13 2,540.99
1. As per Indian Accounting Standard 19 “Employee benefits”, the disclosures as defined are given below :
A) Defined Contribution Plans
The Company has certain defined contribution plans. Contributions are made to provident fund in India for employees at the rate of 12% of basic
salary as per Employees' Provident Fund and Miscellaneous Provisions Act, 1952. The contributions are made to registered provident fund
administered by the government. Contributions are made to Employees' State Insurance at rates specified in the Employees' State Insurance
111
Act, 1948.
The obligation of the Company is limited to the amount contributed and it has no further contractual nor any constructive obligation. Contribution
to defined contribution plan, recognised as expenses for the year is as under:
Employer’s Contribution to Provident Fund 94.04 101.51
Employer's Contribution to Employees' State Insurance 9.11 10.26
B) Defined Benefit Plans

- Post Employment Benefit - Retirement Benefit - Gratuity
The Company has a unfunded defined benefit Gratuity Plan. Every employee is entitled to a benefit equivalent to fifteen days salary last drawn
for each completed year of service in line with the Payment of Gratuity Act, 1972. The same is payable at the time of separation from the
Company or retirement, whichever is earlier. The benefits vest after five years of continuous service. The Company operates post retirement
benefit plans as follows:
I. Reconciliation of Opening and Closing Balances of Defined Benefit Obligation
Defined Benefit Obligation at beginning of the year 145.89 179.72
Current Service Cost 27.15 31.90
Interest Cost 7.60 10.05
Actuarial (Gain)/ Loss (21.93) (63.27)
Benefits Paid (12.81) (12.51)
Defined Benefit Obligation at year end 145.90 145.89
II. Expenses recognised during the year
In Income Statement
Current Service Cost 27.15 31.90
Interest Cost 7.60 10.05
Net Cost 34.75 41.95
In Other Comprehensive income
Actuarial (Gain)/ Loss (21.93) (63.27)
Net (Income) / Expense for the period Recognised in OCI (21.93) (63.27)
III. Actuarial Assumptions
Mortality Table (IALM) 2012-14 2012-14
(Ultimate) (Ultimate)
Discount Rate (per annum) 5.91% 5.45%
Rate of Escalation in Salary (per annum) 9.00% 9.00%
Rate of employee turnover (per annum) 20.00% 25.00%
Discount rate for this valuation is based on yield to maturity (YTM) available on government bonds having term similar to estimated term of
liabilities as per Para 83 of Ind AS 19.
Salary escalation assumption has been set based on the estimates of overall long-term salary growth rates after taking into consideration
expected earnings inflation as well as performance and seniority related increases.
Assumptions regarding employee turnover rates are also set based on estimates of expected long-term future employee turnover within the
Company.
The Scheme does not have sufficient experience (data) in respect of past mortality claims so scheme-specific mortality rates could not be
estimated. Based on professional judgement by the Actuary, it was thought that 100% of IAL mortality table would be appropriate for assessment
of liability in respect of death benefits. The disability rates have not been explicitly allowed for since there is even lesser scheme specific
experience and we believe there is sufficient margin in the chosen mortality assumption to accommodate the impact of disabilities as well.
IV. Effect of future cash flows
The expected contributions for Defined Benefit Plan for the next financial year will be Rs. 21.91 lakhs
The weighted average duration of the defined benefit obligation is 5.71 years (March, 2021 – 5.92 years).
Time Period (In Years) Year Ended March 31, 2022 Year Ended March 31, 2021
112
21.91 21.49
2 - 5 years 78.72 74.91
6 - 10 years 56.54 57.42
11 - 15 years 27.17 26.39
Above 15 years 21.16 21.89
V. Sensitivity Analysis
The sensitivity of the defined benefit obligation to changes in weighted principal assumptions is:
Year Ended March 31, Year Ended March 31,

Particulars
2022 2021
Decrease Increase Decrease Increase
Change in Rate of Discounting
- Delta effect of -/+ 1% (6.84) 7.56 (7.14) 7.90
Change in Rate of Salary Escalation
- Delta effect of -/+ 1% (6.08) 6.50 (6.34) 6.80
Change in Rate of Employee Turnover
- Delta effect of -/+ 25% (6.48) 9.00 (8.15) 11.58
The above sensitivity analyses are based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely
to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to
significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit
method at the end of the reporting period) has been applied as when calculating the defined benefit liability recognised in the balance sheet.
These plans typically expose the company to actuarial risks, investment risk, liquidity risk & legislative risk.
Actuarial Risk: The risks that benefits costs more than expected. All assumptions used to project the liability cash-flows are a source of risk. If
actual experience turns out to be worse than expected experience - there could be a risk of being unable to meet the liabilities as and when they
fall due. E.g.: If assumed salary growth rates turns out to be lesser than reality - this could cause a risk that the provisions are inadequate in
comparison to the actual benefits required to be paid.
Investment Risk: Plan is unfunded and hence no investment risk.
Liquidity Risk: Excessive withdrawals or deaths could put some liquidity pressure. Since the plan is unfunded, this could put the company in a
liquidity stress position if there is a large batch of untimely withdrawals.
Legislative Risk: There could be changes to regulation / legislation governing this Plan that could affect the Company adversely (e.g. introduction
of a minimum benefit). The changes in regulation could potentially increase the plan liabilities.
C) Other Long Term Employee Benefits
- Compensated Absences
The plan provides for leave encashment on termination of employment. Leave obligations covers the Company's liability for earned leave. Based
on past experience, the Company does not expect all employees to take the full amount of accrued leave or require payment for such leave
within next 12 months.
Share-based payments
Share-based compensation benefits were provided to employees under via the "Vitalic ESOP 2019" plan, an employee share scheme which was
discontinued during the previous year vide resolution passed in the Extraordinary General Meeting held on 15th June 2020 and cancellation of all
options under the plan. All outstanding and granted options stand cancelled.
Settlement of Options Scheme
During the previous year, the Company had entered into a settlement agreement with the employees who were offered share options.
The employees have confirmed, agreed, acknowledged and undertook that the ESOP Options granted to them by the Company shall forthwith,
without any further action, stand terminated and cancelled.
As part of the agreement, the employees have agreed to the full and final settlement of their respective share options, waived their rights with
respect to the cancelled options including the right to exercise such ESOP Options under the ESOP plan.
In lieu of cancellation of the ESOP scheme, the management has agreed to compensate eligible employees through a pre-determined cash
settlement and the settlement amount shall be paid out in 4 (four) annual tranches over 4 (four) years subject to continued employment, with the
Company or any of the group entity(ies) which are either subsidiaries and/or affiliates. This liability, based on the pre-determined cash settlement
amount, for the year ended March 31, 2022 has been recorded as Employee share based payment expense and the unpaid amount, if any, as at
March 31, 2022 has been recorded as Employee share based liability.
113
[612700] Notes - Income taxes

Textual
Disclosure of income tax [Text Block] Information (20)
Major components of tax expense (income) [Abstract]
Current tax expense (income) and adjustments for current tax of prior periods [Abstract]
Current tax expense (income) 0 0
Total current tax expense (income) and adjustments for current tax of prior periods 0 0
Total tax expense (income) 0 0
Reconciliation of accounting profit multiplied by applicable tax rates [Abstract]
Accounting profit 1,057.69 104.77
Tax expense (income) at applicable tax rate 266.2 26.37
Other tax effects for reconciliation between accounting profit and tax expense (income) (A) -266.2 (B) -26.37
Total tax expense (income) 0 0
Reconciliation of average effective tax rate and applicable tax rate [Abstract]
Accounting profit 1,057.69 104.77
Applicable tax rate 25.17% 25.17%
Other tax rate effects for reconciliation between accounting profit and tax expense (income) -25.17% -25.17%
Total average effective tax rate 0% 0%
Footnotes
(A)
Carry forward losses utilised
(B)
Carry forward losses utilised
Textual information (20): Disclosure of income tax [Text Block]
Tax Losses
As at As at
March 31, 2022 March 31, 2021
Unused tax losses for which no deferred tax asset has been
37,852.60 38,865.74
recognized
Potential tax benefit @ 25.17% 9,527.50 9,782.51
Unrecognised deferred tax assets relates to unabsorbed depreciation which can be carried forward without any restrictions.
114
[612800] Notes - Borrowing costs

Whether any borrowing costs has been capitalised during the year No No
115
[612900] Notes - Insurance contracts

Whether there are any insurance contracts as per Ind AS 104 No No
116
[613000] Notes - Earnings per share

Textual
Disclosure of earnings per share [Text Block] Information (21)
Basic earnings per share [Abstract]
Basic earnings (loss) per share from continuing operations [INR/shares] 5.69 [INR/shares] 0.57
Total basic earnings (loss) per share [INR/shares] 5.69 [INR/shares] 0.57
Diluted earnings per share [Abstract]
Diluted earnings (loss) per share from continuing operations [INR/shares] 1.92 [INR/shares] 0.33
Total diluted earnings (loss) per share [INR/shares] 1.92 [INR/shares] 0.33
Profit (loss), attributable to ordinary equity holders of parent entity [Abstract]
Profit (loss), attributable to ordinary equity holders of parent entity 1,057.69 104.77
Profit (loss), attributable to ordinary equity holders of parent entity including dilutive effects 1,057.69 104.77
Weighted average shares and adjusted weighted average shares [Abstract]
[shares] [shares]
Weighted average number of ordinary shares outstanding 18,584,788 18,530,659.86
Textual information (21): Disclosure of earnings per share [Text Block]
Earnings Per Share (EPS) Year Ended March 31, 2022 Year Ended March 31, 2021
Face Value per Equity Share (Rs.) 5.00 5.00
Basic Earnings per Share (Rs.) 5.69 0.57
Net Profit as per Profit and Loss Statement attributable to Equity

1,057.69 104.77
Shareholders (Rs. Lacs)
Weighted average number of equity shares used as denominator for

1,85,84,788.00 1,85,30,659.86
calculating EPS
Diluted Earnings per Share (Rs.) 1.92 0.33
Net Profit as per Profit and Loss Statement attributable to Equity

1,057.69 104.77
Shareholders (Rs. Lacs)
Weighted Average number of Equity Shares used as denominator for

5,50,81,226.36 3,16,90,111.92
calculating Diluted EPS
Reconciliation of weighted average number of shares outstanding

1,85,84,788.00 1,85,30,659.86
calculating Basic EPS
Total Weighted Average Potential Equity Shares 3,64,96,438.36 1,31,59,452.05

5,50,81,226.36 3,16,90,111.92
calculating Diluted EPS
117
[613100] Notes - Effects of changes in foreign exchange rates

Whether there is any change in functional currency during the year No No
Description of presentation currency INR
118
[613200] Notes - Cash flow statement

Cash and cash equivalents if different from balance Sheet [Abstract]
Cash and cash equivalents cash flow statement 566.67 314.93 175.65
Cash and cash equivalents 566.67 314.93
Income taxes paid (refund) [Abstract]
Income taxes paid (refund), classified as operating activities -93.14 -59.67
Total income taxes paid (refund) -93.14 -59.67
119
[613300] Notes - Operating segments

Textual
Disclosure of entity's operating segments [Text Block] Information (22)
Whether there are any reportable segments No No
Whether there are any major customers No No
Textual information (22): Disclosure of entity's operating segments [Text Block]
Segment Information
a) Description of segments
The board of directors as chief operating decision maker (CODM) of the Company for the purpose of resource allocation and segment
performance focuses on single business segment of distribution and trading of pharmaceutical products which include medicines, antibiotics,
drugs, biologicals, nutraceuticals and healthcare allied products and hence, there is only one reportable business segment in terms of Ind AS
108 'Operating Segments'.
The Chief operational decision maker (Board of Directors) monitors the operating results of the entity's business for the purpose of making
decisions about resource allocation and performance assessment.
b) Segment revenue
The Company is domiciled in India. Entire revenue from the operating segment is derived from India.
c) Segment Assets
All non-current assets of the Company are located in India.
120
[700100] Notes - Key managerial personnels and directors remuneration and other information
Disclosure of key managerial personnels and directors and remuneration to key managerial personnels and directors [Table]
KMP and Director KMP and Director KMP and Director KMP and Director
Key managerial personnels and directors [Axis] 1 2 3 4
Period FY 2022
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors
[Abstract]
Disclosure of key managerial personnels and directors and
remuneration to key managerial personnels and directors [Line
Items]
MOHANCHAND JETHUSINGH (A) RAMYA
PRADEEP SOHAN SINGH ADVAIT SUHAS KRISHNA
Name of key managerial personnel or director DADHA BHATI PANDIT SINGARAPU
Director identification number of key managerial personnel or
director 00087519 00104046 02972886
Permanent account number of key managerial personnel or
director BILPR4172C
Date of birth of key managerial personnel or director 29/10/1978 08/07/1967 29/10/1978 18/03/1994
Company
Designation of key managerial personnel or director Director Director Director Secretary
MBA/ Masters in B.Com (Corporate
Information Secretariship),
Qualification of key managerial personnel or director B. Com M.Com Finance Technology ACS, LLB
Shares held by key managerial personnel or director (B) [shares] 1 [shares] 0 (C) [shares] 1 [shares] 0
Key managerial personnel or director remuneration [Abstract]
Gross salary to key managerial personnel or director
[Abstract]
Salary key managerial personnel or director 0 0 0 0.5
Gross salary to key managerial personnel or director 0 0 0 0.5
Total key managerial personnel or director remuneration 0 0 0 0.5
Footnotes
(A) Resigned on 25.04.2021
(B) Benefical interest held in the name of Tresara Health Limited
(C) Benefical interest held in the name of Tresara Health Limited
121
[700200] Notes - Corporate social responsibility

Period FY 2022
Whether provisions of corporate social responsibility are applicable on company No
Disclosure of CSR spending [Abstract]
Details of CSR spent during financial year [Abstract]
Amount CSR spent for financial year 0
122
[700300] Disclosure of general information about company

Disclosure of general information about company [Abstract]
Disclosure of company information [Abstract]
NETMEDS
MARKETPLACE
Name of company LIMITED
U51505TN2010P
Corporate identity number LC077105
Permanent account number of entity AAECR9103Q
(A) 6th floor, EA
chambers Tower
I, No. 49, 50L,
Whites Road,
Royapettah,
Chennai, Tamil
Nadu - 600014,
Address of registered office of company India
Commercial and
Type of industry Industrial
Registration date 24/08/2010
Company limited
by shares / Indian
Non-Government
Category/sub-category of company company
Whether company is listed company No
(B) TRESARA
HEALTH
Name of parent entity LIMITED
RELIANCE
INDUSTRIES
Name of ultimate parent of group LIMITED
Disclosure of document information [Abstract]
Date of board meeting when final accounts were approved 19/04/2022
Period covered by financial statements 12 Months 12 Months
Date of start of reporting period 01/04/2021 01/04/2020
Date of end of reporting period 31/03/2022 31/03/2021
Nature of report standalone consolidated Standalone
Financial
Content of report Statements
Description of presentation currency INR
Level of rounding used in financial statements Lakhs
Type of cash flow statement Indirect Method
Disclosure of other general information [Abstract]
(C) Kfin
Technologies
Name of registrar and transfer agent Limited
Selenium Tower
B, Plot no.31 - 32,
Gachibowli,
Financial District,
Nanakramguda,
Hyderabad – 500
Address and contact details of registrar and transfer agent 032
Whether company is maintaining books of account and other relevant books and papers in electronic form Yes
Postal address of place of maintenance of computer servers (storing accounting data) [Abstract]
(D) 6th floor, EA
chambers Tower
I, No. 49, 50L,
Whites Road,
Royapettah,
Chennai, Tamil
Nadu - 600014,
Complete postal address of place of maintenance of computer servers (storing accounting data) India
Name of city of place of maintenance of computer servers (storing accounting data) Chennai
Name of state/ union territory of place of maintenance of computer servers (storing accounting data) Tamil Nadu
Pin code of place of maintenance of computer servers (storing accounting data) 600014
Name of district of place of maintenance of computer servers (storing accounting data) Chennai
ISO country code of place of maintenance of computer servers (storing accounting data) IND
123
Name of country of place of maintenance of computer servers (storing accounting data) India
Phone (with STD/ ISD code) of place of maintenance of computer servers (storing accounting data) 91-41-30254141
Footnotes
(A)
With effect from June 01, 2022
(B)
Formerly known as Tresara Health Private Limited
(C) Formerly known as Kfin Technologies Private Limited
(D)
With effect from June 01, 2022
Disclosure of principal product or services [Table]

Product or Services
Types of principal product or services [Axis] 1
Period FY 2022
Disclosure of principal product or services [Abstract]
Disclosure of principal product or services [Line Items]
Product or service category (ITC 4 digit) code 9983
Other
professional,
technical and
Description of product or service category business services
Turnover of product or service category 10,454.63
Highest turnover contributing product or service (ITC 8 digit) code 99839900
All other
professional,
technical and
Description of product or service business services
Unit of measurement of highest contributing product or service Value
Turnover of highest contributing product or service 10,454.63
124
[700400] Disclosures - Auditors report

Period FY 2022
Textual
Disclosure in auditor’s report explanatory [Text Block] Information (23)
Whether companies auditors report order is applicable on company Yes
Whether auditors' report has been qualified or has any reservations or contains adverse remarks No
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Table]

Auditor's Clause not
favourable remark applicable
Auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Axis] [Member] [Member]
Period FY 2022
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Abstract]
Disclosure of auditor's qualification(s), reservation(s) or adverse remark(s) in auditors' report [Line Items]
Textual
Disclosure in auditors report relating to fixed assets Information (24)
Textual
Disclosure relating to quantitative details of fixed assets Information (25)
Textual
Disclosure relating to physical verification and material discrepancies of fixed assets Information (26)
Textual
Disclosure relating to title deeds of immovable properties Information (27)
Textual
Disclosure in auditors report relating to inventories Information (28)
Textual
Disclosure in auditors report relating to loans Information (29)
Textual
Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies Act, 2013 Information (30)
The Company has
not accepted any
deposit or
amounts which
are deemed to be
deposits. Hence,
reporting under
clause (v) of the
Order is not
Disclosure in auditors report relating to deposits accepted applicable.
The maintenance
of cost records has
not been specified
by the Central
Government
under section
148(1) of the
Companies Act,
Disclosure in auditors report relating to maintenance of cost records 2013.
Textual
Disclosure in auditors report relating to statutory dues [Text Block] Information (31)
Textual
Disclosure relating to regularity in payment of undisputed statutory dues [Text Block] Information (32)
There are no
statutory dues
referred in
sub-clause (a)
above which have
not been deposited
on account of
disputes as on 31
Disclosure relating to disputed statutory dues [Text Block] March 2022.
Textual
Disclosure in auditors report relating to default in repayment of financial dues Information (33)
125
The Company has

not issued any of
its securities
(including debt
instruments)
during the year
and hence
reporting under
clause (x)(a) of
Disclosure in auditors report relating to public offer and term loans used for purpose for which those were the Order is not
raised applicable.
Disclosure in auditors report relating to fraud by the company or on the company by its officers or its Textual
employees reported during period Information (34)
Disclosure in auditors report relating to managerial remuneration -
The Company is
not a Nidhi
Company and
hence reporting
under clause (xii)
of the Order is not
Disclosure in auditors report relating to Nidhi Company applicable.
Textual
Disclosure in auditors report relating to transactions with related parties Information (35)
Disclosure in auditors report relating to preferential allotment or private placement of shares or convertible Textual
debentures Information (36)
Textual
Disclosure in auditors report relating to non-cash transactions with directors or persons connected with him Information (37)
Disclosure in auditors report relating to registration under section 45-IA of Reserve Bank of India Act, Textual
1934 Information (38)
Details regarding auditors [Table]

Auditors [Axis] Auditor 1
Period FY 2022
Details regarding auditors [Abstract]
Details regarding auditors [Line Items]
Category of auditor Auditors firm
DELOITTE
HASKINS &
Name of audit firm SELLS LLP
PALLAVI
MAHESH
Name of auditor signing report SHARMA
117366W/W-1000
Firms registration number of audit firm 18
Membership number of auditor 113861
Indiabulls Finance
Centre, Tower 3,
Senapati Bapat
Marg, Elphinstone
Road (West),
Mumbai,
Maharashtra -
Address of auditors 400013
Permanent account number of auditor or auditor's firm AACFD4815A
SRN of form ADT-1 R66898024
Date of signing audit report by auditors 19/04/2022
Date of signing of balance sheet by auditors 19/04/2022
Textual information (23): Disclosure in auditor’s report explanatory [Text Block]
INDEPENDENT AUDITOR'S REPORT

To The Members of Netmeds Marketplace Limited
Report on the Audit of the Financial Statements
Opinion
We have audited the accompanying financial statements of Netmeds Marketplace Limited (“the Company”), which comprise the Balance Sheet
as at 31 March 2022, and the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Cash Flows and the
Statement of Changes in Equity for the year then ended, and a summary of significant accounting policies and other explanatory information.
In our opinion and to the best of our information and according to the explanations given to us, the aforesaid financial statements give the
information required by the Companies Act, 2013 (“the Act”) in the manner so required and give a true and fair view in conformity with the Indian
126
Accounting Standards prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015, as
amended, (“Ind AS”) and other accounting principles generally accepted in India, of the state of affairs of the Company as at 31 March 2022, and
its profit and total comprehensive income, its cash flows and the changes in equity for the year ended on that date.
Basis for Opinion
We conducted our audit of the financial statements in accordance with the Standards on Auditing specified under section 143(10) of the Act
(SAs). Our responsibilities under those Standards are further described in the Auditor’s Responsibility for the Audit of the Financial Statements
section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered
Accountants of India (ICAI) together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of
the Act and the Rules made thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the
ICAI’s Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our audit opinion on
the financial statements.
Information Other than the Financial Statements and Auditor’s Report Thereon
• The Company’s Board of Directors is responsible for the other information. The other information comprises the information included in the
Directors report, but does not include the financial statements and our auditor’s report thereon.
• Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.
• In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the
other information is materially inconsistent with the financial statements or our knowledge obtained during the course of our audit or otherwise
appears to be materially misstated.
• If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report
that fact. We have nothing to report in this regard.
Management’s Responsibility for the Financial Statements
The Company's Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these
financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash
flows and changes in equity of the Company in accordance with the Ind AS and other accounting principles generally accepted in India. This
responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets
of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies;
making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial
controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and
presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is responsible for assessing the Company’s ability to continue as a going concern, disclosing,
as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate
the Company or to cease operations, or has no realistic alternative but to do so.
Those Board of Directors are also responsible for overseeing the Company’s financial reporting process.
Auditor’s Responsibility for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement,
whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is
not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can
arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the
economic decisions of users taken on the basis of these financial statements.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We
also:
• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit
procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of
not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery,
intentional omissions, misrepresentations, or the override of internal control.
• Obtain an understanding of internal financial control relevant to the audit in order to design audit procedures that are appropriate in the
circumstances. Under section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate
internal financial controls system in place and the operating effectiveness of such controls.
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the
management.
• Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained,
whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a
going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures
in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence
obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going
concern.
• Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial
statements represent the underlying transactions and events in a manner that achieves fair presentation.
Materiality is the magnitude of misstatements in the financial statements that, individually or in aggregate, makes it probable that the economic
decisions of a reasonably knowledgeable user of the financial statements may be influenced. We consider quantitative materiality and qualitative
factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified
misstatements in the financial statements.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant
audit findings, including any significant deficiencies in internal control that we identify during our audit.
127
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence,
and where applicable, related safeguards.
Report on Other Legal and Regulatory Requirements
1. As required by Section 143(3) of the Act, based on our audit, we report, that:
a. We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the
purposes of our audit.
b. In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those
books.
c. The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, the Statement of Cash Flows and Statement of
Changes in Equity dealt with by this Report are in agreement with the books of account.
d. In our opinion, the aforesaid financial statements comply with the Ind AS specified under Section 133 of the Act.
e. On the basis of the written representations received from the directors as on 31 March, 2022 taken on record by the Board of Directors, none
of the directors is disqualified as on 31 March 2022 from being appointed as a director in terms of Section 164(2) of the Act.
f. With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating effectiveness of such
controls, refer to our separate Report in “Annexure A”. Our report expresses an unmodified opinion on the adequacy and operating effectiveness
of the Company’s internal financial controls over financial reporting.
g. With respect to the other matters to be included in the Auditor’s report in accordance with the requirements of Section 197(16) of the Act, as
amended, in our opinion and to the best of our information and according to the explanations given to us, no remuneration is paid / payable by
the Company to its directors during the year in accordance with the provisions of section 197 of the Act.
h. With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and Auditors)
Rules, 2014, as amended in our opinion and to the best of our information and according to the explanations given to us:
i. The Company does not have any pending litigations which would impact its financial position.
ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.
iii. There were no amounts which were required to be transferred to the Investor Education and Protection Fund by the Company.
iv. a. The Management has represented that, to the best of its knowledge and belief, as disclosed in the notes to accounts, no funds (which are
material either individually or in the aggregate) have been advanced or loaned or invested (either from borrowed funds or share premium or any
other sources or kind of funds) by the Company to or in any other person or entity, including foreign entities.
b. The Management has represented, that, to the best of its knowledge and belief, as disclosed in the notes to accounts, no funds (which are
material either individually or in the aggregate) have been received by the Company from any person or entity, including foreign entities.
c. Based on the audit procedures that has been considered reasonable and appropriate in the circumstances, nothing has come to our notice
that has caused us to believe that the representations under sub-clause (i) and (ii) of Rule 11(e), as provided under (a) and (b) above, contain
any material mis-statement.
v. The Company has not declared or paid any dividend during the year and has not proposed final dividend for the year.
2. As required by the Companies (Auditor’s Report) Order, 2020 (“the Order”) issued by the Central Government in terms of Section 143(11) of
the Act, we give in “Annexure B” a statement on the matters specified in paragraphs 3 and 4 of the Order.
For DELOITTE HASKINS & SELLS LLP
Chartered Accountants
(Firm’s Registration No. 117366W/W-100018)
PALLAVI SHARMA
Partner
Membership No. 113861
UDIN: 22113861AHJBQL4139
Place: Mumbai
Date: 19 April 2022
ANNEXURE “A” TO THE INDEPENDENT AUDITOR’S REPORT
(Referred to in paragraph 1(f) under ‘Report on Other Legal and Regulatory Requirements’ section of our report of even date)
Report on the Internal Financial Controls Over Financial Reporting under Clause (i) of Sub-section 3 of Section 143 of the Companies Act, 2013
(“the Act”)
We have audited the internal financial controls over financial reporting of Netmeds Marketplace Limited (“the Company”), as of 31 March 2022 in
conjunction with our audit of the financial statements of the Company for the year ended on that date.
Management’s Responsibility for Internal Financial Controls
The Company’s management is responsible for establishing and maintaining internal financial controls based on the internal control over
financial reporting criteria established by the Company considering the essential components of internal control stated in the Guidance Note on
Audit of Internal Financial Controls Over Financial Reporting issued by the Institute of Chartered Accountants of India. These responsibilities
include the design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the
orderly and efficient conduct of its business, including adherence to company’s policies, the safeguarding of its assets, the prevention and
detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial
information, as required under the Companies Act, 2013.
Auditor’s Responsibility
Our responsibility is to express an opinion on the Company's internal financial controls over financial reporting of the Company based on our
audit. We conducted our audit in accordance with the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting (the
“Guidance Note”) issued by the Institute of Chartered Accountants of India and the Standards on Auditing prescribed under Section 143(10) of
the Companies Act, 2013, to the extent applicable to an audit of internal financial controls. Those Standards and the Guidance Note require that
128
we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether adequate internal financial
controls over financial reporting was established and maintained and if such controls operated effectively in all material respects.
Our audit involves performing procedures to obtain audit evidence about the adequacy of the internal financial controls system over financial
reporting and their operating effectiveness. Our audit of internal financial controls over financial reporting included obtaining an understanding of
internal financial controls over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk. The procedures selected depend on the auditor’s judgement, including the
assessment of the risks of material misstatement of the financial statements, whether due to fraud or error.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the Company’s
internal financial controls system over financial reporting.
Meaning of Internal Financial Controls Over Financial Reporting
A company's internal financial control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
A company's internal financial control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorisations of
management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorised
acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
Inherent Limitations of Internal Financial Controls Over Financial Reporting
Because of the inherent limitations of internal financial controls over financial reporting, including the possibility of collusion or improper
management override of controls, material misstatements due to error or fraud may occur and not be detected. Also, projections of any
evaluation of the internal financial controls over financial reporting to future periods are subject to the risk that the internal financial control over
financial reporting may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.
Opinion
In our opinion, to the best of our information and according to the explanations given to us, the Company has, in all material respects, an
adequate internal financial controls system over financial reporting and such internal financial controls over financial reporting were operating
effectively as at 31 March 2022, based on the criteria for internal financial control over financial reporting established by the Company
considering the essential components of internal control stated in the Guidance Note on Audit of Internal Financial Controls Over Financial
Reporting issued by the Institute of Chartered Accountants of India.
PALLAVI SHARMA
Partner
Place: Mumbai
Date: 19 April 2022
ANNEXURE B TO THE INDEPENDENT AUDITOR’S REPORT
(Referred to in paragraph 2 under ‘Report on Other Legal and Regulatory Requirements’ section of our report of even date)
In terms of the information and explanations sought by us and given by the Company and the books of account and records examined by us in
the normal course of audit and to the best of our knowledge and belief, we state that:
(i) (a) A. The Company has maintained proper records showing full particulars, including quantitative details and situation of the property, plant
and equipment.
B. The Company has maintained proper records showing full particulars of intangible assets.
(b) The property, plant and equipment were physically verified during the year by the Management which, in our opinion, provides for physical
verification at reasonable intervals. No material discrepancies were noticed on such verification.
(c) The Company does not have any immovable properties of freehold land or building. In respect of immovable properties that have been taken
on lease and disclosed in the financial statements as right-of-use assets, the lease agreements are in the name of the Company, where the
Company is the lessee in the agreement.
(d) The Company has not revalued any of its property, plant and equipment (including right of use assets) and intangible assets during the year.
(e) No proceedings have been initiated during the year or are pending against the Company as at 31 March 2022 for holding any benami
property under the Benami Transactions (Prohibition) Act, 1988 (as amended in 2016) and rules made thereunder.
(ii) (a) The Company does not have any inventory and hence reporting under clause (ii)(a) of the Order is not applicable.
(b) According to the information and explanations given to us, at any point of time of the year, the Company has not been sanctioned any working
capital facility from banks or financial institutions and hence reporting under clause (ii)(b) of the Order is not applicable.
(iii) The Company has made investments in mutual funds (other parties). The Company has not made any investments in companies, firms,
Limited Liability Partnerships. The Company has not provided any guarantee or security, and granted any loans or advances in the nature of
loans, secured or unsecured, to companies, firms, Limited Liability Partnerships or any other parties during the year, in respect of which:
a) The Company has not provided any loans or advances in the nature of loans or stood guarantee, or provided security to any other entity
during the year, and hence reporting under clause (iii)(a) of the Order is not applicable.
b) The investments made during the year are, in our opinion, prima facie, not prejudicial to the Company’s interest.
c) The Company has not provided any loans or advances in the nature of loans, and hence reporting under clause (iii)(c) of the Order is not
applicable.
129
d) According to the information and explanations given to us, the Company has not provided any loans or advances in the nature of loans, and
hence reporting under clause (iii)(d) of the Order is not applicable.
e) No loan or advance in the nature of loan granted by the Company, hence reporting under clause (iii)(e) is not applicable.
f) According to information and explanations given to us and based on the audit procedures performed, the Company has not granted any loans
or advances in the nature of loans either repayable on demand or without specifying any terms or period of repayment during the year. Hence,
reporting under clause (iii)(f) is not applicable.
(iv) According to information and explanation given to us, the Company has not granted any loans, made investments or provided guarantees or
securities that are covered under the provisions of sections 185 or 186 of the Companies Act, 2013, and hence reporting under clause (iv) of the
Order is not applicable
(v) The Company has not accepted any deposit or amounts which are deemed to be deposits. Hence, reporting under clause (v) of the Order is
not applicable.
(vi) The maintenance of cost records has not been specified by the Central Government under section 148(1) of the Companies Act, 2013.
(vii) According to the information and explanations given to us, in respect of statutory dues:
(a) Undisputed statutory dues, including Goods and service tax, Provident Fund, Employees’ State Insurance, Income-tax, sales tax, service tax,
cess and other material statutory dues applicable to the Company have been regularly in deposited by it with the appropriate authorities in all
cases during the year. We have been informed that the provisions of duty of Custom, duty of Excise, Value Added Tax are not applicable to the
Company.
There were no undisputed amounts payable in respect of Goods and service tax, Provident Fund, Employees’ State Insurance, Income-tax,
sales tax, service tax, cess and other material statutory dues in arrears as at 31 March 2022 for a period of more than six months from the date
they became payable.
(b) There are no statutory dues referred in sub-clause (a) above which have not been deposited on account of disputes as on 31 March 2022.
(viii) There were no transactions relating to previously unrecorded income that were surrendered or disclosed as income in the tax assessments
under the Income Tax Act, 1961 (43 of 1961) during the year.
(ix) (a) The Company has not taken any loans or other borrowings from any lender. Hence reporting under clause (ix)(a) of the Order is not
applicable to the Company.
(b) The Company has not been declared wilful defaulter by any bank or financial institution or government or any government authority.
(c) To the best of our knowledge and belief, in our opinion, term loans availed by the Company were, applied by the Company during the year for
the purposes for which the loans were obtained
(d) On an overall examination of the financial statements of the Company, the funds raised on short-term basis have, prima facie, not been used
during the year for long-term purposes by the Company.
(e) The Company has not made any investment in or given any new loan or advances to its subsidiary and did not have any associate or joint
venture during the year and hence, reporting under clause (ix)(e) of the Order is not applicable.
(f) The Company has not raised any loans during the year and hence reporting on clause (ix)(f) of the Order is not applicable.
(x) (a) The Company has not issued any of its securities (including debt instruments) during the year and hence reporting under clause (x)(a) of
the Order is not applicable.
(b) During the year the Company has not made any preferential allotment or private placement of shares or convertible debentures (fully or partly
or optionally) and hence reporting under clause (x)(b) of the Order is not applicable to the Company.
(xi) (a) To the best of our knowledge, no fraud by the Company and no material fraud on the Company has been noticed or reported during the
year.
(b) To the best of our knowledge, no report under sub-section (12) of section 143 of the Companies Act has been filed in Form ADT-4 as
prescribed under rule 13 of Companies (Audit and Auditors) Rules, 2014 with the Central Government, during the year and up to the date of this
report.
(c) As represented to us by the Management, there were no whistle blower complaints received by the Company during the year.
(xii) The Company is not a Nidhi Company and hence reporting under clause (xii) of the Order is not applicable.
(xiii) In our opinion, the Company is in compliance with Section 177 and 188 of the Companies Act, where applicable, for all transactions with the
related parties and the details of related party transactions have been disclosed in the financial statements etc. as required by the applicable
accounting standards
(xiv) In our opinion and according to the information and explanations given to us, the Company is not required to have an internal audit under
Section 138 of the Companies Act, hence reporting under clause (xiv) of the Order is not applicable.
(xv) In our opinion during the year the Company has not entered into any non-cash transactions with any of its directors or directors of its holding
company, subsidiary company or persons connected with such directors and hence provisions of section 192 of the Companies Act, 2013 are not
(xvi) The Company is not required to be registered under section 45-IA of the Reserve Bank of India Act, 1934. Hence reporting under clause
(xvi)(a), (b) and (c) of the Order is not applicable.
The Group does not have any Core Investment Company (CIC) as part of the Group as per the definition of Group contained in the Core
Investment Companies (Reserve Bank) Directions, 2016 and hence the reporting under clause (xvi)(d) of the Order is not applicable.
(xvii) The Company has not incurred cash losses during the financial year covered by our audit and the immediately preceding financial year.
(xviii) There has been no resignation of the statutory auditors of the Company during the year.
(xix) On the basis of the financial ratios, ageing and expected dates of realization of financial assets and payment of financial liabilities, other
information accompanying the financial statements and our knowledge of the Board of Directors and Management plans and based on our
examination of the evidence supporting the assumptions, nothing has come to our attention, which causes us to believe that any material
uncertainty exists as on the date of the audit report indicating that Company is not capable of meeting its liabilities existing at the date of balance
sheet as and when they fall due within a period of one year from the balance sheet date. We, however, state that this is not an assurance as to
130
the future viability of the Company. We further state that our reporting is based on the facts up to the date of the audit report and we neither give
any guarantee nor any assurance that all liabilities falling due within a period of one year from the balance sheet date, will get discharged by the
Company as and when they fall due.
(xx) The Company was not having net worth of rupees five hundred crore or more, or turnover of rupees one thousand crore or more or a net
profit of rupees five crore or more during the immediately preceding financial year and hence, provisions of Section 135 of the Act are not
applicable to the Company during the year. Accordingly, reporting under clause (xx) of the Order is not applicable for the year.
PALLAVI SHARMA
Partner
Place: Mumbai
Date: 19 April 2022
Textual information (24): Disclosure in auditors report relating to fixed assets
(a) A. The Company has maintained proper records showing full particulars, including quantitative details and situation of the property, plant and
equipment.
(b) The property, plant and equipment were physically verified during the year by the Management which, in our opinion, provides for physical
(c) The Company does not have any immovable properties of freehold land or building. In respect of immovable properties that have been taken
on lease and disclosed in the financial statements as right-of-use assets, the lease agreements are in the name of the Company, where the
(d) The Company has not revalued any of its property, plant and equipment (including right of use assets) and intangible assets during the year.
(e) No proceedings have been initiated during the year or are pending against the Company as at 31 March 2022 for holding any benami
property under the Benami Transactions (Prohibition) Act, 1988 (as amended in 2016) and rules made thereunder.
Textual information (25): Disclosure relating to quantitative details of fixed assets
A. The Company has maintained proper records showing full particulars, including quantitative details and situation of the property, plant and
equipment.
Textual information (26): Disclosure relating to physical verification and material discrepancies of fixed assets
The property, plant and equipment were physically verified during the year by the Management which, in our opinion, provides for physical
Textual information (27): Disclosure relating to title deeds of immovable properties
The Company does not have any immovable properties of freehold land or building. In respect of immovable properties that have been taken on
lease and disclosed in the financial statements as right-of-use assets, the lease agreements are in the name of the Company, where the
Textual information (28): Disclosure in auditors report relating to inventories
(a) The Company does not have any inventory and hence reporting under clause (ii)(a) of the Order is not applicable.
(b) According to the information and explanations given to us, at any point of time of the year, the Company has not been sanctioned any working
capital facility from banks or financial institutions and hence reporting under clause (ii)(b) of the Order is not applicable.
Textual information (29): Disclosure in auditors report relating to loans
(iii) The Company has made investments in mutual funds (other parties). The Company has not made any investments in companies, firms,
Limited Liability Partnerships. The Company has not provided any guarantee or security, and granted any loans or advances in the nature of
loans, secured or unsecured, to companies, firms, Limited Liability Partnerships or any other parties during the year, in respect of which:
a) The Company has not provided any loans or advances in the nature of loans or stood guarantee, or provided security to any other entity
during the year, and hence reporting under clause (iii)(a) of the Order is not applicable.
b) The investments made during the year are, in our opinion, prima facie, not prejudicial to the Company’s interest.
c) The Company has not provided any loans or advances in the nature of loans, and hence reporting under clause (iii)(c) of the Order is not
applicable.
131
d) According to the information and explanations given to us, the Company has not provided any loans or advances in the nature of loans, and
hence reporting under clause (iii)(d) of the Order is not applicable.
e) No loan or advance in the nature of loan granted by the Company, hence reporting under clause (iii)(e) is not applicable.
f) According to information and explanations given to us and based on the audit procedures performed, the Company has not granted any loans
or advances in the nature of loans either repayable on demand or without specifying any terms or period of repayment during the year. Hence,
reporting under clause (iii)(f) is not applicable.
Textual information (30): Disclosure in auditors report relating to compliance with Section 185 and 186 of Companies
Act, 2013
According to information and explanation given to us, the Company has not granted any loans, made investments or provided guarantees or
securities that are covered under the provisions of sections 185 or 186 of the Companies Act, 2013, and hence reporting under clause (iv) of the
Order is not applicable
Textual information (31): Disclosure in auditors report relating to statutory dues [Text Block]
According to the information and explanations given to us, in respect of statutory dues:
(a) Undisputed statutory dues, including Goods and service tax, Provident Fund, Employees’ State Insurance, Income-tax, sales tax, service tax,
Company.
(b) There are no statutory dues referred in sub-clause (a) above which have not been deposited on account of disputes as on 31 March 2022.
Textual information (32): Disclosure relating to regularity in payment of undisputed statutory dues [Text Block]
Undisputed statutory dues, including Goods and service tax, Provident Fund, Employees’ State Insurance, Income-tax, sales tax, service tax,
Company.
Textual information (33): Disclosure in auditors report relating to default in repayment of financial dues
(a) The Company has not taken any loans or other borrowings from any lender. Hence reporting under clause (ix)(a) of the Order is not
(b) The Company has not been declared wilful defaulter by any bank or financial institution or government or any government authority.
(c) To the best of our knowledge and belief, in our opinion, term loans availed by the Company were, applied by the Company during the year for
the purposes for which the loans were obtained
(d) On an overall examination of the financial statements of the Company, the funds raised on short-term basis have, prima facie, not been used
during the year for long-term purposes by the Company.
(e) The Company has not made any investment in or given any new loan or advances to its subsidiary and did not have any associate or joint
venture during the year and hence, reporting under clause (ix)(e) of the Order is not applicable.
(f) The Company has not raised any loans during the year and hence reporting on clause (ix)(f) of the Order is not applicable.
Textual information (34): Disclosure in auditors report relating to fraud by the company or on the company by its
officers or its employees reported during period
(a) To the best of our knowledge, no fraud by the Company and no material fraud on the Company has been noticed or reported during the year.
(b) To the best of our knowledge, no report under sub-section (12) of section 143 of the Companies Act has been filed in Form ADT-4 as
prescribed under rule 13 of Companies (Audit and Auditors) Rules, 2014 with the Central Government, during the year and up to the date of this
report.
(c) As represented to us by the Management, there were no whistle blower complaints received by the Company during the year.
Textual information (35): Disclosure in auditors report relating to transactions with related parties
132
In our opinion, the Company is in compliance with Section 177 and 188 of the Companies Act, where applicable, for all transactions with the
related parties and the details of related party transactions have been disclosed in the financial statements etc. as required by the applicable
accounting standards
Textual information (36): Disclosure in auditors report relating to preferential allotment or private placement of shares
or convertible debentures
During the year the Company has not made any preferential allotment or private placement of shares or convertible debentures (fully or partly or
optionally) and hence reporting under clause (x)(b) of the Order is not applicable to the Company.
Textual information (37): Disclosure in auditors report relating to non-cash transactions with directors or persons
connected with him
In our opinion during the year the Company has not entered into any non-cash transactions with any of its directors or directors of its holding
company, subsidiary company or persons connected with such directors and hence provisions of section 192 of the Companies Act, 2013 are not
Textual information (38): Disclosure in auditors report relating to registration under section 45-IA of Reserve Bank of
India Act, 1934
The Company is not required to be registered under section 45-IA of the Reserve Bank of India Act, 1934. Hence reporting under clause (xvi)(a),
(b) and (c) of the Order is not applicable.
The Group does not have any Core Investment Company (CIC) as part of the Group as per the definition of Group contained in the Core
Investment Companies (Reserve Bank) Directions, 2016 and hence the reporting under clause (xvi)(d) of the Order is not applicable.
133
[700500] Disclosures - Signatories of financial statements
Details of directors signing financial statements [Table]

Directors signing financial statements [Axis] Director 1 Director 2 Director 3
Period FY 2022
Details of directors signing financial statements [Abstract]
Details of directors signing financial statements [Line Items]
Name of director signing financial statements [Abstract]
First name of director MOHANCHAND JETHUSINGH ADVAIT
Middle name of director PRADEEP SOHAN SINGH SUHAS
Last name of director DADHA BHATI PANDIT
Designation of director Director Director Director
Director identification number of director 00087519 00104046 02972886
Date of signing of financial statements by director 19/04/2022 19/04/2022 19/04/2022
134
[700600] Disclosures - Directors report

Period FY 2022
Textual
Disclosure in board of directors report explanatory [Text Block] Information (39)
Textual
Description of state of companies affair Information (40)
The Board of
Directors of the
Company has not
transferred any
amount to the
Reserves for the
Disclosure relating to amounts if any which is proposed to carry to any reserves year under review.
The Board of
Directors of the
Company has not
recommended any
dividend on the
equity shares of
the Company for
the financial year
Disclosures relating to amount recommended to be paid as dividend under review.
Textual
Details regarding energy conservation Information (41)
Textual
Details regarding technology absorption Information (42)
The Foreign
Exchange earned
in terms of Actual
Inflows: Rs.
19,215; The
Foreign Exchange
outgo in terms of
Actual Outflows:
Details regarding foreign exchange earnings and outgo Rs. 60,33,845.
Textual
Disclosures in director’s responsibility statement Information (43)
There have been
no material
changes and
commitments
affecting the
financial position
of the Company
between the end
of the Financial
Period and date of
Details of material changes and commitment occurred during period affecting financial position of company this Report.
During the
financial year
under review,
there were no
investments made,
loans given or
guarantees given
or securities
provided by the
Company in terms
of Section 186 of
Particulars of loans guarantee investment under section 186 [Text Block] the Act.
Textual
Particulars of contracts/arrangements with related parties under section 188(1) [Text Block] Information (44)
Disclosure of extract of annual return as provided under section 92(3) [Text Block] Not Applicable
Disclosure of statement on declaration given by independent directors under section 149(6) [Text Block] Not Applicable
Disclosure for companies covered under section 178(1) on directors appointment and remuneration including other matters
provided under section 178(3) [Text Block] Not Applicable
Textual
Disclosure of statement on development and implementation of risk management policy [Text Block] Information (45)
Details on policy development and implementation by company on corporate social responsibility initiatives taken during year
[Text Block] Not Applicable
135
Textual
Disclosure of financial summary or highlights [Text Block] Information (46)
There has been no
change in the
nature of business
Disclosure of change in nature of business [Text Block] of the Company
Textual
Details of directors or key managerial personnels who were appointed or have resigned during year [Text Block] Information (47)
During the
financial year
under review, no
company has
become or ceased
to be the Compan
y’s
subsidiary, joint
venture or
Disclosure of companies which have become or ceased to be its subsidiaries, joint ventures or associate companies during year associate
[Text Block] company.
Textual
Details relating to deposits covered under chapter v of companies act [Text Block] Information (48)
Details of deposits which are not in compliance with requirements of chapter v of act [Text Block] Not Applicable
No significant or
material orders
were passed by
the Regulators or
Courts or
Tribunals, which
impact the going
concern status and
the Company&#8
Details of significant and material orders passed by regulators or courts or tribunals impacting going concern status and 217;s operations
company’s operations in future [Text Block] in future.
Textual
Details regarding adequacy of internal financial controls with reference to financial statements [Text Block] Information (49)
Textual
Disclosure of appointment and remuneration of director or managerial personnel if any, in the financial year [Text Block] Information (50)
Number of meetings of board [pure] 4
Details of principal business activities contributing 10% or more of total turnover of company [Table]
Product/service 1
Principal business activities of company [Axis] [Member]
Period FY 2022
Details of principal business activities contributing 10% or more of total turnover of company [Abstract]
Details of principal business activities contributing 10% or more of total turnover of company [Line Items]
Other
professional,
scientific and
technical activities
Name of main product/service n.e.c
Technical Support
Description of main product/service Services
NIC code of product/service 74909
Percentage to total turnover of company 97.01%
Details of directors signing board report [Table]

Directors signing board report [Axis] Director 1 Director 2
Period FY 2022
Details of signatories of board report [Abstract]
Details of directors signing board report [Line Items]
Name of director signing board report [Abstract]
First name of director MOHANCHAND ADVAIT
Middle name of director PRADEEP SUHAS
Last name of director DADHA PANDIT
Designation of director Director Director
Director identification number of director 00087519 02972886
Date of signing board report 19/04/2022 19/04/2022
136
Textual information (39): Disclosure in board of directors report explanatory [Text Block]
BOARD’S REPORT
Dear Members,
The Board of Directors present the Company’s Twelfth Annual Report and the Company’s audited financial statement for the financial year
ended March 31, 2022.
Financial Results
The Company’s financial performance for the financial year ended March 31, 2022 is summarized below:
(Rs. in Lakh) (Rs. in Lakh)
Particulars 2021-22 2020-21
Revenue from operations 10,776.96 13,423.42
Other Income 371.76 1,700.34
Profit before Tax 1,057.69 104.77
Less: Current tax - -
Deferred tax - -
Profit for the year 1,057.69 104.76
Add: Other Comprehensive Income (OCI) 21.93 63.34
Total Comprehensive Income of the year 1,079.62 168.11
Add: Balance in Profit & Loss Account (46,284.15) (46,452.26)
Less: Appropriation - -
Closing balance (including other comprehensive income) (45,204.53) (46,284.15)
Transfer to Reserves
The Board of Directors of the Company has not transferred any amount to the Reserves for the year under review.
Results of operations and the state of Company’s affairs
During the year under review, the Company achieved a total income of Rs.11,148.72 Lakh as compared to Rs. 15,123.76 Lakh in the previous
year and earned a profit of Rs.1057.69 Lakh as compared to Rs. 104.77 Lakh in the previous year.
Dividend
The Board of Directors of the Company has not recommended any dividend on the equity shares of the Company for the financial year under
review.
Details of material changes from the end of financial year
There have been no material changes and commitments affecting the financial position of the Company between the end of the Financial Period
and date of this Report.
Debentures
During the financial year under review, the Company has redeemed 3,800 Optionally Fully Convertible Debentures allotted to Tresara Health
Limited.
Subsidiaries, Joint Ventures and Associate Companies
During the financial year under review, no company has become or ceased to be the Company’s subsidiary, joint venture or associate company.
Secretarial Standards
The Directors state that applicable Secretarial Standards, i.e. SS-1 and SS-2 relating to ‘Meetings of the Board of Directors’ and ‘General
Meetings’, respectively, have been followed by the Company.
Directors’ Responsibility Statement
Your Directors state that:
(a) in the preparation of the annual accounts for the financial year ended March 31, 2022, the applicable accounting standards read with
requirements set out under Schedule III to the Companies Act, 2013 (the “Act”), have been followed and there are no material departures from
the same;
(b) the Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs of the Company as at March 31, 2022 and of the profit of the Company for the
financial year ended on that date;
(c) the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
(d) the Directors have prepared the accounts on a ‘going concern’ basis; and
(e) the Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are
adequate and operating effectively.
Contracts or arrangements with Related Parties
All contracts /arrangements/transactions entered by the Company during the financial year with related parties were in its ordinary course of
business and on an arm’s length basis. During the financial year, the Company had not entered into any contract / arrangement / transaction with
137
related parties which is required to be reported in Form No. AOC-2 in terms of Section 134(3)(h) read with Section 188 of the Act and Rule 8(2) of
the Companies (Accounts) Rules, 2014.
Members may refer to Note no. 32 to the financial statement which sets out related party disclosures pursuant to Indian Accounting Standards.
Risk Management
The Company has in place a Risk Management Policy which provides for a robust risk management framework to identify and assess risks such
as operational, financial, regulatory and other risks. There is an adequate risk management infrastructure in place capable of addressing these
risks.
The Company manages monitors and reports on the principal risks and uncertainties that can impact its ability to achieve its strategic objectives.
The Company’s management systems, organisational structures, processes, standards, code of conduct and behaviours together form the
Reliance Management System (RMS) that governs how the Company conducts the business and manages associated risks.
Internal Financial Control
Internal Financial Controls are an integrated part of the risk management process, addressing financial and financial reporting risks. The internal
financial controls have been documented, digitised and embedded in the business processes.
Assurance on the effectiveness of internal financial controls is obtained through 3 Lines of Defence which include:
(a) Management reviews and control self-assessment;
(b) Continuous control monitoring by functional experts;
(c) Testing of the internal financial control systems by the statutory auditors during the course of their audit.
The Company believes that these systems provide reasonable assurance that the Company’s internal financial controls are designed effectively
and are operating as intended.
Directors
The members of the Company at their Annual General Meeting (“AGM”) held on September 15, 2021, appointed Shri Advait Suhas Pandit (DIN:
02972886) as Director of the Company.
In accordance with the provisions of the Act and the Articles of Association of the Company, Shri M Pradeep Dadha (DIN: 00087519), Director of
the Company retires by rotation at the ensuing AGM of the Company. The Board of Directors has recommended his re-appointment.
Statutory Auditors
M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, were appointed as Statutory Auditors of the Company for a term of 5 (five)
consecutive years at the Annual General Meeting held on September 30, 2020. The Auditors have confirmed that they are not disqualified from
continuing as Auditors of the Company.
The Notes on financial statements referred to in the Auditors’ Report are self-explanatory and do not call for any further comments. The Auditors’
Report does not contain any qualification, reservation or adverse remark or disclaimer.
Disclosures:
(I) Meetings of the Board
4 (Four) meetings of the Board of Directors were held during the financial year 2021-2022.
(II) Prevention of Sexual Harassment at Workplace
As per the requirements of the Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013 (“POSH Act”) and
Rules made thereunder, the Company has Internal Committee to address complaints against sexual harassment in accordance with the POSH
Act. The Company has in place Anti-Sexual Harassment Policy which ensures a free and fair enquiry process with clear timelines for resolution.
To build awareness in this area, the Company has been conducting online programme on a continuous basis. Further, there were no cases/
complaints filed during the financial year under review.
(III) Particulars of Loans given, Investments made, Guarantees given, and Securities provided.
During the financial year under review, there were no investments made, loans given or guarantees given or securities provided by the Company
in terms of Section 186 of the Act.
(IV) Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo
A. Conservation of Energy:
i) Steps taken or impact on conservation of energy:
Your Company is engaged in software development and support services and carries on its activities in an environmentally friendly and energy
efficient manner. Considering the nature of the Company’s business, there is no reporting to be made on conservation of energy in its operations.
The Company recognizes the importance of energy conservation in decreasing the adverse effects of global warming and climate change.
ii) Steps taken by the Company for utilising alternate sources of energy:
Considering the nature of Company’s business, the Company has not taken any special measures for utilising alternate sources of energy.
iii) The capital investment on energy conservation equipments:
The Company has not made any capital investment on energy conservation equipment.
B. Technology Absorption:
i) Efforts made towards technology absorption:
The Company has not entered into any technology agreement or collaborations.
ii) The benefits derived like product improvement, cost reduction, product development or import substitution: Not Applicable
iii) Information regarding imported technology (Imported during the last three years):
The Company has not imported any technology during the last three years.
iv) Expenditure incurred on Research and Development: Nil
C. Foreign Exchange Earnings and Outgo:
The Foreign Exchange earned in terms of Actual Inflows: Rs. 19,215; The Foreign Exchange outgo in terms of Actual Outflows: Rs. 60,33,845.
General
The Board of Directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these
item during the financial year under review:
138
1. Details relating to deposits covered under Chapter V of the Act.

2. Issue of equity shares with differential rights as to dividend, voting or otherwise.
3. Issue of shares (including sweat equity shares) to employees of the Company under any scheme.
4. The Company has not provided money for the purchase of its own shares by employees or by trustees for the benefit of employees.
5. No significant or material orders were passed by the Regulators or Courts or Tribunals, which impact the going concern status and the
Company’s operations in future.
6. No fraud has been reported by the Auditors to the Board of Directors of the Company.
7. Details as prescribed under Section 197(12) of the Act.
8. The Company is not required to maintain cost records in terms of section 148(1) of the Act.
9. There has been no change in the nature of business of the Company.
10. Reporting requirements under Rule 8(1) of the Companies (Accounts) Rules, 2014, as there were no subsidiary and/or associate company.
11. Constitution of CSR committee and spending towards Corporate Social Responsibility in terms of Section 135 of the Act.
12. There is no application made / proceeding pending under the Insolvency and Bankruptcy Code, 2016.
13. There was no instance of one-time settlement with any Banks or Financial Institutions.
Acknowledgement:
The Board of Directors places on records its sincere appreciation for the assistance and co-operation received from Banks, Government and
regulatory authorities, customers, vendors, and members during the year under review. Your Board take this opportunity to express deep sense
of appreciation for the committed services by the Company’s employees and executives.
For and on behalf of the Board of Directors
sd/-
M Pradeep Dadha Director
DIN: 00087519
Sd/-
Advait Suhas Pandit Director
DIN: 02972886
Date: April 19, 2022
Place: Chennai
Textual information (40): Description of state of companies affair
During the year under review, the Company achieved a total income of Rs.11,148.72 Lakh as compared to Rs. 15,123.76 Lakh in the previous
year and earned a profit of Rs.1057.69 Lakh as compared to Rs. 104.77 Lakh in the previous year.
Textual information (41): Details regarding energy conservation
Conservation of Energy:
i) Steps taken or impact on conservation of energy:
Your Company is engaged in software development and support services and carries on its activities in an environmentally friendly and energy
efficient manner. Considering the nature of the Company’s business, there is no reporting to be made on conservation of energy in its operations.
The Company recognizes the importance of energy conservation in decreasing the adverse effects of global warming and climate change.
ii) Steps taken by the Company for utilising alternate sources of energy:
Considering the nature of Company’s business, the Company has not taken any special measures for utilising alternate sources of energy.
iii) The capital investment on energy conservation equipments:
The Company has not made any capital investment on energy conservation equipment.
Textual information (42): Details regarding technology absorption
Technology Absorption:
i) Efforts made towards technology absorption:
The Company has not entered into any technology agreement or collaborations.
ii) The benefits derived like product improvement, cost reduction, product development or import substitution: Not Applicable
iii) Information regarding imported technology (Imported during the last three years):
The Company has not imported any technology during the last three years.
iv) Expenditure incurred on Research and Development: Nil
Textual information (43): Disclosures in director’s responsibility statement
Your Directors state that:

(a) in the preparation of the annual accounts for the financial year ended March 31, 2022, the applicable accounting standards read with
139
requirements set out under Schedule III to the Companies Act, 2013 (the “Act”), have been followed and there are no material departures from
the same;
(b) the Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs of the Company as at March 31, 2022 and of the profit of the Company for the
financial year ended on that date;
(c) the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of
the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
(d) the Directors have prepared the accounts on a ‘going concern’ basis; and
(e) the Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are
adequate and operating effectively.
Textual information (44): Particulars of contracts/arrangements with related parties under section 188(1) [Text Block]
All contracts /arrangements/transactions entered by the Company during the financial year with related parties were in its ordinary course of
business and on an arm’s length basis. During the financial year, the Company had not entered into any contract / arrangement / transaction with
related parties which is required to be reported in Form No. AOC-2 in terms of Section 134(3)(h) read with Section 188 of the Act and Rule 8(2) of
the Companies (Accounts) Rules, 2014.
Members may refer to Note no. 32 to the financial statement which sets out related party disclosures pursuant to Indian Accounting Standards.
Textual information (45): Disclosure of statement on development and implementation of risk management policy [Text
Block]
The Company has in place a Risk Management Policy which provides for a robust risk management framework to identify and assess risks such
as operational, financial, regulatory and other risks. There is an adequate risk management infrastructure in place capable of addressing these
risks.
The Company manages monitors and reports on the principal risks and uncertainties that can impact its ability to achieve its strategic objectives.
The Company’s management systems, organisational structures, processes, standards, code of conduct and behaviours together form the
Reliance Management System (RMS) that governs how the Company conducts the business and manages associated risks.
Textual information (46): Disclosure of financial summary or highlights [Text Block]
Financial Results
The Company’s financial performance for the financial year ended March 31, 2022 is summarized below:
(Rs. in Lakh) (Rs. in Lakh)
Particulars 2021-22 2020-21
Revenue from operations 10,776.96 13,423.42
Other Income 371.76 1,700.34
Profit before Tax 1,057.69 104.77
Less: Current tax - -
Deferred tax - -
Profit for the year 1,057.69 104.76
Add: Other Comprehensive Income (OCI) 21.93 63.34
Total Comprehensive Income of the year 1,079.62 168.11
Add: Balance in Profit & Loss Account (46,284.15) (46,452.26)
Less: Appropriation - -
Closing balance (including other comprehensive income) (45,204.53) (46,284.15)
Textual information (47): Details of directors or key managerial personnels who were appointed or have resigned
during year [Text Block]
The members of the Company at their Annual General Meeting (“AGM”) held on September 15, 2021, appointed Shri Advait Suhas Pandit (DIN:
02972886) as Director of the Company.
In accordance with the provisions of the Act and the Articles of Association of the Company, Shri M Pradeep Dadha (DIN: 00087519), Director of
the Company retires by rotation at the ensuing AGM of the Company. The Board of Directors has recommended his re-appointment.
140
Textual information (48): Details relating to deposits covered under chapter v of companies act [Text Block]
Details relating to deposits covered under Chapter V of the Act.
Textual information (49): Details regarding adequacy of internal financial controls with reference to financial
statements [Text Block]
Internal Financial Controls are an integrated part of the risk management process, addressing financial and financial reporting risks. The internal
financial controls have been documented, digitised and embedded in the business processes.
Assurance on the effectiveness of internal financial controls is obtained through 3 Lines of Defence which include:
(a) Management reviews and control self-assessment;
(b) Continuous control monitoring by functional experts;
(c) Testing of the internal financial control systems by the statutory auditors during the course of their audit.
The Company believes that these systems provide reasonable assurance that the Company’s internal financial controls are designed effectively
and are operating as intended.
Textual information (50): Disclosure of appointment and remuneration of director or managerial personnel if any, in
the financial year [Text Block]
Details as prescribed under Section 197(12) of the Act.
141
[700700] Disclosures - Secretarial audit report

Period FY 2022
Whether secretarial audit report is applicable on company No
142

Netmeds Marketplace Limited Financial Statements for FY 2022

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Netmeds Marketplace Limited Financial Statements for FY 2022

Uploaded by

Copyright:

Available Formats

NETMEDS MARKETPLACE LIMITED

Standalone Financial Statements for period 01/04/2021 to 31/03/2022

[110000] Balance sheet

Unless otherwise specified, all monetary values are in Lakhs of INR

Borrowings, current 745.74 3,928.33

Property, plant and equipment 206.44

Right-of-use assets 13.06

Property, plant and equipment 155.54

Right-of-use assets 23.52

Property, plant and equipment 214.62

Right-of-use assets 9,469.35

Instruments classified as Equity 1,200.00

Reserves and surplus 832.10

Instruments classified as Equity 1,580.00

Reserves and surplus (247.52)

(H) Lease Liabilities

(I) Lease Liabilities

total outstanding dues of micro enterprises and small enterprises 16.53

total outstanding dues of micro enterprises and small enterprises 28.70

Lease Liabilities 11.13

Other Financial Liabilities 476.99

Lease Liabilities 10.06

Other Financial Liabilities 540.91

[210000] Statement of profit and loss

Unless otherwise specified, all monetary values are in Lakhs of INR

Income from Services 12,760.52

Less: GST Recovered 1,983.56

Revenue from Operations 10,776.96

Income from Services 15,833.02

Less: GST Recovered 2,409.60

Revenue from Operations 13,423.42

Earnings per share [Table]

[210000a] Statement of profit and loss

Unless otherwise specified, all monetary values are in Lakhs of INR

[310000] Cash flow statement,direct

Unless otherwise specified, all monetary values are in Lakhs of INR

(A) Proceeds from Sale of Financial instruments

(B) Proceeds from Sale of Financial instruments

(C) Purchase of Financial instruments

(D) Purchase of Financial instruments

(E) Deposits with bank (net)

(F) Deposits with bank (net)

(G) Equity Contribution

(H) Redemption of Debentures

[320000] Cash flow statement, indirect

Unless otherwise specified, all monetary values are in Lakhs of INR

(A) (Increase)/Decrease in other current and non-current assets

(B) (Increase)/Decrease in other current and non-current assets

(C) Interest income on refund of Income Tax

Unwinding of interest on security deposit (0.84)

Gain/ loss on Investment (17.18)

Unwinding of interest on security deposit (3.92)

Gain or loss on termination of lease (813.63)

Gain/ loss on Investment (1.50)

Net Gain on Financial Assets (1.74)

(F) Liabilities written back

Provision for financial guarantee contracts (210.40)

Provision for doubtful advances 24.71

Reversal of provision for doubtful balances (186.81)

Goodwill written off 9.40

Sundry Creditors written back (2.89)

(H) Proceeds from Sale of Financial instruments